<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions to improve adherence to inhaled steroids for asthma - Normansell, R - 2017 | Cochrane Library</title> <meta content="Interventions to improve adherence to inhaled steroids for asthma - Normansell, R - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012226.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions to improve adherence to inhaled steroids for asthma - Normansell, R - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012226.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012226.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Interventions to improve adherence to inhaled steroids for asthma" name="citation_title"/> <meta content="Rebecca Normansell" name="citation_author"/> <meta content="St George's, University of London" name="citation_author_institution"/> <meta content="rnormans@sgul.ac.uk" name="citation_author_email"/> <meta content="Kayleigh M Kew" name="citation_author"/> <meta content="BMJ Knowledge Centre" name="citation_author_institution"/> <meta content="Elizabeth Stovold" name="citation_author"/> <meta content="St George's, University of London" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD012226.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/04/18" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012226.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012226.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012226.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Medication Adherence; Administration, Inhalation; Adrenal Cortex Hormones [administration &amp; dosage]; Anti‐Asthmatic Agents [*administration &amp; dosage]; Asthma [*drug therapy]; Directly Observed Therapy; Disease Progression; Health Services Needs and Demand [statistics &amp; numerical data]; Patient Education as Topic; Quality of Life; Randomized Controlled Trials as Topic; Reminder Systems; Steroids [*administration &amp; dosage]; Time Factors" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012226.pub2&amp;doi=10.1002/14651858.CD012226.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="FKeXZrqu";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012226\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012226\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ms","pl","fr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012226.pub2",title:"Interventions to improve adherence to inhaled steroids for asthma",firstPublishedDate:"Apr 18, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Airways Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=FKeXZrqu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012226.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012226.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012226.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012226.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012226.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012226.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012226.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012226.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012226.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012226.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>7440 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012226.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-sec-0120"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-sec-0061"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-sec-0114"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/appendices#CD012226-sec-0125"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/table_n/CD012226StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/table_n/CD012226StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions to improve adherence to inhaled steroids for asthma</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/information#CD012226-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Rebecca Normansell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/information#CD012226-cr-0003">Kayleigh M Kew</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012226.pub2/information#CD012226-cr-0004">Elizabeth Stovold</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/information/en#CD012226-sec-0138">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 18 April 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012226.pub2">https://doi.org/10.1002/14651858.CD012226.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012226-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012226-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012226-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012226-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012226-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012226-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012226-abs-0001" lang="en"> <section id="CD012226-sec-0001"> <h3 class="title" id="CD012226-sec-0001">Background</h3> <p>Despite its proven efficacy in improving symptoms and reducing exacerbations, many patients with asthma are not fully adherent to their steroid inhaler. Suboptimal adherence leads to poorer clinical outcomes and increased health service utilisation, and has been identified as a contributing factor to a third of asthma deaths in the UK. Reasons for non‐adherence vary, and a variety of interventions have been proposed to help people improve treatment adherence. </p> </section> <section id="CD012226-sec-0002"> <h3 class="title" id="CD012226-sec-0002">Objectives</h3> <p>To assess the efficacy and safety of interventions intended to improve adherence to inhaled corticosteroids among people with asthma. </p> </section> <section id="CD012226-sec-0003"> <h3 class="title" id="CD012226-sec-0003">Search methods</h3> <p>We identified trials from the Cochrane Airways Trials Register, which contains studies identified through multiple electronic searches and handsearches of other sources. We also searched trial registries and reference lists of primary studies. We conducted the most recent searches on 18 November 2016. </p> </section> <section id="CD012226-sec-0004"> <h3 class="title" id="CD012226-sec-0004">Selection criteria</h3> <p>We included parallel and cluster randomised controlled trials of any duration conducted in any setting. We included studies reported as full‐text articles, those published as abstracts only and unpublished data. We included trials of adults and children with asthma and a current prescription for an inhaled corticosteroid (ICS) (as monotherapy or in combination with a long‐acting beta<sub>2</sub>‐agonist (LABA)). Eligible trials compared an intervention primarily aimed at improving adherence to ICS versus usual care or an alternative intervention. </p> </section> <section id="CD012226-sec-0005"> <h3 class="title" id="CD012226-sec-0005">Data collection and analysis</h3> <p>Two review authors screened the searches, extracted study characteristics and outcome data from included studies and assessed risk of bias. Primary outcomes were adherence to ICS, exacerbations requiring at least oral corticosteroids and asthma control. We graded results and presented evidence in 'Summary of findings' tables for each comparison. </p> <p>We analysed dichotomous data as odds ratios, and continuous data as mean differences or standardised mean differences, all using a random‐effects model. We described skewed data narratively. We made no a priori assumptions about how trials would be categorised but conducted meta‐analyses only if treatments, participants and the underlying clinical question were similar enough for pooling to make sense. </p> </section> <section id="CD012226-sec-0006"> <h3 class="title" id="CD012226-sec-0006">Main results</h3> <p>We included 39 parallel randomised controlled trials (RCTs) involving adults and children with asthma, 28 of which (n = 16,303) contributed data to at least one meta‐analysis. Follow‐up ranged from two months to two years (median six months), and trials were conducted mainly in high‐income countries. Most studies reported some measure of adherence to ICS and a variety of other outcomes such as quality of life and asthma control. Studies generally were at low or unclear risk of selection bias and at high risk of biases associated with blinding. We considered around half the studies to be at high risk for attrition bias and selective outcome reporting. </p> <p>We classified studies into four comparisons: adherence education versus control (20 studies); electronic trackers or reminders versus control (11 studies); simplified drug regimens versus usual drug regimens (four studies); and school‐based directly observed therapy (three studies). Two studies are described separately. </p> <p>All pooled results for adherence education, electronic trackers or reminders and simplified regimens showed better adherence than controls. Analyses limited to studies using objective measures revealed that adherence education showed a benefit of 20 percentage points over control (95% confidence interval (CI) 7.52 to 32.74; five studies; low‐quality evidence); electronic trackers or reminders led to better adherence of 19 percentage points (95% CI 14.47 to 25.26; six studies; moderate‐quality evidence); and simplified regimens led to better adherence of 4 percentage points (95% CI 1.88 to 6.16; three studies; moderate‐quality evidence). Our confidence in the evidence was reduced by risk of bias and inconsistency. </p> <p>Improvements in adherence were not consistently translated into observable benefit for clinical outcomes in our pooled analyses. None of the intervention types showed clear benefit for our primary clinical outcomes ‐ exacerbations requiring an oral corticosteroid (OCS) (evidence of very low to low quality) and asthma control (evidence of low to moderate quality); nor for our secondary outcomes ‐ unscheduled visits (evidence of very low to moderate quality) and quality of life (evidence of low to moderate quality). However, some individual studies reported observed benefits for OCS and use of healthcare services. Most school or work absence data were skewed and were difficult to interpret (evidence of low quality, when graded), and most studies did not specifically measure or report adverse events. </p> <p>Studies investigating the possible benefit of administering ICS at school did not measure adherence, exacerbations requiring OCS, asthma control or adverse events. One study showed fewer unscheduled visits, and another found no differences; data could not be combined. </p> </section> <section id="CD012226-sec-0007"> <h3 class="title" id="CD012226-sec-0007">Authors' conclusions</h3> <p>Pooled results suggest that a variety of interventions can improve adherence. The clinical relevance of this improvement, highlighted by uncertain and inconsistent impact on clinical outcomes such as quality of life and asthma control, is less clear. We have low to moderate confidence in these findings owing to concerns about risk of bias and inconsistency. Future studies would benefit from predefining an evidence‐based 'cut‐off' for acceptable adherence and using objective adherence measures and validated tools and questionnaires. When possible, covert monitoring and some form of blinding or active control may help disentangle effects of the intervention from effects of inclusion in an adherence trial. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012226-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012226-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012226-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012226-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012226-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012226-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD012226-abs-0007">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012226-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012226-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012226-abs-0004" lang="en"> <h3>Strategies to help people with asthma take their steroid inhaler as prescribed</h3> <p><b>Background to the question</b> </p> <p>Inhalers containing steroids improve asthma‐related symptoms and reduce asthma attacks when taken regularly. But many people with asthma do not take them as prescribed. This leads to more symptoms and flare‐ups, which have been linked to a third of asthma deaths in the UK. </p> <p>Missing doses is sometimes called 'non‐adherence'. Reasons for missing doses vary from person to person. For example, people often forget to take their inhaler or have a busy and unpredictable lifestyle that makes it difficult to fit this in. Some people do not appreciate the need for taking inhalers as prescribed. Some people choose to reduce or discontinue taking steroids. This can happen for many reasons, including side effects, fear of side effects or a perception that benefits do not outweigh disadvantages. </p> <p>The aim of this review was to find out whether strategies to help people with asthma take their steroid inhaler really work, and whether improved adherence leads to other benefits. </p> <p><b>Study characteristics</b> </p> <p>We found 39 studies including more than 16,000 adults and children with asthma who were taking a steroid inhaler. Most studies collected data at six months, so we can really apply the messages in this review only over six months ‐ we cannot say whether these methods are effective in a few years time, for example. We searched multiple sources for relevant studies. This review is current as of November 2016. </p> <p>Different studies tried different ways to help people take their inhaler more regularly. We grouped studies according to four ways of helping people take their inhaler: providing education about adherence (20 studies); using electronic monitoring or reminders to take the inhaler (11 studies); making the drug easier to take (e.g. once instead of twice a day, one inhaler instead of two) (four studies); and giving the inhaler during school hours (three studies). </p> <p>We mainly looked for whether strategies helped people to take their inhaler as prescribed, and whether people had fewer asthma attacks and better asthma control. </p> <p><b>Key results</b> </p> <p>People who were given education were better at taking their inhaler than controls; 20% more people took their treatment (likely to be somewhere between 8% and 33% more). Those given trackers or electronic reminders were 19% better at using their inhaler than controls (14% and 25%). People who were given an easier way of taking their inhaler (e.g. fewer times a day) were only 4% better than those who carried on as usual (2% and 6%). </p> <p>Unfortunately, these efforts to help people take their inhaler as prescribed generally did not lead to obvious benefit for things like asthma control and number of attacks, but in most cases, we could not tell either way. We also did not see a difference for quality of life or time people needed off school or work, but the evidence was often uncertain. </p> <p>Studies investigating the possible benefit of giving children their inhaler during school hours did not actually measure how often they missed doses. </p> <p><b>Quality of the evidence</b> </p> <p>It's difficult to tell whether these different strategies are worth using because studies were quite different from one other. This variation means that we cannot be sure what the real benefit is, beyond improving adherence. Sometimes we did not find enough studies to detect a difference between groups. The fact that most people knew which group they were in also reduced our confidence in the findings because this can affect things like how positively people respond to questionnaires. We had concerns about how many people dropped out of about half the studies, and we are uncertain whether studies reported everything they measured. </p> <p><b>Key message</b> </p> <p>The studies we found suggest that various strategies can help people with asthma take their inhaler better, compared with "control" (e.g. usual asthma care). However, many of these studies were quite different from one another, and we are not certain about whether people will find that their asthma is improved as a result of this approach. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012226-sec-0120" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012226-sec-0120"></div> <h3 class="title" id="CD012226-sec-0121">Implications for practice</h3> <section id="CD012226-sec-0121"> <p>Our findings suggest that interventions to improve ICS adherence in adults and children with asthma can increase adherence, whether objectively or subjectively measured. This finding was consistent across the three comparisons performed to measure this. The clinical relevance of this improvement, highlighted by uncertain and inconsistent impact on clinical outcomes such as quality of life and asthma control, is less clear. Overall, we have low to moderate confidence in these findings owing to concerns about risk of bias and inconsistency. </p> </section> <h3 class="title" id="CD012226-sec-0122">Implications for research</h3> <section id="CD012226-sec-0122"> <p>Guidelines for asthma management consistently call for routine discussion of adherence with patients, and evidence suggests that poor adherence may contribute to unfavourable outcomes. This fact emphasises the importance of research conducted to investigate interventions that may be recommended to practitioners and their patients. Future studies would benefit from ensuring that investigators use validated tools for outcome measurement, such as the Asthma Control Test (ACT), the Asthma Control Questionnaire (ACQ) and the Asthma Quality of Life Questionnaire (AQLQ), and provide adequate details regarding baseline asthma severity among participants. Given that our confidence in our findings was reduced by concerns about performance and detection biases, we suggest that some form of blinding or active control is important to include, when possible. This would help to elucidate the contribution of the intervention itself to improved adherence, beyond the potential benefit of inclusion in an adherence trial. It may be helpful for trialists to prespecify a threshold for 'acceptable' adherence and to perform a dichotomous analysis of those achieving this level and those not achieving it. The inconsistent impact observed in terms of clinical outcomes may have occurred because most participants did not achieve this threshold (Comparisons 1 and 2), or because baseline/control group adherence was already at a high level (Comparison 3). Targeting those at high risk or known to have poor adherence may provide evidence that is more 'useful' in the real world, which may be affected by budget constraints. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012226-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012226-sec-0029"></div> <div class="table" id="CD012226-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Adherence education compared with controls for asthma</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Adherence education compared with controls for asthma</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> asthma<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> adherence education<br/> <b>Comparison:</b> control group (no education) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="2" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with controls</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with adherence education</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>% Adherence</b> </p> <p>WMD of follow‐up 71.7 weeks (all studies)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Objective measures</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean adherence in the control group was <b>46.7%</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean adherence with adherence education was <b>20.13% higher</b> (7.52 higher to 32.74 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>280</p> <p>(5 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only studies in which adherence was measured with an electronic monitor</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>All measures</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean adherence in the control group was <b>57.1%</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean adherence with adherence education was <b>11.59% higher</b> (3.72 higher to 19.46 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1693<br/> (10 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Exacerbations requiring OCS</b> </p> <p>(people with 1 or more)</p> <p>WMD of follow‐up 30.8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>149 per 1000</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>242 per 1000</b> </p> <p>(148 to 370)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.82<br/> (0.99 to 3.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>349<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Asthma control (ACQ)</b> </p> <p>WMD of follow‐up 28.5 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean ACQ score was <b>1.52</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean score with adherence education was <b>0.03 better</b> (0.49 better to 0.43 worse) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>455<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>a,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates better control. Scale 0 to 6. MCID 0.5</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Asthma control (ACT)</b> </p> <p>WMD of follow‐up 29.5 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean ACT score was <b>18.88</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean score with adherence education was <b>0.30 better</b> <br/> (1.43 better to 0.82 worse) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>333<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>a,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicates better control. Scale 5 to 25. MCID 3</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Unsheduled visits to a healthcare provider</b> </p> <p>(people with 1 or more)</p> <p>WMD of follow‐up 67.2 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>159 per 1000</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>83 per 1000</b> <br/> (35 to 184) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.48<br/> (0.19 to 1.19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>688<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>a,b,d,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Includes visits to ED, GP, hospital for any cause</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Absenteeism</b> </p> <p>WMD of follow‐up 63.3 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>We did not perform an analysis of absences because the data were heavily skewed</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>109<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not graded</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Quality of life (AQLQ)</b> </p> <p>WMD of follow‐up 27.4 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean AQLQ score was <b>5</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean score with adherence education was <b>0.01 better</b> (0.20 worse to 0.23 better) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>734<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>a,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicates better QOL. Scale 1 to 7. MCID 0.5</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <br/> ACQ: Asthma Control Questionnaire; ACT: Asthma Control Test; AQLQ: Asthma Quality of Life Questionnaire; CI: confidence interval; ED: emergency department; GP: general practitioner; MCID: minimal clinically important difference; OCS: oral corticosteroid; OR: odds ratio; QOL: quality of life; RCT: randomised controlled trial; WMD: weighted mean duration </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to the estimate of effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of effect but may be substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>a</sup>Downgraded once primarily owing to risk of bias from open‐label trials and some concerns regarding attrition bias, selective reporting and selection bias (‐1 risk of bias) </p> <p><sup>b</sup>Downgraded once owing to inconsistency between study results (‐1 inconsistency) </p> <p><sup>c</sup>Funnel plot examined; no clear evidence of publication bias (no downgrade for publication bias) </p> <p><sup>d</sup>Confidence intervals include no difference and/or potential important harm or benefit of the intervention (‐1 imprecision) </p> <p><sup>e</sup>Confidence intervals fall within the established MCID for this scale (no downgrade for imprecision) </p> <p><sup>f</sup>Studies contributing to this analysis reported different types of unscheduled visits and some recorded visits for any cause rather than asthma alone (‐1 indirectness) </p> <p><sup>g</sup>Unclear how absenteeism was defined or reported, and different participants may have different thresholds for missing work or school. One study was conducted in children and the other in adults. Combined, this makes the outcome hard to interpret </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012226-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Electronic trackers or reminders (± feedback) compared with controls for asthma</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Electronic trackers or reminders (</b> ±<b>feedback) compared with controls for asthma</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> asthma<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> electronic trackers or reminders (± feedback)<br/> <b>Comparison:</b> control group </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="2" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with controls</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with electronic trackers or reminders (± feedback)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>% Adherence</b> </p> <p>WMD of follow‐up 47.6 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Objective measures only</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean adherence in the control group was <b>53.27%</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean adherence was <b>19.86% higher</b> (14.47 higher to 25.26 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>555</p> <p>(6 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only studies in which adherence was measured with an electronic monitor</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>All measures</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean adherence in the control group was <b>56.06%</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean adherence with trackers was <b>18.41% higher</b> (11.82 higher to 25.00 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>762</p> <p>(8 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Exacerbations requiring OCS</b> </p> <p>(people with at least 1)</p> <p>WMD of follow‐up 48.6 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>218 per 1000</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>169 per 1000</b> <br/> (94 to 280) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.72<br/> (0.37 to 1.39) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3063<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY <b>LOW</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Asthma control (ACQ)</b> </p> <p>WMD of follow‐up 43.0 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean ACQ score in the control group was <b>0.89</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean score with trackers or reminders was <b>0.24 better</b> (0.29 worse to 0.78 better) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>109<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates better control. Scale 0 to 6. MCID 0.5</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Asthma control (ACT)</b> </p> <p>WMD of follow‐up 34.0 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean ACT score in the control group was <b>20.04</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean score with trackers or reminders was <b>0.74 better</b> (0.20 worse to 1.69 better) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>596<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,b,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicates better control. Scale 5 to 25. MCID 3</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Unscheduled healthcare visits to a healthcare provider (ED)</b> </p> <p>WMD of follow‐up 50.0 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>84 per 1000</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95 per 1000</b> <br/> (75 to 119) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.14<br/> (0.88 to 1.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2918<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two studies (n = 2865) also reported hospitalisations. OR 0.97 (0.53 to 1.78)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Absenteeism</b> </p> <p>(people with at least 1 absence)</p> <p>Follow‐up 26 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>327 per 1000</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>409 per 1000</b> <br/> (285 to 546) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.42<br/> (0.82 to 2.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>220<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>c,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Quality of life (AQLQ)</b> </p> <p>WMD of follow‐up 36.8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean AQLQ score in the control group was <b>5.15</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean score with trackers or reminders was <b>0.03 worse</b> (0.13 better to 0.20 worse) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>369<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>a,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicated better QOL. Scale 1 to 7. MCID 0.5</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> ACQ: Asthma Control Questionnaire; ACT: Asthma Control Test; AQLQ: Asthma Quality of Life Questionnaire; CI: confidence interval; ED: emergency department; MCID: minimal clinically important difference; OCS: oral corticosteroid; OR: odds ratio; QOL: quality of life; RCT: randomised controlled trial; WMD: weighted mean duration </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to the estimate of effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of effect but may be substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>a</sup>Downgraded once primarily owing to risk of bias from open‐label trials and some concerns regarding attrition bias, selective reporting and selection bias (‐1 risk of bias) </p> <p><sup>b</sup>Downgraded once for inconsistency between study results (‐1 inconsistency) </p> <p><sup>c</sup>Confidence intervals include no difference and potential important harm and benefit of the intervention (‐1 imprecision) </p> <p><sup>d</sup>Confidence intervals fall within the MCID for this scale (no downgrade for imprecision) </p> <p><sup>e</sup>Downgraded once owing to risk of performance and detection bias (‐1 risk of bias) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012226-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Simplified compared with usual regimens for asthma</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Simplified compared with usual regimens for asthma</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> asthma<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> simplified regimens<br/> <b>Comparison:</b> usual regimens </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with usual regimens</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with simplified regimens</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>% Adherence (objective measures)</b> </p> <p>WMD of follow‐up 12.9 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean adherence in the control group was <b>86.73%</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean adherence with simplified regimens was <b>4.02%</b> higher<br/> (1.88 higher to 6.16 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1310<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only studies in which adherence was measured with an electronic monitor</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Exacerbations requiring OCS</b> </p> <p>People with 1 or more</p> <p>Follow‐up 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>125 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> <br/> (24 to 823) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 2.33<br/> (0.17 to 32.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asthma control (ACQ)</b> </p> <p>Follow‐up 24 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean ACQ score in the control group was <b>0.89</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean score with simplified regimens was <b>0.03 better</b> (0.34 better to 0.28 worse) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates better control. Scale 0 to 6. MCID 0.5</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unscheduled visits</b> </p> <p>Follow‐up 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>63 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>72 per 1000</b> <br/> (46 to 113) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.17<br/> (0.72 to 1.90) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1037<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Absence from work/school</b> </p> <p>Follow‐up 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> <br/> (7 to 43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.93<br/> (0.37 to 2.30) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1037<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in quality of life (ITG‐ASF)</b> </p> <p>Follow‐up 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change in quality of life in the control group was <b>14</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change with simplified regimens was <b>6 points better</b> <br/> (0.76 worse to 12.76 better) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1037<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicates better QOL. Range 0 to 100. MCID not known</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All adverse events</b> </p> <p>Follow‐up 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>175 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>139 per 1000</b> <br/> (106 to 181) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.76<br/> (0.56 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1233<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> ACQ: Asthma Control Questionnaire; CI: confidence interval; ITG‐ASF: Integrated Therapeutics Group ‐ Asthma Short Form; MCID: minimal clinically important difference; OCS: oral corticosteroid; OR: odds ratio; QOL: quality of life; RCT: randomised controlled trial; WMD: weighted mean duration </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to the estimate of effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of effect but may be substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded once primarily owing to lack of blinding and some concerns regarding attrition bias, selective reporting and selection bias (‐1 risk of bias) </p> <p><sup>b</sup>One very small trial resulting in very wide confidence intervals (‐2 imprecision) </p> <p><sup>c</sup>Although confidence intervals fall within the MCID, only one study contributed to this outcome (‐1 imprecision) </p> <p><sup>d</sup>Confidence intervals include both important potential harm and benefit of the intervention (‐1 imprecision) </p> <p><sup>e</sup>Confidence intervals do not exclude no difference (‐1 imprecision) </p> <p><sup>f</sup>Confidence intervals range from no difference to an important benefit of simplified regimens (‐1 imprecision) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012226-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">School‐based ICS therapy compared with home therapy for asthma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>School‐based ICS therapy compared with home therapy for asthma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> children with asthma </p> <p><b>Settings:</b> school </p> <p><b>Intervention:</b> ICS given at school </p> <p><b>Comparison:</b> ICS given at home </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>School‐based ICS therapy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unscheduled visits</b> </p> <p>1 or more hospitalisations for any cause</p> <p>WMD of follow‐up 35.8 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b> <br/> (8 to 96) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.58 (0.16 to 2.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>279<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life (PACQLQ)</b> </p> <p>1 to 7; higher is better</p> <p>WMD of follow‐up 35.8 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean PAQLQ score in the control group was <b>6.31</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean score in the intervention groups was<br/> <b>0.25 higher</b> (0.01 to 0.49 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>279<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝</p> <p><b>MODERATE</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> <p>Follow‐up 30 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>No events observed in either arm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not graded</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> CI: confidence interval; ICS: inhaled corticosteroid; OR: odds ratio; PAQLQ: Paediatric Asthma Quality of Life Questionnaire; RCT: randomised controlled trial; WMD: weighted mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>No data could be meta‐analysed for adherence, exacerbations requiring OCS, asthma control or absenteeism. Some data are presented narratively in the review </p> <p><sup>a</sup>Both contributing studies considered at high risk for performance and detection bias </p> <p><sup>b</sup>Confidence intervals include both potential harm and benefit of the intervention </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012226-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012226-sec-0030"></div> <section id="CD012226-sec-0031"> <h3 class="title" id="CD012226-sec-0031">Description of the condition</h3> <p>Asthma is a chronic breathing condition that affects more than 300 million adults and children worldwide (<a href="./references#CD012226-bbs2-0122" title="Global Asthma Network. The Global Asthma Report 2014. http://www.globalasthmareport.org/ (accessed 13 December 2016). [http://www.globalasthmareport.org/index.php (accessed 2 February 2016)] ">Global Asthma Report 2014</a>). Asthma can cause shortness of breath, chest tightness and cough and typically presents with wheezing. Many people with asthma experience intermittent worsening of their asthma symptoms, known as 'exacerbations', 'flare‐ups' or 'attacks' (<a href="./references#CD012226-bbs2-0121" title="Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2016. www.ginasthma.org (accessed 13 December 2016). [http://www.ginasthma.org/ (accessed 2 February 2016)] ">GINA 2016</a>). Approximately 20% of people with asthma have at some point been admitted to hospital or attended an emergency department for asthma treatment (<a href="./references#CD012226-bbs2-0139" title="RodrigoGJ , RodrigoC , HallJB . Acute asthma in adults. A review. Chest2004;125(3):1081‐102. ">Rodrigo 2004</a>). Attacks can be triggered by common irritants and allergens such as pollution, tobacco smoke, pollen and house dust mites (<a href="./references#CD012226-bbs2-0113" title="Centers for Disease Control and Prevention (CDC). Common asthma triggers. https://www.cdc.gov/asthma/triggers.html (accessed 13 December 2016). [http://www.cdc.gov/asthma/triggers.html (accessed 2 February 2016)] ">CDC 2016</a>). Asthma is under‐diagnosed and under‐treated worldwide. Most asthma‐related deaths occur in middle‐income and low‐income countries. Poorly controlled asthma places a huge burden on individuals, their families and society (<a href="./references#CD012226-bbs2-0141" title="World Health Organization. Asthma fact sheets. http://www.who.int/mediacentre/factsheets/fs307/en/ (accessed 13 December 2016). [http://www.who.int/mediacentre/factsheets/fs307/en/ (accessed 2 February 2016)] ">WHO 2013</a>). </p> <p>The mainstay of asthma treatment for all but the mildest cases consists of inhaled corticosteroids (ICSs) (<a href="./references#CD012226-bbs2-0104" title="BarnesPJ , PedersenS . Efficacy and safety of inhaled corticosteroids in asthma. American Review of Respiratory Diseases1993;148:1‐26. ">Barnes 1993</a>), which are also known as 'preventer' or 'controller' medications (i.e. the intention is that they are used once or twice daily (depending on the preparation), even when well, to maintain control over symptoms). Inhaled corticosteroids, which are delivered directly to a patient’s airways via an inhaler or a nebuliser, work by suppressing the multiple inflammatory cascades that are activated in the airways of a person with asthma. Inflammation leads to increased mucus production and airway constriction, which in turn contribute to symptoms of asthma. Reduction in underlying inflammation through sustained use of an ICS can result in symptom improvement and reduced asthma‐related morbidity and mortality (<a href="./references#CD012226-bbs2-0106" title="BarnesPJ , AdcockIM . How do corticosteroids work in asthma?. Annals of Internal Medicine2003;139:359‐70. ">Barnes 2003</a>; <a href="./references#CD012226-bbs2-0111" title="BårnesCB , UlrikSC . Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respiratory Care2015;60(3):455‐68. ">Bårnes 2015</a>). </p> <p>Inhaled corticosteroids commonly used today include budesonide, beclomethasone, fluticasone (propionate and furoate), mometasone and ciclesonide. They can be given alone or in combination with other preventer medications such as long‐acting beta<sub>2</sub>‐agonists (LABAs) or leukotriene receptor antagonists (LTRAs) (<a href="./references#CD012226-bbs2-0110" title="Joint Formulary Committee. British National Formulary (online). https://www.bnf.org/products/bnf‐online/ accessed 13 December 2016). [http://www.medicinescomplete.com (accessed 2 February 2016)] ">BNF</a>). </p> </section> <section id="CD012226-sec-0032"> <h3 class="title" id="CD012226-sec-0032">Description of the intervention</h3> <p>Despite its proven efficacy, many patients are not fully adherent to their prescribed ICS (<a href="./references#CD012226-bbs2-0111" title="BårnesCB , UlrikSC . Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respiratory Care2015;60(3):455‐68. ">Bårnes 2015</a>). Adherence is described by the World Health Organization (WHO) as "the degree to which use of medication by the patient corresponds with the prescribed regimen"; WHO emphasises the "diversity and complexity of adherence behaviour". In addition, patients with asthma may be fully adherent to preventer medication when symptomatic but poorly adherent when well (<a href="./references#CD012226-bbs2-0142" title="World Health Organization. Adherence to long‐term therapies. Evidence for action. http://www.who.int/chp/knowledge/publications/adherence_report/en/ (accessed 13 December 2016). [ISBN 92 4 154599 2] ">WHO Report 2003</a>). This may reflect the fact that, unlike rescue medication, which gives immediate relief of symptoms (i.e. a 'reliever' or 'rescue' inhaler containing a short‐acting beta<sub>2</sub>‐agonist (SABA) such as salbutamol), an ICS given for airway inflammation may take several weeks to provide maximal benefit. </p> <p>Reasons for non‐adherence to asthma therapies, including ICSs, vary among individuals. Commonly cited reasons include complexity of the treatment regimen; cost; administration route; and patient beliefs about therapy, including safety, necessity and risk of dependence. Lower socioeconomic status, inclusion in a minority ethnic group and fewer years of education have also been associated with reduced adherence (<a href="./references#CD012226-bbs2-0111" title="BårnesCB , UlrikSC . Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respiratory Care2015;60(3):455‐68. ">Bårnes 2015</a>; <a href="./references#CD012226-bbs2-0109" title="BenderBG , BenderSE . Patient‐identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunology and Allergy Clinics of North America2005;25(1):107‐30. ">Bender 2005</a>; <a href="./references#CD012226-bbs2-0114" title="ClarkN , JonesP , KellerS , VermiereI . Patient factors and compliance with asthma therapy. Respiratory Medicine1999;93:856‐62. ">Clark 1999</a>; <a href="./references#CD012226-bbs2-0115" title="CochraneGM , HorneR , ChanezI . Compliance in asthma. Respiratory Medicine1999;93:763‐9. ">Cochrane 1999</a>). </p> <p>Understanding the underlying reasons for non‐adherence is essential for tackling the problem. The <a href="./references#CD012226-bbs2-0142" title="World Health Organization. Adherence to long‐term therapies. Evidence for action. http://www.who.int/chp/knowledge/publications/adherence_report/en/ (accessed 13 December 2016). [ISBN 92 4 154599 2] ">WHO Report 2003</a> has subcategorised these reasons as follows. </p> <p> <ul id="CD012226-list-0001"> <li> <p>'Erratic non‐adherence' ‐ perhaps most common and largely the result of forgetfulness or a busy, unpredictable lifestyle. </p> </li> <li> <p>'Unwitting non‐adherence' ‐ usually the result of failure to appreciate the specifics of regimens or the need for adherence. </p> </li> <li> <p>'Intelligent non‐adherence' ‐ the result of a purposeful choice to reduce or discontinue ICS use for many reasons, including side effects, fear of side effects or a perception that the benefits do not outweigh the disadvantages. </p> </li> </ul> </p> <p>Similarly, <a href="./references#CD012226-bbs2-0126" title="HorneR , WeinmanJ . Self‐regulation and self‐management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non‐adherence to preventer medication. Psychology and Health2002;17:17‐32. ">Horne 2002</a>, which reported a cross‐sectional survey of people with asthma who completed validated questionnaires, identified that adherence was primarily associated with doubts about the necessity for the medication and concerns about the side effects of treatment. This study reported that a more negative perception of the consequences of illness is associated with poorer adherence to preventer medication. A possible explanation for this unexpected finding is that those who are already poorly adherent may be more likely to experience poorer asthma control and thus may rate the consequences of illness more negatively. </p> <p>Interventions to improve adherence to ICS may take many forms, including audiovisual reminders (<a href="./references#CD012226-bbs2-0009" title="CharlesT , QuinnD , WeatherallM , AldingtonS , BeasleyR , HoltS . An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. Journal of Allergy and Clinical Immunology2007;119(4):811‐6. ">Charles 2007</a>), electronic monitoring of dosing with clinician feedback (<a href="./references#CD012226-bbs2-0035" title="OnyirimbaF , ApterA , ReisineS , LittM , McCuskerC , ConnorsM , et al. Direct clinician‐to‐patient feedback discussion of inhaled steroid use: its effect on adherence. Annals of Allergy, Asthma and Immunology2003;90(4):411‐5. ">Onyirimba 2003</a>), interactive voice response system via mobile phone (<a href="./references#CD012226-bbs2-0133" title="MulvaneySA , HoYX , CalaCM , ChenQ , NianH , PattersonBL . Assessing adolescent asthma symptoms and adherence using mobile phones. Journal of Medical Internet Research2013;15(7):e141. [DOI: 10.2196/jmir.2413] ">Mulvaney 2013</a>), text message reminders (<a href="./references#CD012226-bbs2-0127" title="JohnsonKB , PattersonBL , HoY‐X , ChenQ , NianH , DavisonCL . The feasibility of text reminders to improve medication adherence in adolescents with asthma. Journal of the American Medical Informatics Association2015;0:1‐8. [DOI: 10.1093/jamia/ocv158] ">Johnson 2015</a>) and more comprehensive patient or parent education (<a href="./references#CD012226-bbs2-0107" title="BenderBG . Overcoming barriers to non adherence in asthma treatment. Journal of Allergy and Clinical Immunology2002;109(6 Suppl):554‐9. ">Bender 2002</a>). </p> </section> <section id="CD012226-sec-0033"> <h3 class="title" id="CD012226-sec-0033">How the intervention might work</h3> <p>How the intervention works will be directly related to the type of non‐adherence targeted and the type of intervention offered. The simplest interventions proposed to tackle 'erratic non‐adherence' might work by providing a very basic prompt to patients to remember to use their inhaler. Multi‐faceted interventions that involve tackling 'unwitting' or 'intelligent' non‐adherence might comprise patient education and partnership building between healthcare professionals and patients and are likely to work through more complex psychological and behavioural pathways. </p> <p>A recently updated Cochrane Review assessing the evidence for interventions to improve adherence across the whole spectrum of health care identified 109 randomised controlled trials (RCTs) for inclusion. Review authors concluded that a small number of trials, which implemented complex interventions, demonstrated improvement in adherence and clinical outcomes, suggesting that the more rudimentary interventions generally have little impact. This may reflect the likelihood that any individual under treatment for asthma will likely have a combination of reasons for non‐adherence, possibly both intentional and unintentional (<a href="./references#CD012226-bbs2-0126" title="HorneR , WeinmanJ . Self‐regulation and self‐management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non‐adherence to preventer medication. Psychology and Health2002;17:17‐32. ">Horne 2002</a>). However, the highly complex nature of the interventions implemented in these 'successful' trials casts doubts on their feasibility in a real‐life setting (<a href="./references#CD012226-bbs2-0135" title="NieuwlaatR , WilczynskiN , NavarroT , HobsonN , JefferyR , KeepanasserilA . Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews2014, Issue 11. [DOI: 10.1002/14651858.CD000011.pub4] ">Nieuwlaat 2014</a>). </p> <p>Medication adherence is recognised to deteriorate often during adolescence (<a href="./references#CD012226-bbs2-0118" title="DinwiddieR , MüllerWG . Adolescent treatment compliance in asthma. Journal of the Royal Society of Medicine2002;95(2):68‐71. ">Dinwiddie 2002</a>). Patients in this age group might be particularly receptive to newer technologies for assisting with adherence, for example, Internet‐based care and text message reminders. However, the authors of <a href="./references#CD012226-bbs2-0135" title="NieuwlaatR , WilczynskiN , NavarroT , HobsonN , JefferyR , KeepanasserilA . Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews2014, Issue 11. [DOI: 10.1002/14651858.CD000011.pub4] ">Nieuwlaat 2014</a> concluded that evidence is currently insufficient to show with certainty whether these newer methods of improving adherence are effective. </p> <p>Lower levels of adherence in minority communities and among those from lower socioeconomic groups suggest that even when access to health care and prescription coverage is equal (<a href="./references#CD012226-bbs2-0128" title="KrishnanJA , DietteGB , SkinnerEA , ClarkBD , SteinwachsD , WuAW . Race and sex differences in consistency of care with national asthma guidelines in managed care organizations. Archives of Internal Medicine2001;161(13):1660‐8. ">Krishnan 2001</a>), cultural tailoring of interventions may be required for successful treatment. </p> </section> <section id="CD012226-sec-0034"> <h3 class="title" id="CD012226-sec-0034">Why it is important to do this review</h3> <p>Suboptimal adherence leads to poorer clinical outcomes and increased health service utilisation. Although difficult to quantify, studies report that up to, and possibly in excess of, 50% of participants are non‐adherent to their prescribed ICS (<a href="./references#CD012226-bbs2-0111" title="BårnesCB , UlrikSC . Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respiratory Care2015;60(3):455‐68. ">Bårnes 2015</a>; <a href="./references#CD012226-bbs2-0108" title="BenderBG , RandC . Medication non‐adherence and asthma treatment cost. Current Opinion in Allergy and Clinical Immunology2004;4(3):191‐5. ">Bender 2004</a>; <a href="./references#CD012226-bbs2-0130" title="MakhinovaT , BarnerJC , RichardsKM , RascatiKL . Asthma controller medication adherence, risk of exacerbation, and use of rescue agents among Texas Medicaid patients with persistent asthma. Journal of Managed Care and Specialty Pharmacy2015;21(12):1124‐32. ">Mahkinova 2015</a>; <a href="./references#CD012226-bbs2-0134" title="MurphyAC , ProeschalA , BrightlingCE , WardlawAJ , PavordI , BraddingP . The relationship between clinical outcomes and medication adherence in difficult‐to‐control asthma. Thorax2012;67(8):751‐3. ">Murphy 2012</a>; <a href="./references#CD012226-bbs2-0137" title="RandCS , WiseRA . Measuring adherence to asthma medication regimens. American Journal of Respiratory and Critical Care Medicine1994;149(2):S69‐78. ">Rand 1994</a>; <a href="./references#CD012226-bbs2-0143" title="WilliamsLK , PladevallM , XiH , PetersonEL , JosephC , LafataJE . Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. Journal of Allergy and Clinical Immunology2004;114(6):1288‐93. ">Williams 2003</a>). Failure to take appropriate medication was found to be a potentially avoidable factor contributing to approximately one‐third of asthma deaths in the UK over the course of a year (<a href="./references#CD012226-bbs2-0136" title="National Review of Asthma Deaths. Why asthma still kills: the national review of asthma deaths. https://www.rcplondon.ac.uk/sites/default/files/why‐asthma‐still‐kills‐full‐report.pdf (accessed 7 April 2016). ">NRAD 2014</a>). <a href="./references#CD012226-bbs2-0130" title="MakhinovaT , BarnerJC , RichardsKM , RascatiKL . Asthma controller medication adherence, risk of exacerbation, and use of rescue agents among Texas Medicaid patients with persistent asthma. Journal of Managed Care and Specialty Pharmacy2015;21(12):1124‐32. ">Mahkinova 2015</a> demonstrated that patients who are adherent to their preventer medication make fewer claims for oral corticosteroid prescriptions, reflecting a lower rate of exacerbation. <a href="./references#CD012226-bbs2-0143" title="WilliamsLK , PladevallM , XiH , PetersonEL , JosephC , LafataJE . Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. Journal of Allergy and Clinical Immunology2004;114(6):1288‐93. ">Williams 2003</a> identified an association between hospitalisations and emergency department visits and non‐adherence to ICS. <a href="./references#CD012226-bbs2-0134" title="MurphyAC , ProeschalA , BrightlingCE , WardlawAJ , PavordI , BraddingP . The relationship between clinical outcomes and medication adherence in difficult‐to‐control asthma. Thorax2012;67(8):751‐3. ">Murphy 2012</a> found that non‐adherence was an independent predictor of the need for ventilation therapy in acute severe asthma, as well as lower forced expiratory volume in one second (FEV<sub>1</sub>) and higher sputum eosinophils, both of which are markers of poorly controlled asthma. A 2015 review of ICS adherence in asthma found that 24% of exacerbations and 60% of asthma‐related hospitalisations could be attributed to poor adherence (<a href="./references#CD012226-bbs2-0111" title="BårnesCB , UlrikSC . Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respiratory Care2015;60(3):455‐68. ">Bårnes 2015</a>). In addition, it is well recognised that uncontrolled asthma places a greater financial burden on an economy than is incurred by controlled asthma (<a href="./references#CD012226-bbs2-0105" title="BarnesPJ , JonssonB , KlimJB . The costs of asthma. European Respiratory Journal1996;9:636‐42. ">Barnes 1996</a>; <a href="./references#CD012226-bbs2-0122" title="Global Asthma Network. The Global Asthma Report 2014. http://www.globalasthmareport.org/ (accessed 13 December 2016). [http://www.globalasthmareport.org/index.php (accessed 2 February 2016)] ">Global Asthma Report 2014</a>). </p> <p>Evidence shows that many people with asthma benefit greatly from regular use of an ICS. However, ways that healthcare professionals can best assist patients in maintaining adherence remain unclear. We are conducting this review to explore this topic. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012226-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012226-sec-0035"></div> <p>To assess the efficacy and safety of interventions intended to improve adherence to inhaled corticosteroids among people with asthma. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012226-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012226-sec-0036"></div> <section id="CD012226-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012226-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included parallel and cluster RCTs of any duration conducted in any setting. If we identified cross‐over trials, we included only data from the first part of the study because of the potential for carry‐over effects of the intervention. </p> <p>We included studies reported as full‐text articles, those published as abstracts only and unpublished data. </p> </section> <section id="CD012226-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included adults and children of any age with a diagnosis of asthma, according to international or national guidelines or as diagnosed by a healthcare professional, and currently prescribed an ICS alone or in combination with a LABA. We excluded participants with other respiratory comorbidities such as chronic obstructive pulmonary disease (COPD) or bronchiectasis. If we identified trials in which only a subset of participants had received a diagnosis of asthma, we included these participants if we could obtain disaggregated data. If we identified trials targeting improved adherence to asthma therapies generally, and at least 80% of participants were using an ICS at baseline, we included these trials in the review. We also included trials in which the intervention was targeted at a healthcare professional (the trial "participant"), who in turn would deliver the adherence intervention to patients with asthma. </p> </section> <section id="CD012226-sec-0040"> <h4 class="title">Types of interventions</h4> <p>We included trials that compared an intervention primarily aimed at improving adherence to ICS (± LABA) versus: </p> <p> <ul id="CD012226-list-0002"> <li> <p>usual care/no additional intervention;</p> </li> <li> <p>an alternative intervention that does not primarily aim to increase adherence; or</p> </li> <li> <p>an alternative intervention of a different type or intensity, also aimed at improving adherence. </p> </li> </ul> </p> <p>Interventions may range from simple automated reminders to more complex behavioural, psychological and motivational interventions. Interventions may be delivered to the participant or to the parent/career by any healthcare professional or trained peer. Interventions may also be delivered to a healthcare professional. We allowed other co‐interventions in the management of asthma provided they were provided in the same way for intervention and comparison groups, for example, a personalised asthma action plan (PAAP) + adherence prompt versus PAAP alone. </p> </section> <section id="CD012226-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD012226-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012226-list-0003"> <li> <p>Adherence to ICS (as reported by trialists; e.g. self‐report via diary or questionnaire, electronic monitoring, prescription monitoring/pharmacy claims data). </p> </li> <li> <p>Exacerbations requiring at least oral corticosteroids.</p> </li> <li> <p>Asthma control (ideally measured on a validated scale such as the Asthma Control Test (ACT)). </p> </li> </ul> </p> </section> <section id="CD012226-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012226-list-0004"> <li> <p>Unscheduled visits to a healthcare provider.</p> </li> <li> <p>Absenteeism from work/school.</p> </li> <li> <p>Quality of life (ideally measured on a validated scale such as the Asthma Quality of Life Questionnaire (AQLQ)). </p> </li> <li> <p>All adverse events*.</p> </li> </ul> </p> <p>We chose adherence as a primary outcome, as studies will be aiming to improve this outcome. However, we believe it is important to assess whether improvement in adherence translates into improved clinical outcomes; thus, we have included exacerbations and asthma control as primary outcomes in the belief that these are important to patients. Outcomes of adverse events, absenteeism and quality of life are also important to patients. Unscheduled visits to a healthcare provider are important to patients as well and serve as a marker of usage of healthcare services. </p> <p>If outcomes were reported at multiple time points, we extracted and included the latest reported time point. If studies reported post‐intervention follow‐up, we extracted this information and presented it narratively. </p> <p>Reporting one or more of the outcomes listed here was not a criterion for inclusion of trials in this review. </p> <p>*If we identified serious adverse events reported as 'asthma', we described these narratively, as they are likely to represent a severe exacerbation requiring at least hospitalisation. </p> </section> </section> </section> <section id="CD012226-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012226-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We identified trials from the Cochrane Airways Trials Register, which is maintained by the Information Specialist for the Group. The Cochrane Airways Trials Register contains studies identified from several sources. </p> <p> <ul id="CD012226-list-0005"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL), through the Cochrane Register of Studies Online (crso.cochrane.org/). </p> </li> <li> <p>Weekly searches of MEDLINE Ovid SP 1946 to date.</p> </li> <li> <p>Weekly searches of Embase Ovid SP 1974 to date.</p> </li> <li> <p>Monthly searches of PsycINFO Ovid SP.</p> </li> <li> <p>Monthly searches of the Cumulative Index to Nursing and Allied Health Literature (CINAHL) EBSCO. </p> </li> <li> <p>Monthly searches of the Allied and Complementary Medicine Database (AMED) EBSCO.</p> </li> <li> <p>Handsearches of the proceedings of major respiratory conferences.</p> </li> </ul> </p> <p>Studies contained in the Trials Register are identified through search strategies based on the scope of Cochrane Airways. Details of these strategies, as well as a list of handsearched conference proceedings, are provided in <a href="./appendices#CD012226-sec-0126">Appendix 1</a>. See <a href="./appendices#CD012226-sec-0132">Appendix 2</a> for search terms used to identify studies for this review. We conducted the primary search on 20 May 2016, and updated the search on 18 November 2016. </p> <p>We conducted additional searches of the Cochrane Central Register of Controlled Trials (CENTRAL) (all years to 18 November 2016) and MEDLINE Ovid (1946 to 18 November 2016) to identify adherence trials targeting mixed populations including people with asthma (<a href="./appendices#CD012226-sec-0132">Appendix 2</a>). </p> <p>We searched the following trials registries on 20 May 2016 and 18 November 2016.</p> <p> <ol id="CD012226-list-0006"> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (www.clinicaltrials.gov).</p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (apps.who.int/trialsearch/).</p> </li> </ol> </p> <p>We did not apply any restrictions on the language of publication.</p> </section> <section id="CD012226-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We checked the reference lists of all primary studies and review articles for additional references. We searched relevant manufacturer websites for trial information. </p> <p>We searched on 23 November 2016 for errata or retractions from included studies published in full text on PubMed (<a href="http://www.ncbi.nlm.nih.gov/pubmed" target="_blank">www.ncbi.nlm.nih.gov/pubmed</a>). </p> </section> </section> <section id="CD012226-sec-0047"> <h3 class="title" id="CD012226-sec-0047">Data collection and analysis</h3> <section id="CD012226-sec-0048"> <h4 class="title">Selection of studies</h4> <p>We used the Rayyan Web app (<a href="./references#CD012226-bbs2-0119" title="ElmagarmidA , FedorowiczZ , HammadyH , IlyasI , KhabsaM , OuzzaniM . Rayyan: a systematic reviews web app for exploring and filtering searches for eligible studies for Cochrane Reviews. Evidence‐Informed Public Health: Opportunities and Challenges. Abstracts of the 22nd Cochrane Colloquium; 2014 21‐26 Sep; Hyderabad, India. 2014. ">Elmagarmid 2014</a>) to independently screen titles and abstracts of all studies identified by the search for possible inclusion, and we coded each study as 'include' (eligible or potentially eligible/unclear) or 'exclude'. KK screened all titles and abstracts, and RN and ES each screened one‐half. We retrieved full‐text study reports/publications, and two review authors (RN and KK) independently screened them to identify studies for inclusion, and to identify and record reasons for exclusion of ineligible studies. We resolved disagreements through discussion, or, if required, we consulted the third review author (ES). We identified and excluded duplicates and collated multiple reports of the same study, so that each study rather than each report was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) flow diagram and <a href="./references#CD012226-sec-0145" title="">Characteristics of excluded studies</a> table (<a href="./references#CD012226-bbs2-0132" title="MoherD , LiberatiA , TetzlaffJ , AltmanD . Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLoS Medicine2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097] ">Moher 2009</a>). </p> </section> <section id="CD012226-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>We planned to use <a href="./references#CD012226-bbs2-0116" title="Veritas Health Innovation. Covidence systematic review software. Veritas Health Innovation, 2015. [https://www.covidence.org/] ">Covidence 2015</a> to extract study characteristics and outcome data, but we found it too time consuming and instead used an Excel data extraction form that we each piloted on at least one study. We planned that one review author (RN) would extract the following study characteristics from included studies, but instead we shared the studies equally between all three review authors (RN, ES and KK). </p> <p> <ul id="CD012226-list-0007"> <li> <p>Methods: study design, total duration of study, details of any 'run‐in' period, number of study centres and locations, study setting, withdrawals and date of study. </p> </li> <li> <p>Participants: N, mean age, age range, gender, severity of condition, diagnostic criteria, baseline lung function, smoking history, inclusion criteria and exclusion criteria. </p> </li> <li> <p>Interventions: intervention, comparison, concomitant medications and excluded medications.</p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected and time points reported.</p> </li> <li> <p>Notes: funding for trial and notable conflicts of interest of trial authors.</p> </li> </ul> </p> <p>Each review author extracted outcome data independently from two‐thirds of the studies so that data from each study were extracted twice. We noted in the <a href="./references#CD012226-sec-0144" title="">Characteristics of included studies</a> table if outcome data were not reported in a useable way. We resolved disagreements by reaching consensus or by involving a third review author (RN, KK or ES). One review author (RN) transferred data to the Review Manager (<a href="./references#CD012226-bbs2-0138" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) file. We double‐checked that data had been entered correctly by comparing data presented in the systematic review against study reports. A second review author (KK or ES) spot‐checked study characteristics for accuracy against the trial report. </p> </section> <section id="CD012226-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>As for numerical data extraction, each review author independently assessed risk of bias for two‐thirds of the included studies, so that each study was assessed twice. We used the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012226-bbs2-0125" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We resolved disagreements by discussion or by consultation with the third review author who had not already assessed the study (RN, KK or ES). We assessed risk of bias according to the following domains. </p> <p> <ul id="CD012226-list-0008"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Other bias.</p> </li> </ul> </p> <p>We graded each potential source of bias as high, low or unclear and provided a quote from the study report together with a justification for our judgement in the 'Risk of bias' table. We summarised risk of bias judgements across different studies for each of the domains listed. We considered blinding separately for different key outcomes when necessary (e.g. for an unblinded outcome assessment, risk of bias for all‐cause mortality may be very different than for a patient‐reported pain scale). When information on risk of bias relates to unpublished data or correspondence with a trialist, we noted this in the 'Risk of bias' table. </p> <p>When considering a treatment effect, we took into account the risk of bias for studies that contributed to that outcome. </p> <section id="CD012226-sec-0051"> <h5 class="title">Assesment of bias in conducting the systematic review</h5> <p>We conducted the review according to this published protocol and reported deviations from it in the <a href="#CD012226-sec-0142">Differences between protocol and review</a> section of the systematic review. </p> </section> </section> <section id="CD012226-sec-0052"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed dichotomous data using Mantel‐Haenzsel odds ratios (ORs) with a random‐effects model and 95% confidence intervals (CIs). When rare events were reported, we used Peto ORs. When data were reported as rates or times‐to‐events (e.g. exacerbations), we analysed them as time‐to‐event or rate ratios. We transformed reported rate ratios into log‐rate ratios and analysed them using a random‐effects model and generic inverse variance (GIV) in Review Manager 5 (<a href="./references#CD012226-bbs2-0138" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We entered data presented as a scale with a consistent direction of effect. </p> <p>We analysed continuous outcomes (e.g. ACT, AQLQ) as mean differences (MDs) or as standardised mean differences (SMDs) using a random‐effects model and 95% CIs. We used change from baseline scores when available. </p> <p>We undertook meta‐analyses only when this was meaningful (i.e. if treatments, participants and the underlying clinical question were similar enough for pooling to make sense). </p> <p>We narratively described skewed data reported as medians and interquartile ranges.</p> <p>When multiple trial arms were reported in a single trial, we included only the relevant arms. If two comparisons (e.g. intervention A vs usual care, intervention B vs usual care) were combined in the same meta‐analysis, we halved the control group to avoid double‐counting. </p> <p>If both change from baseline and endpoint scores were available for continuous data, we used change from baseline unless most studies reported endpoint scores. Similarly, we preferred adjusted data examined by analysis of variance (ANOVA) to account for baseline differences when available. </p> <p>When both per‐protocol/completer and intention‐to‐treat (ITT) analyses were provided in a single report, we used the latter. </p> </section> <section id="CD012226-sec-0053"> <h4 class="title">Unit of analysis issues</h4> <p>We analysed dichotomous data using participants (rather than events) as the unit of analysis. However, if exacerbations were reported as rate ratios, we analysed them on this basis. We meta‐analysed data from cluster RCTs only if available data had been, or could be, adjusted to account for clustering. We adjusted data from <a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a> for meta‐analysis using an intracluster correlation coefficient (ICC) of 0.037 (based on the ACT score, kindly supplied by the study author team). However, this adjustment had very little impact on the meta‐analyses, and so we have used the raw unadjusted data. </p> </section> <section id="CD012226-sec-0054"> <h4 class="title">Dealing with missing data</h4> <p>We contacted investigators or study sponsors to verify key study characteristics and to request missing numerical outcome data when possible (e.g. when a study is identified as abstract only). When this was not possible, and missing data were thought to introduce serious bias, we considered this in the GRADE rating for the affected outcome. </p> </section> <section id="CD012226-sec-0055"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the I² statistic to measure heterogeneity among the trials in each analysis. If we identified substantial heterogeneity, we reported this and explored possible causes through prespecified subgroup analyses.  </p> </section> <section id="CD012226-sec-0056"> <h4 class="title">Assessment of reporting biases</h4> <p>When we were able to pool more than 10 studies, we created and examined a funnel plot to explore possible small study and publication biases. </p> </section> <section id="CD012226-sec-0057"> <h4 class="title">Data synthesis</h4> <p>We used a random‐effects model and performed a sensitivity analysis using a fixed‐effect model. </p> <section id="CD012226-sec-0058"> <h5 class="title">'Summary of findings' table</h5> <p>We created four 'Summary of findings' tables, one for each of the comparisons, using the following outcomes: adherence to ICS; exacerbations requiring at least an oral corticosteroid (OCS); asthma control; quality of life; unscheduled visits to a healthcare provider; absenteeism from work/school; and adverse events. We used the five GRADE (Grades of Recommendation, Assessment, Development and Evaluation Working Group) considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of a body of evidence as it relates to studies that contributed data to the prespecified outcomes. We used methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012226-bbs2-0125" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) and GRADEpro software (<a href="./references#CD012226-bbs2-0123" title="GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 6 February 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2014. ">GRADEpro GDT</a>). We justified all decisions to downgrade or upgrade the quality of studies by using footnotes, and we made comments to aid readers' understanding of the review when necessary. </p> </section> </section> <section id="CD012226-sec-0059"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned the following subgroup analyses.</p> <p> <ul id="CD012226-list-0009"> <li> <p>Type of intervention: interventions meeting the definition of a complex intervention* versus simpler interventions. </p> </li> <li> <p>Age of participants: adults versus adolescents versus children.</p> </li> <li> <p>To whom the intervention is delivered: participant/parent/career versus healthcare professional. </p> </li> </ul> </p> <p>We constructed an additional table to present other potential factors across studies that may alter the treatment effect (e.g. type, delivery, dose and schedule of ICS; whether treatment was given in a combination inhaler with a LABA; baseline severity of asthma). </p> <p>We used the following outcomes in subgroup analyses.</p> <p> <ul id="CD012226-list-0010"> <li> <p>Adherence to ICS.</p> </li> <li> <p>Exacerbations requiring at least an OCS.</p> </li> <li> <p>Asthma control.</p> </li> </ul> </p> <p>We used the formal test for subgroup interactions provided in <a href="./references#CD012226-bbs2-0138" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>. </p> <p>*Complex interventions are conventionally described as those including 'several interacting components' (<a href="./references#CD012226-bbs2-0112" title="CampbellM , FitzpatrickR , HainesA , KinmonthAL , SandercockP , SpiegelhalterD . Framework for design and evaluation of complex interventions to improve health. BMJ2000;321:694‐6. ">Campbell 2000</a>). From a public health point of view, complex interventions, which are likely to involve a substantial educational element, and population‐based interventions, which may include cluster RCTs, are thought to have greater overall impact on patient behaviour. Simpler interventions, such as cue reminders, will not address the more complex issues of adherence, and effects may be less likely to persist beyond removal of the intervention. Thus, we considered this an important subgroup analysis for inclusion. </p> </section> <section id="CD012226-sec-0060"> <h4 class="title">Sensitivity analysis</h4> <p>We planned the following sensitivity analyses.</p> <p> <ul id="CD012226-list-0011"> <li> <p>Excluding unpublished data.</p> </li> <li> <p>Excluding trials considered at high risk of selection bias.</p> </li> <li> <p>Excluding trials in which not all participants were prescribed ICS at baseline.</p> </li> <li> <p>Excluding trials in which adherence was measured via non‐objective methods (e.g. diary, self‐report). In a post hoc change to our analysis plan, we have presented studies using objective measures (i.e. electronic inhaler monitors) as the primary analysis for % adherence, as we deemed this to be a more useful analysis. An analysis including studies using all measures then follows. </p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012226-sec-0061" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012226-sec-0061"></div> <section id="CD012226-sec-0062"> <h3 class="title">Description of studies</h3> <section id="CD012226-sec-0063"> <h4 class="title">Results of the search</h4> <p>Through database searches, we retrieved 2707 references. Our searches of other resources, including trials registries, revealed 127 additional records. Once duplicates had been removed, we had a total of 1725 records left to screen. We excluded 1575 records on the basis of titles and abstracts. We obtained the full text of the remaining 150 records. We excluded 45 studies (51 references), added five studies to <a href="./references#CD012226-bbs1-0003" title="">Studies awaiting classification</a> and listed 13 studies as ongoing (15 records). We included 39 studies (79 references). For further details of our screening process, see the study flow diagram (<a href="#CD012226-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD012226-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012226-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012226-sec-0064"> <h4 class="title">Included studies</h4> <p>Thirty‐nine studies met our inclusion criteria, and 28 of these contributed data to at least one meta‐analysis. These studies included a total of 16,303 participants who were randomly assigned to comparisons of interest in this review. The largest study was a pragmatic trial that included 9603 pre‐existing users of ICS, and the smallest included 12. The median total number of participants was 102. Investigators reported three trials as conference abstracts only (<a href="./references#CD012226-bbs2-0005" title="BlackPN , GarrattE , ArandjusC , SalmonBT , SutherlandG . An inhaler with ring tones improves compliance with inhaled steroids in childhood asthma [Abstract]. American Thoracic Society International Conference; May 16‐21, 2008; Toronto. 2008:Poster #A46. ">Black 2008</a>; <a href="./references#CD012226-bbs2-0015" title="HartCAH , LoveAM , GibsonNA , MorganN , PatonJY . Effects of an educational intervention directed at parental beliefs and anxieties about inhaled steroid medication of adherence. American Journal of Respiratory and Critical Care Medicine2002;165:A420. ">Hart 2002</a>; <a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a>), one on the clinicaltrials.gov website (<a href="./references#CD012226-bbs2-0033" title="NCT02413528 . Pilot study of a mobile asthma adherence intervention [Pilot study of a mobile intervention to increase adherence to asthma medication among adolescents]. https://clinicaltrials.gov/show/NCT02413528 (first received 7 April 2015). ">NCT02413528</a>) and one as a pharmaceutical company report (<a href="./references#CD012226-bbs2-0003" title="ADERE PEDIATRIC1 . Prospective, parallel‐group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticasone 50/250 mcg (Seretide) twice a day. ADERE PROJECT (Pediatric). //www.gsk‐clinicalstudyregister.com/study/ADERE%20PEDIATRIC%201?search=compound&amp;compound=fluticasone‐propionate‐salmeterol#rs (first received 28 September 2008). ">ADERE PEDIATRIC 1</a>). The remainder were full‐text peer‐reviewed journal articles. We present a summary of the characteristics of included studies in <a href="#CD012226-tbl-0005">Table 1</a>. </p> <div class="table" id="CD012226-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Comparison 1 study characteristics: adherence education</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID ("first received" date for clinical trials registries)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total n</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration of intervention/follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adherence measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0020" title="ApterAJ , BogenDK , WangX , RandCS , McElligottS , PolskyD , et al. Intervening to improve adherence and asthma outcomes in urban adults with moderate or severe asthma [Abstract]. American Journal of Respiratory and Critical Care Medicine2011;183:A3791. ApterAJ , WangX , BogenDK , RandCS , McElligottS , PolskyD , et al. Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial. Journal of Aallergy and Clinical Immunology2011;128(3):516‐23. NCT00115323 . Comparison of two medication adherence strategies to improve asthma treatment adherence [Individualized interventions to improve asthma adherence]. https://clinicaltrials.gov/show/NCT00115323 (first received 21 June 2005). [NCT00115323] ">NCT00115323</a> </p> <p>(2005)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13/26 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Problem‐solving intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Asthma education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, AQLQ, ACQ, LFTs, hospitalisation,</p> <p>ED visits, participant satisfaction</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0004" title="BenderBG , ApterA , BogenDK , DickinsonP , FisherL , WamboldtFS , et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. Journal of the American Board of Family Medicine2010;23(2):159‐65. ">Bender 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interactive voice response intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor or canister weight</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, AQLQ, ACT, Beliefs about</p> <p>Medication Questionnaire</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a> </p> <p>(2009)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Telephone speech recognition intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total ICS supplied/total prescribed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, beta‐agonist use, OCS use, primary care, ED and out of hours visits, hospitalisations, participant satisfaction </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0010" title="ChatkinJM , BlancoDC , ScagliaN , WagnerMB , FritscherCC , ChatkinJ , et al. Impact of a low‐cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. Journal of Asthma2006;43(4):263‐6. ">Chatkin 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adolescents and adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Brazil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Telephone counselling</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ususal care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Number of inhalations recorded on the disks"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0021" title="NCT00149487 . Enhancing treatment adherence in pediatric asthma with a problem solving intervention [Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma]. https://clinicaltrials.gov/ct2/show/NCT00149487 (first received 6 September 2005). NCT00149487 . Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma. clinicaltrials.gov/show/NCT00149487 (first received 6 September 2005). RohanJ , DrotarD , McNallyK , SchluchterM , RiekertK , VavrekP , et al. Adherence to pediatric asthma treatment in economically disadvantaged African‐American children and adolescents: an application of growth curve analysis. Journal of Pediatric Psychology2010;35(4):394‐404. ">NCT00149487</a> </p> <p>(2005)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17 weeks/1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Problem‐solving intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Family‐based intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, symptoms, use of healthcare services, reliever medication use</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0022" title="AdamsCD , JosephKE , MacLarenJE , DeMoreM , KovenL , DetweilerMF , et al. Parent‐youth teamwork in pediatric asthma management [Abstract]. Journal of Allergy and Clinical Immunology2004;113(2):S159. DuncanCL , HoganMB , TienKJ , GravesMM , ChorneyJM , ZettlerMD , et al. Efficacy of a parent‐youth teamwork intervention to promote adherence in pediatric asthma. Journal of Pediatric Psychology2013;38(6):617‐28. NCT00166582 . Parent‐youth teamwork in pediatric asthma management. https://clinicaltrials.gov/show/NCT00166582 (first received 9 September 2009). ">NCT00166582</a> </p> <p>(2009)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Team work intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Asthma education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, Parent‐Adolescent Conflict Questionnaire, Functional Severity Index, LFTs, Consumer Satisfaction Survey </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 GPs, 143 patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adolescents and adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Personalised adherence discussion (PAD)</p> <p>PAD + inhaler reminder feedback (IRF)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ACT, AQLQ, Hospital Anxiety and Depression Scale, Medication Adherence Report Scale, LFTs, exacerbations </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0012" title="GallefossF , BakkePS . How does patient education and self‐management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. American Journal of Respiratory and Critical Care Medicine1999;160(6):2000‐5. GallefossF , BakkePS . Impact of patient education and self‐management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine2000;94(3):279‐87. [CRS: 4900100000008905] GallefossF , BakkePS , RsgaardPK , KjaersgaardP . Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1999;159(3):812‐7. [CENTRAL: 160267; CRS: 4900100000006265; PUBMED: 10051255] ">Gallefoss 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Norway</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Asthma education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prescribed doses/dispensed doses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, GP visits, absenteeism, days in hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0028" title="GambleJ , HeaneyLG . An individualised nurse‐led programme to improve adherence in patients with difficult asthma ‐ 12 month outcomes. American Journal of Respiratory and Critical Care Medicine2010;181(1):A3258. GambleJ , StevensonM , HeaneyLG . A study of a multi‐level intervention to improve non‐adherence in difficult to control asthma. Respiratory Medicine2011;105(9):1308‐15. NCT01064869 . A nurse led programme to improve adherence in difficult asthma [Evaluation of the benefits of an individualised menu driven nurse led programme to improve adherence in difficult asthma]. clinicaltrials.gov/show/NCT01064869 (first received 8 February 2010). ">NCT01064869</a> </p> <p>(2010)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks/1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported, but mean age suggests adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Northern Ireland</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nurse‐led psychoeducation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ususal care (difficult asthma service)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percent of prescriptions refilled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, OCS, beta‐agonist use, hospital admissions, LFTs, ACQ, AQLQ, Hospital Anxiety and Despression Scale </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0003" title="ADERE PEDIATRIC1 . Prospective, parallel‐group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticasone 50/250 mcg (Seretide) twice a day. ADERE PROJECT (Pediatric). //www.gsk‐clinicalstudyregister.com/study/ADERE%20PEDIATRIC%201?search=compound&amp;compound=fluticasone‐propionate‐salmeterol#rs (first received 28 September 2008). ">ADERE PEDIATRIC 1</a> </p> <p>(2008)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>298</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Brazil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Telephone follow‐up intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage of actual doses/number expected</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, disease control, quality of life (SF‐36)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0015" title="HartCAH , LoveAM , GibsonNA , MorganN , PatonJY . Effects of an educational intervention directed at parental beliefs and anxieties about inhaled steroid medication of adherence. American Journal of Respiratory and Critical Care Medicine2002;165:A420. ">Hart 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Asthma education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, beliefs and anxieties about adherence</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0026" title="HederosCA , JansonS , HedlinG . Group discussions with parents have long‐term positive effects on the management of asthma with good cost‐benefit. Acta Paediatrica2005;94(5):602‐8. NCT00516633 . Intervention study to improve adherence in asthma [Does improved information in the form of group discussions with parents of newly diagnosed asthmatic children lead to a better quality of life for the families, an improved adherence and better development of the lung function of the children?]. clinicaltrials.gov/show/NCT00516633 (first received 13 August 2007). ">NCT00516633</a> </p> <p>(2007)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26 weeks/78 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sweden</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group discussion plus basic education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Basic education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diaries and canister weight</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, views on adherence, days hospitalised, ED visits, exacerbations</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0016" title="KampsJL . Improving adherence to inhaled corticosteroids in children with asthma [Dissertation]. University of Kansas, 2002. KampsJL , RapoffMA , RobertsMC , VarelaRE , BarnardM , OlsonN . Improving adherence to inhaled corticosteroids in children with asthma: a pilot of a randomized clinical trial. Children's Health Care2008;37(4):261‐77. ">Kamps 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks/52 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Specific adherence improvement strategies (education, monitoring, etc.)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care plus education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, LFTs, PedsQL, healthcare costs</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0029" title="LavoieK , MoullecG , BlaisL , BeauchesneM‐F , LemiereC , LabrecqueM , et al. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, nonadherent asthmatics: results from a randomized controlled pilot study [Abstract]. Chest2011;140(4):915A. LavoieKL , LemiereC , LabrecqueM , BlaisL , BeauchesneM , MoullecG , et al. The efficacy of motivational interviewing on asthma medication adherence in non‐adherent, poorly controlled asthmatics: preliminary results of the asthma control trial (ACT). Psychosomatic Medicine2011;7(3):A‐9. LavoieKL , MoullecG , LemiereC , BlaisL , LabrecqueM , BeauchesneM‐F , et al. Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial. Patient Preference and Adherence2014;8:1555‐69. NCT01132430 . Motivational interviewing for medication adherence in asthma [Impact of a motivational interviewing intervention on medication adherence in patients with asthma]. https://clinicaltrials.gov/show/NCT01132430 (first received 27 May 2010). ">NCT01132430</a> </p> <p>(2010)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks/52 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Canada</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Motivational interviewing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prescribed treatment days/number of days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, asthma control, quality of life, asthma‐related self‐efficacy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0019" title="MehuysE , VanBortelL , DeBolleL , VanTongelenI , AnnemansL , RemonJP , et al. Effectiveness of pharmacist intervention for asthma control improvement. European Respiratory Journal2008;31(4):790‐9. MehuysE , vanBortelL , deBolleL , vanTongelenI , RemonJ‐P , AnnemansL , et al. Does pharmacist intervention lead to appropriate use of asthma medication and improved asthma control? [Leidt apothekersadvies over het optimaal gebruik van astmamedicatie tot een verbetering van de astmacontrole? Een gerandomiseerde gecontroleerde studie]. Farmaceutisch Tijdschrift voor Belgie2008;85(1):1‐9. ">Mehuys 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Belgium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prescription refill rates, self‐reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ACT, diary card, rescue medication use, ED visits, hospitalisations, AQLQ, Knowledge of Asthma and Asthma Medicine Questionnaire, inhalation technique </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0030" title="MosnaimG , LiH , MartinM , BelicePJ , AveryE , RyanN , et al. The use of coping peer support and mp3 technology to improve adherence to inhaled corticosteroids among low‐income minority adolescents. Journal of Allergy and Clinical Immunology2013;131(2):AB133 [478]. MosnaimG , LiH , MartinM , RichardsonD , BelicePJ , AveryE , et al. The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology: In Practice2013;1(5):485‐93. NCT01169883 . Coping peer intervention for adherence. https://clinicaltrials.gov/show/NCT01169883 (first received 23 July 2010). PowellL . The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology2013;0(5):485‐93. ">NCT01169883</a> </p> <p>(2010)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adolescents</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence messaging and group sessions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Attention control"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, asthma knowledge, ICS knowledge, ICS self‐efficacy, social support, exacerbations</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0033" title="NCT02413528 . Pilot study of a mobile asthma adherence intervention [Pilot study of a mobile intervention to increase adherence to asthma medication among adolescents]. https://clinicaltrials.gov/show/NCT02413528 (first received 7 April 2015). ">NCT02413528</a> </p> <p>(2015)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adolescents</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence monitoring and incentivisation via app and sensor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, ACT</p> <p><b>NB:</b> study terminated </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0035" title="OnyirimbaF , ApterA , ReisineS , LittM , McCuskerC , ConnorsM , et al. Direct clinician‐to‐patient feedback discussion of inhaled steroid use: its effect on adherence. Annals of Allergy, Asthma and Immunology2003;90(4):411‐5. ">Onyirimba 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence monitoring and education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Monitoring without feedback</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, rescue medication use, AQLQ, LFTs</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a> </p> <p>(2005)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prescription refill rates, self‐reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, symptoms, night‐time awakenings, ED visits, hospitalisation, OCS courses</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0038" title="UlrikCS , ClaudiusBK , TammM , HarvingH , SierstedHC , BackerV , et al. Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial.[Erratum appears in Clin Respir J. 2009 Jul;3(3):185]. Clinical Respiratory Journal2009;3(3):161‐8. ">Ulrik 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Denmark and Switzerland</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence education and study medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study medication alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dose counting in returned investigational product</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, asthma control, LFTs, symptoms, rescue medication use, night‐time awakenings, adverse events, AQLQ, asthma severity, adverse events, vital signs </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0024" title="NCT00414817 . Telephone‐based program to promote inhaled corticosteroid adherence among individuals with asthma [Phone calls to promote adherence with inhaled corticosteroids]. clinicaltrials.gov/show/NCT00414817 (first received 20 December 2006). VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of automated phone calls to support inhaled corticosteroids (ICS) adherence. American Thoracic Society International Conference; May 15‐20, 2009; San Diego. 2009:A1089 [Poster #518]. VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of health information technology to improve medication adherence. American Journal of Managed Care2011;17(12):SP79‐87. VollmerWM , XuM , FeldsteinA , SmithD , WaterburyA , RandC . Comparison of pharmacy‐based measures of medication adherence. BMC Health Services Research2012;12:155. ">NCT00414817</a> </p> <p>(2006)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14,064 (6903 previous ICS users)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Telephone interactive voice recognition intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacy‐based adherence measures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, use of healthcare services, economic evaluation</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACQ: Asthma Control Questionnaire; ACT: Asthma Control Test; AQLQ: Asthma Quality of Life Questionnaire; ED: emergency department; GP: general practitioner; ICS: inhaled corticosteroid; IRF: inhaler reminder feedback; LFTs: lung function tests; OCS: oral corticosteroid; PAD: personalised adherence discussion; PedsQL: Paediatric Quality of Life Inventory; SF‐36: Short‐Form Health Survey </p> </div> </div> <section id="CD012226-sec-0065"> <h5 class="title">Methods</h5> <p>As per our protocol, all included trials were RCTs with parallel design that compared an intervention to improve adherence to inhaled corticosteroids versus usual care or an alternative intervention not specifically designed to improve adherence, or of a lower intensity. Two studies used a cluster randomised design (<a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a>; <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a>); the remainder were randomised at an individual participant level. One study included four relevant arms (personalised adherence discussion (PAD); inhaler reminders and feedback (IRF); PAD + IRF; and usual care; <a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a>). Two studies included three relevant arms: <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a> randomised participants to adherence monitoring and education, education or usual care; and <a href="./references#CD012226-bbs2-0022" title="AdamsCD , JosephKE , MacLarenJE , DeMoreM , KovenL , DetweilerMF , et al. Parent‐youth teamwork in pediatric asthma management [Abstract]. Journal of Allergy and Clinical Immunology2004;113(2):S159. DuncanCL , HoganMB , TienKJ , GravesMM , ChorneyJM , ZettlerMD , et al. Efficacy of a parent‐youth teamwork intervention to promote adherence in pediatric asthma. Journal of Pediatric Psychology2013;38(6):617‐28. NCT00166582 . Parent‐youth teamwork in pediatric asthma management. https://clinicaltrials.gov/show/NCT00166582 (first received 9 September 2009). ">NCT00166582</a> randomised participants to a team work intervention, an asthma education intervention (not deemed relevant to this review) or usual care. The remainder were two‐arm parallel‐group trials. </p> <p>Intevention length varied, and follow‐up continued from two months to two years. The median duration of follow‐up was 24 weeks. Several studies reported a previous run‐in period during which participants were stabilised on an asthma treatment regimen. Outcome data were extracted at the last time point reported to assess enduring effects of the intervention. Trials were conducted in a variety of mainly high‐income countries worldwide. Most were carried out in the USA (<a href="./references#CD012226-bbs2-0004" title="BenderBG , ApterA , BogenDK , DickinsonP , FisherL , WamboldtFS , et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. Journal of the American Board of Family Medicine2010;23(2):159‐65. ">Bender 2010</a>; <a href="./references#CD012226-bbs2-0013" title="GeraldLB , McClureLA , HarringtonKF , ManganJM , GibsonL , AtchisonJ , et al. Design of the supervised asthma therapy study: implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials2008;29(2):304‐10. GeraldLB , McClureLA , ManganJM , HarringtonKF , GibsonL , ErwinS , et al. Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school‐based supervised asthma therapy. Pediatrics2009;123(2):466‐74. GeraldLB , PatelK , ZhangS , McClureL . Secondhand smoke exposure and asthma morbidity among elementary school children enrolled in a clinical trial. Chest2007;132(4):461. [DOI: 10.1378/chest.132.4_MeetingAbstracts.461] McClureLA , HarringtonKF , GrahamH , GeraldLB . Internet‐based monitoring of asthma symptoms, peak flow meter readings, and absence data in a school‐based clinical trial. Clinical Trials2008;5(1):31‐7. ">Gerald 2009</a>; <a href="./references#CD012226-bbs2-0014" title="HaltermanJS , SzilagyiPG , YoosHL , ConnKM , KaczorowskiJM , HolzhauerRJ , et al. Benefits of a school‐based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Archives of Pediatric and Adolescent Medicine2004;158(5):460‐7. ">Halterman 2004</a>; <a href="./references#CD012226-bbs2-0016" title="KampsJL . Improving adherence to inhaled corticosteroids in children with asthma [Dissertation]. University of Kansas, 2002. KampsJL , RapoffMA , RobertsMC , VarelaRE , BarnardM , OlsonN . Improving adherence to inhaled corticosteroids in children with asthma: a pilot of a randomized clinical trial. Children's Health Care2008;37(4):261‐77. ">Kamps 2008</a>; <a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a>; <a href="./references#CD012226-bbs2-0020" title="ApterAJ , BogenDK , WangX , RandCS , McElligottS , PolskyD , et al. Intervening to improve adherence and asthma outcomes in urban adults with moderate or severe asthma [Abstract]. American Journal of Respiratory and Critical Care Medicine2011;183:A3791. ApterAJ , WangX , BogenDK , RandCS , McElligottS , PolskyD , et al. Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial. Journal of Aallergy and Clinical Immunology2011;128(3):516‐23. NCT00115323 . Comparison of two medication adherence strategies to improve asthma treatment adherence [Individualized interventions to improve asthma adherence]. https://clinicaltrials.gov/show/NCT00115323 (first received 21 June 2005). [NCT00115323] ">NCT00115323</a>; <a href="./references#CD012226-bbs2-0021" title="NCT00149487 . Enhancing treatment adherence in pediatric asthma with a problem solving intervention [Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma]. https://clinicaltrials.gov/ct2/show/NCT00149487 (first received 6 September 2005). NCT00149487 . Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma. clinicaltrials.gov/show/NCT00149487 (first received 6 September 2005). RohanJ , DrotarD , McNallyK , SchluchterM , RiekertK , VavrekP , et al. Adherence to pediatric asthma treatment in economically disadvantaged African‐American children and adolescents: an application of growth curve analysis. Journal of Pediatric Psychology2010;35(4):394‐404. ">NCT00149487</a>; <a href="./references#CD012226-bbs2-0022" title="AdamsCD , JosephKE , MacLarenJE , DeMoreM , KovenL , DetweilerMF , et al. Parent‐youth teamwork in pediatric asthma management [Abstract]. Journal of Allergy and Clinical Immunology2004;113(2):S159. DuncanCL , HoganMB , TienKJ , GravesMM , ChorneyJM , ZettlerMD , et al. Efficacy of a parent‐youth teamwork intervention to promote adherence in pediatric asthma. Journal of Pediatric Psychology2013;38(6):617‐28. NCT00166582 . Parent‐youth teamwork in pediatric asthma management. https://clinicaltrials.gov/show/NCT00166582 (first received 9 September 2009). ">NCT00166582</a>; <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a>; <a href="./references#CD012226-bbs2-0024" title="NCT00414817 . Telephone‐based program to promote inhaled corticosteroid adherence among individuals with asthma [Phone calls to promote adherence with inhaled corticosteroids]. clinicaltrials.gov/show/NCT00414817 (first received 20 December 2006). VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of automated phone calls to support inhaled corticosteroids (ICS) adherence. American Thoracic Society International Conference; May 15‐20, 2009; San Diego. 2009:A1089 [Poster #518]. VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of health information technology to improve medication adherence. American Journal of Managed Care2011;17(12):SP79‐87. VollmerWM , XuM , FeldsteinA , SmithD , WaterburyA , RandC . Comparison of pharmacy‐based measures of medication adherence. BMC Health Services Research2012;12:155. ">NCT00414817</a>; <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a>; <a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a>; <a href="./references#CD012226-bbs2-0030" title="MosnaimG , LiH , MartinM , BelicePJ , AveryE , RyanN , et al. The use of coping peer support and mp3 technology to improve adherence to inhaled corticosteroids among low‐income minority adolescents. Journal of Allergy and Clinical Immunology2013;131(2):AB133 [478]. MosnaimG , LiH , MartinM , RichardsonD , BelicePJ , AveryE , et al. The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology: In Practice2013;1(5):485‐93. NCT01169883 . Coping peer intervention for adherence. https://clinicaltrials.gov/show/NCT01169883 (first received 23 July 2010). PowellL . The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology2013;0(5):485‐93. ">NCT01169883</a>; <a href="./references#CD012226-bbs2-0031" title="HaltermanJS , FagnanoM , MontesG , FisherS , TremblayP , TajonR , et al. The school‐based preventive asthma care trial: results of a pilot study. Journal of Pediatrics2012;161(6):1109‐15. HaltermanJS , SauerJ , FagnanoM , MontesG , FisherS , TremblayP , et al. Working toward a sustainable system of asthma care: development of the School‐Based Preventive Asthma Care Technology (SB‐PACT) trial. Journal of Asthma2012;49(4):395‐400. NCT01175434 . School‐based preventive asthma care technology: a trial using a novel technology to improve adherence (SB‐PACT). https://clinicaltrials.gov/ct2/show/NCT01175434 (first received 16 April 2010). ">NCT01175434</a>; <a href="./references#CD012226-bbs2-0032" title="Kolmodin MacDonellK , NaarS , Gibson‐ScipioW , LamP , SecordE . The Detroit young adult asthma project: pilot of a technology‐based medication adherence intervention for African‐American emerging adults. Journal of Adolescent Health2016;59(4):465‐71. [DOI: 10.1016/j.jadohealth.2016.05.016] NCT01714141 . Multi‐component technology intervention for minority emerging adults with asthma. https://clinicaltrials.gov/ct2/show/NCT01714141 (accessed 21 July 2016). ">NCT01714141</a>; <a href="./references#CD012226-bbs2-0033" title="NCT02413528 . Pilot study of a mobile asthma adherence intervention [Pilot study of a mobile intervention to increase adherence to asthma medication among adolescents]. https://clinicaltrials.gov/show/NCT02413528 (first received 7 April 2015). ">NCT02413528</a>; <a href="./references#CD012226-bbs2-0035" title="OnyirimbaF , ApterA , ReisineS , LittM , McCuskerC , ConnorsM , et al. Direct clinician‐to‐patient feedback discussion of inhaled steroid use: its effect on adherence. Annals of Allergy, Asthma and Immunology2003;90(4):411‐5. ">Onyirimba 2003</a>), the UK (<a href="./references#CD012226-bbs2-0006" title="BosleyCM , ParryDT , CochraneGM . Patient compliance with inhaled medication: does combining beta‐agonists with corticosteroids improve compliance?. European Respiratory Journal1994;7(3):504‐9. ">Bosley 1994</a>; <a href="./references#CD012226-bbs2-0015" title="HartCAH , LoveAM , GibsonNA , MorganN , PatonJY . Effects of an educational intervention directed at parental beliefs and anxieties about inhaled steroid medication of adherence. American Journal of Respiratory and Critical Care Medicine2002;165:A420. ">Hart 2002</a>; <a href="./references#CD012226-bbs2-0017" title="KoufopoulosJT , ConnerMT , GardnerPH , KellarI . A web‐based and mobile health social support intervention to promote adherence to inhaled asthma medications: randomized controlled trial. Journal of Medical Internet Research2016;18(6):e122. [CRS: 4900132000024092; PUBMED: 27298211] ">Koufopoulos 2016</a>; <a href="./references#CD012226-bbs2-0028" title="GambleJ , HeaneyLG . An individualised nurse‐led programme to improve adherence in patients with difficult asthma ‐ 12 month outcomes. American Journal of Respiratory and Critical Care Medicine2010;181(1):A3258. GambleJ , StevensonM , HeaneyLG . A study of a multi‐level intervention to improve non‐adherence in difficult to control asthma. Respiratory Medicine2011;105(9):1308‐15. NCT01064869 . A nurse led programme to improve adherence in difficult asthma [Evaluation of the benefits of an individualised menu driven nurse led programme to improve adherence in difficult asthma]. clinicaltrials.gov/show/NCT01064869 (first received 8 February 2010). ">NCT01064869</a>; <a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a>; <a href="./references#CD012226-bbs2-0036" title="PriceD , RobertsonA , BullenK , RandC , HorneR , StaudingerH . Improved adherence with once‐daily versus twice‐daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open‐label study. BMC Pulmonary Medicine2010;10:1. ">Price 2010</a>), New Zealand (<a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a>; <a href="./references#CD012226-bbs2-0005" title="BlackPN , GarrattE , ArandjusC , SalmonBT , SutherlandG . An inhaler with ring tones improves compliance with inhaled steroids in childhood asthma [Abstract]. American Thoracic Society International Conference; May 16‐21, 2008; Toronto. 2008:Poster #A46. ">Black 2008</a>; <a href="./references#CD012226-bbs2-0008" title="ChanAH , StewartAW , HarrisonJ , CamargoCAJr , BlackPN , MitchellEA . The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial. Lancet Respiratory Medicine2015;3(3):210‐9. ">Chan 2015</a>; <a href="./references#CD012226-bbs2-0009" title="CharlesT , QuinnD , WeatherallM , AldingtonS , BeasleyR , HoltS . An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. Journal of Allergy and Clinical Immunology2007;119(4):811‐6. ">Charles 2007</a>) and Australia (<a href="./references#CD012226-bbs2-0002" title="ACTRN12607000489493 . The impact of providing feedback on adherence in childhood asthma. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=82288 (first received 14 September 2007). BurgessSW , SlyPD , DevadasonSG . Providing feedback on adherence increases use of preventive medication by asthmatic children. Journal of Asthma2010;47(2):198‐201. ">ACTRN12607000489493</a>; <a href="./references#CD012226-bbs2-0007" title="BurgessSW , SlyPD , CooperDM , DevadasonSG . Novel spacer device does not improve adherence in childhood asthma. Pediatric Pulmonology2007;42(8):736‐9. ">Burgess 2007</a>; <a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a>). The remainder were carried out in Brazil (<a href="./references#CD012226-bbs2-0003" title="ADERE PEDIATRIC1 . Prospective, parallel‐group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticasone 50/250 mcg (Seretide) twice a day. ADERE PROJECT (Pediatric). //www.gsk‐clinicalstudyregister.com/study/ADERE%20PEDIATRIC%201?search=compound&amp;compound=fluticasone‐propionate‐salmeterol#rs (first received 28 September 2008). ">ADERE PEDIATRIC 1</a>; <a href="./references#CD012226-bbs2-0010" title="ChatkinJM , BlancoDC , ScagliaN , WagnerMB , FritscherCC , ChatkinJ , et al. Impact of a low‐cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. Journal of Asthma2006;43(4):263‐6. ">Chatkin 2006</a>), Norway (<a href="./references#CD012226-bbs2-0012" title="GallefossF , BakkePS . How does patient education and self‐management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. American Journal of Respiratory and Critical Care Medicine1999;160(6):2000‐5. GallefossF , BakkePS . Impact of patient education and self‐management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine2000;94(3):279‐87. [CRS: 4900100000008905] GallefossF , BakkePS , RsgaardPK , KjaersgaardP . Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1999;159(3):812‐7. [CENTRAL: 160267; CRS: 4900100000006265; PUBMED: 10051255] ">Gallefoss 1999</a>), Sweden (<a href="./references#CD012226-bbs2-0026" title="HederosCA , JansonS , HedlinG . Group discussions with parents have long‐term positive effects on the management of asthma with good cost‐benefit. Acta Paediatrica2005;94(5):602‐8. NCT00516633 . Intervention study to improve adherence in asthma [Does improved information in the form of group discussions with parents of newly diagnosed asthmatic children lead to a better quality of life for the families, an improved adherence and better development of the lung function of the children?]. clinicaltrials.gov/show/NCT00516633 (first received 13 August 2007). ">NCT00516633</a>), The Netherlands (<a href="./references#CD012226-bbs2-0039" title="GoossensLMA , VasbinderEC , van DenBemtPMLA , Rutten‐Van MolkenMPMH . Cost‐effectiveness of real‐time medication monitoring in children with asthma. Value in Health2014;17(7):A329. VasbinderE , GoossensL , JanssensH , deWinterB , vanDijkL , VultoA , et al. E‐monitoring of asthma therapy to improve compliance in children (E‐MATIC). European Respiratory Journal2016;46:758‐67. [DOI: 10.1183/13993003.01698‐2015] VasbinderEC , GoossensLMA , JanssensH , deWinterBCM , vanDijkL , VultoAG , et al. E‐Monitoring of asthma therapy to improve compliance in children (E‐MATIC). Pharmacoepidemiology and Drug Safety2015;24(S1):489. [DOI: 10.1002/pds] VasbinderEC , JanssensHM , Rutten‐van MolkenMP , vanDijkL , deWinterBC , deGrootRC , et al. e‐Monitoring of asthma therapy to improve compliance in children using a real‐time medication monitoring system (RTMM): the e‐MATIC study protocol. BMC Medical Informatics and Decision Making2013;13(1):38. ">Vasbinder 2015 E‐MATIC</a>), Canada (<a href="./references#CD012226-bbs2-0029" title="LavoieK , MoullecG , BlaisL , BeauchesneM‐F , LemiereC , LabrecqueM , et al. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, nonadherent asthmatics: results from a randomized controlled pilot study [Abstract]. Chest2011;140(4):915A. LavoieKL , LemiereC , LabrecqueM , BlaisL , BeauchesneM , MoullecG , et al. The efficacy of motivational interviewing on asthma medication adherence in non‐adherent, poorly controlled asthmatics: preliminary results of the asthma control trial (ACT). Psychosomatic Medicine2011;7(3):A‐9. LavoieKL , MoullecG , LemiereC , BlaisL , LabrecqueM , BeauchesneM‐F , et al. Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial. Patient Preference and Adherence2014;8:1555‐69. NCT01132430 . Motivational interviewing for medication adherence in asthma [Impact of a motivational interviewing intervention on medication adherence in patients with asthma]. https://clinicaltrials.gov/show/NCT01132430 (first received 27 May 2010). ">NCT01132430</a>), Belgium (<a href="./references#CD012226-bbs2-0019" title="MehuysE , VanBortelL , DeBolleL , VanTongelenI , AnnemansL , RemonJP , et al. Effectiveness of pharmacist intervention for asthma control improvement. European Respiratory Journal2008;31(4):790‐9. MehuysE , vanBortelL , deBolleL , vanTongelenI , RemonJ‐P , AnnemansL , et al. Does pharmacist intervention lead to appropriate use of asthma medication and improved asthma control? [Leidt apothekersadvies over het optimaal gebruik van astmamedicatie tot een verbetering van de astmacontrole? Een gerandomiseerde gecontroleerde studie]. Farmaceutisch Tijdschrift voor Belgie2008;85(1):1‐9. ">Mehuys 2008</a>), Denmark (<a href="./references#CD012226-bbs2-0037" title="StrandbygaardU , ThomsenSF , BackerV . A daily SMS reminder increases adherence to asthma treatment: a three‐month follow‐up study. Respiratory Medicine2010;104(2):166‐71. ">Strandbygaard 2010</a>) and Denmark and Switzerland (<a href="./references#CD012226-bbs2-0038" title="UlrikCS , ClaudiusBK , TammM , HarvingH , SierstedHC , BackerV , et al. Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial.[Erratum appears in Clin Respir J. 2009 Jul;3(3):185]. Clinical Respiratory Journal2009;3(3):161‐8. ">Ulrik 2009</a>). </p> </section> <section id="CD012226-sec-0066"> <h5 class="title">Participants</h5> <p>We included studies involving both children and adults. Eighteen studies included only children, 20 studies included adults and/or adolescents only and one study recruited both adults and children. Most studies did not specify the ethnicity of participants. </p> <p>All studies included participants with a diagnosis of asthma. Almost all studies required participants to be using ICS at baseline, although in two studies (<a href="./references#CD012226-bbs2-0037" title="StrandbygaardU , ThomsenSF , BackerV . A daily SMS reminder increases adherence to asthma treatment: a three‐month follow‐up study. Respiratory Medicine2010;104(2):166‐71. ">Strandbygaard 2010</a>; <a href="./references#CD012226-bbs2-0038" title="UlrikCS , ClaudiusBK , TammM , HarvingH , SierstedHC , BackerV , et al. Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial.[Erratum appears in Clin Respir J. 2009 Jul;3(3):185]. Clinical Respiratory Journal2009;3(3):161‐8. ">Ulrik 2009</a>), some participants were commenced on ICS during the run‐in period. Asthma severity at baseline was inconsistently reported, so it is not possible to characterise the population in this review as a whole. When available, we extracted information about baseline severity and reported this in the <a href="./references#CD012226-sec-0144" title="">Characteristics of included studies</a> tables. </p> </section> <section id="CD012226-sec-0067"> <h5 class="title">Interventions</h5> <p>Studies included a variety of comparisons, which we classified into four broad groups. Some studies appear in more than one comparison, as they included three or more arms. Most studies did not specify which additional medications were allowed or disallowed, so we assume that most participants continued their usual asthma medication regimen. We have outlined below the four broad comparisons. </p> <section id="CD012226-sec-0068"> <h6 class="title">Adherence education versus control (Table 1)</h6> <p>We included the following studies in this group: <a href="./references#CD012226-bbs2-0004" title="BenderBG , ApterA , BogenDK , DickinsonP , FisherL , WamboldtFS , et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. Journal of the American Board of Family Medicine2010;23(2):159‐65. ">Bender 2010</a>; <a href="./references#CD012226-bbs2-0010" title="ChatkinJM , BlancoDC , ScagliaN , WagnerMB , FritscherCC , ChatkinJ , et al. Impact of a low‐cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. Journal of Asthma2006;43(4):263‐6. ">Chatkin 2006</a>; <a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a>; <a href="./references#CD012226-bbs2-0020" title="ApterAJ , BogenDK , WangX , RandCS , McElligottS , PolskyD , et al. Intervening to improve adherence and asthma outcomes in urban adults with moderate or severe asthma [Abstract]. American Journal of Respiratory and Critical Care Medicine2011;183:A3791. ApterAJ , WangX , BogenDK , RandCS , McElligottS , PolskyD , et al. Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial. Journal of Aallergy and Clinical Immunology2011;128(3):516‐23. NCT00115323 . Comparison of two medication adherence strategies to improve asthma treatment adherence [Individualized interventions to improve asthma adherence]. https://clinicaltrials.gov/show/NCT00115323 (first received 21 June 2005). [NCT00115323] ">NCT00115323</a>; <a href="./references#CD012226-bbs2-0021" title="NCT00149487 . Enhancing treatment adherence in pediatric asthma with a problem solving intervention [Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma]. https://clinicaltrials.gov/ct2/show/NCT00149487 (first received 6 September 2005). NCT00149487 . Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma. clinicaltrials.gov/show/NCT00149487 (first received 6 September 2005). RohanJ , DrotarD , McNallyK , SchluchterM , RiekertK , VavrekP , et al. Adherence to pediatric asthma treatment in economically disadvantaged African‐American children and adolescents: an application of growth curve analysis. Journal of Pediatric Psychology2010;35(4):394‐404. ">NCT00149487</a>; <a href="./references#CD012226-bbs2-0022" title="AdamsCD , JosephKE , MacLarenJE , DeMoreM , KovenL , DetweilerMF , et al. Parent‐youth teamwork in pediatric asthma management [Abstract]. Journal of Allergy and Clinical Immunology2004;113(2):S159. DuncanCL , HoganMB , TienKJ , GravesMM , ChorneyJM , ZettlerMD , et al. Efficacy of a parent‐youth teamwork intervention to promote adherence in pediatric asthma. Journal of Pediatric Psychology2013;38(6):617‐28. NCT00166582 . Parent‐youth teamwork in pediatric asthma management. https://clinicaltrials.gov/show/NCT00166582 (first received 9 September 2009). ">NCT00166582</a>; <a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a> (PAD and PAD + IRF groups vs IRF and control groups); <a href="./references#CD012226-bbs2-0003" title="ADERE PEDIATRIC1 . Prospective, parallel‐group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticasone 50/250 mcg (Seretide) twice a day. ADERE PROJECT (Pediatric). //www.gsk‐clinicalstudyregister.com/study/ADERE%20PEDIATRIC%201?search=compound&amp;compound=fluticasone‐propionate‐salmeterol#rs (first received 28 September 2008). ">ADERE PEDIATRIC 1</a>; <a href="./references#CD012226-bbs2-0012" title="GallefossF , BakkePS . How does patient education and self‐management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. American Journal of Respiratory and Critical Care Medicine1999;160(6):2000‐5. GallefossF , BakkePS . Impact of patient education and self‐management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine2000;94(3):279‐87. [CRS: 4900100000008905] GallefossF , BakkePS , RsgaardPK , KjaersgaardP . Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1999;159(3):812‐7. [CENTRAL: 160267; CRS: 4900100000006265; PUBMED: 10051255] ">Gallefoss 1999</a>; <a href="./references#CD012226-bbs2-0015" title="HartCAH , LoveAM , GibsonNA , MorganN , PatonJY . Effects of an educational intervention directed at parental beliefs and anxieties about inhaled steroid medication of adherence. American Journal of Respiratory and Critical Care Medicine2002;165:A420. ">Hart 2002</a>; <a href="./references#CD012226-bbs2-0016" title="KampsJL . Improving adherence to inhaled corticosteroids in children with asthma [Dissertation]. University of Kansas, 2002. KampsJL , RapoffMA , RobertsMC , VarelaRE , BarnardM , OlsonN . Improving adherence to inhaled corticosteroids in children with asthma: a pilot of a randomized clinical trial. Children's Health Care2008;37(4):261‐77. ">Kamps 2008</a>; <a href="./references#CD012226-bbs2-0019" title="MehuysE , VanBortelL , DeBolleL , VanTongelenI , AnnemansL , RemonJP , et al. Effectiveness of pharmacist intervention for asthma control improvement. European Respiratory Journal2008;31(4):790‐9. MehuysE , vanBortelL , deBolleL , vanTongelenI , RemonJ‐P , AnnemansL , et al. Does pharmacist intervention lead to appropriate use of asthma medication and improved asthma control? [Leidt apothekersadvies over het optimaal gebruik van astmamedicatie tot een verbetering van de astmacontrole? Een gerandomiseerde gecontroleerde studie]. Farmaceutisch Tijdschrift voor Belgie2008;85(1):1‐9. ">Mehuys 2008</a>; <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a> (adherence monitoring and education vs control and education alone vs control); <a href="./references#CD012226-bbs2-0026" title="HederosCA , JansonS , HedlinG . Group discussions with parents have long‐term positive effects on the management of asthma with good cost‐benefit. Acta Paediatrica2005;94(5):602‐8. NCT00516633 . Intervention study to improve adherence in asthma [Does improved information in the form of group discussions with parents of newly diagnosed asthmatic children lead to a better quality of life for the families, an improved adherence and better development of the lung function of the children?]. clinicaltrials.gov/show/NCT00516633 (first received 13 August 2007). ">NCT00516633</a>; <a href="./references#CD012226-bbs2-0028" title="GambleJ , HeaneyLG . An individualised nurse‐led programme to improve adherence in patients with difficult asthma ‐ 12 month outcomes. American Journal of Respiratory and Critical Care Medicine2010;181(1):A3258. GambleJ , StevensonM , HeaneyLG . A study of a multi‐level intervention to improve non‐adherence in difficult to control asthma. Respiratory Medicine2011;105(9):1308‐15. NCT01064869 . A nurse led programme to improve adherence in difficult asthma [Evaluation of the benefits of an individualised menu driven nurse led programme to improve adherence in difficult asthma]. clinicaltrials.gov/show/NCT01064869 (first received 8 February 2010). ">NCT01064869</a>; <a href="./references#CD012226-bbs2-0029" title="LavoieK , MoullecG , BlaisL , BeauchesneM‐F , LemiereC , LabrecqueM , et al. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, nonadherent asthmatics: results from a randomized controlled pilot study [Abstract]. Chest2011;140(4):915A. LavoieKL , LemiereC , LabrecqueM , BlaisL , BeauchesneM , MoullecG , et al. The efficacy of motivational interviewing on asthma medication adherence in non‐adherent, poorly controlled asthmatics: preliminary results of the asthma control trial (ACT). Psychosomatic Medicine2011;7(3):A‐9. LavoieKL , MoullecG , LemiereC , BlaisL , LabrecqueM , BeauchesneM‐F , et al. Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial. Patient Preference and Adherence2014;8:1555‐69. NCT01132430 . Motivational interviewing for medication adherence in asthma [Impact of a motivational interviewing intervention on medication adherence in patients with asthma]. https://clinicaltrials.gov/show/NCT01132430 (first received 27 May 2010). ">NCT01132430</a>; <a href="./references#CD012226-bbs2-0030" title="MosnaimG , LiH , MartinM , BelicePJ , AveryE , RyanN , et al. The use of coping peer support and mp3 technology to improve adherence to inhaled corticosteroids among low‐income minority adolescents. Journal of Allergy and Clinical Immunology2013;131(2):AB133 [478]. MosnaimG , LiH , MartinM , RichardsonD , BelicePJ , AveryE , et al. The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology: In Practice2013;1(5):485‐93. NCT01169883 . Coping peer intervention for adherence. https://clinicaltrials.gov/show/NCT01169883 (first received 23 July 2010). PowellL . The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology2013;0(5):485‐93. ">NCT01169883</a>; <a href="./references#CD012226-bbs2-0035" title="OnyirimbaF , ApterA , ReisineS , LittM , McCuskerC , ConnorsM , et al. Direct clinician‐to‐patient feedback discussion of inhaled steroid use: its effect on adherence. Annals of Allergy, Asthma and Immunology2003;90(4):411‐5. ">Onyirimba 2003</a> (adherence education and usual care arms); and <a href="./references#CD012226-bbs2-0038" title="UlrikCS , ClaudiusBK , TammM , HarvingH , SierstedHC , BackerV , et al. Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial.[Erratum appears in Clin Respir J. 2009 Jul;3(3):185]. Clinical Respiratory Journal2009;3(3):161‐8. ">Ulrik 2009</a>; and <a href="./references#CD012226-bbs2-0024" title="NCT00414817 . Telephone‐based program to promote inhaled corticosteroid adherence among individuals with asthma [Phone calls to promote adherence with inhaled corticosteroids]. clinicaltrials.gov/show/NCT00414817 (first received 20 December 2006). VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of automated phone calls to support inhaled corticosteroids (ICS) adherence. American Thoracic Society International Conference; May 15‐20, 2009; San Diego. 2009:A1089 [Poster #518]. VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of health information technology to improve medication adherence. American Journal of Managed Care2011;17(12):SP79‐87. VollmerWM , XuM , FeldsteinA , SmithD , WaterburyA , RandC . Comparison of pharmacy‐based measures of medication adherence. BMC Health Services Research2012;12:155. ">NCT00414817</a>. As per our protocol, we further classified these studies into those delivering a complex intervention versus those not delivering a complex intervention. We performed subgroup analysis when possible according to this classification. </p> <p>Included studies tested a wide range of educational interventions, including one‐to‐one and group face‐to‐face adherence education sessions; motivational interviewing; family‐based problem‐solving interventions; team work interventions; nurse‐led psychoeducation; telephone interventions; and interactive voice recognition systems. Full details can be found under <a href="./references#CD012226-sec-0144" title="">Characteristics of included studies</a> and are summarised in <a href="#CD012226-tbl-0005">Table 1</a>. </p> <p>We classified most of the education interventions as complex (i.e. they involved multiple interacting components and were tailored to the individual). However, we classified as non‐complex three studies using voice recognition software to deliver adherence education and reminders (<a href="./references#CD012226-bbs2-0004" title="BenderBG , ApterA , BogenDK , DickinsonP , FisherL , WamboldtFS , et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. Journal of the American Board of Family Medicine2010;23(2):159‐65. ">Bender 2010</a>; <a href="./references#CD012226-bbs2-0024" title="NCT00414817 . Telephone‐based program to promote inhaled corticosteroid adherence among individuals with asthma [Phone calls to promote adherence with inhaled corticosteroids]. clinicaltrials.gov/show/NCT00414817 (first received 20 December 2006). VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of automated phone calls to support inhaled corticosteroids (ICS) adherence. American Thoracic Society International Conference; May 15‐20, 2009; San Diego. 2009:A1089 [Poster #518]. VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of health information technology to improve medication adherence. American Journal of Managed Care2011;17(12):SP79‐87. VollmerWM , XuM , FeldsteinA , SmithD , WaterburyA , RandC . Comparison of pharmacy‐based measures of medication adherence. BMC Health Services Research2012;12:155. ">NCT00414817</a>; <a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a>). Participants in <a href="./references#CD012226-bbs2-0010" title="ChatkinJM , BlancoDC , ScagliaN , WagnerMB , FritscherCC , ChatkinJ , et al. Impact of a low‐cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. Journal of Asthma2006;43(4):263‐6. ">Chatkin 2006</a> received a maximum 10‐minute phone call from a trained nursing student to promote adherence; we judged this intervention to be non‐complex, although we lacked detail about the contents of the call. Another study, which deviated from protocol and for which we do not have results, stated that participants received telephone 'medical guidance'; we classified this intervention as non‐complex (<a href="./references#CD012226-bbs2-0003" title="ADERE PEDIATRIC1 . Prospective, parallel‐group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticasone 50/250 mcg (Seretide) twice a day. ADERE PROJECT (Pediatric). //www.gsk‐clinicalstudyregister.com/study/ADERE%20PEDIATRIC%201?search=compound&amp;compound=fluticasone‐propionate‐salmeterol#rs (first received 28 September 2008). ">ADERE PEDIATRIC 1</a>). </p> </section> <section id="CD012226-sec-0069"> <h6 class="title">Electronic trackers or reminders versus control (Table 2)</h6> <p>Studies that used electronic adherence trackers plus feedback to participants included <a href="./references#CD012226-bbs2-0002" title="ACTRN12607000489493 . The impact of providing feedback on adherence in childhood asthma. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=82288 (first received 14 September 2007). BurgessSW , SlyPD , DevadasonSG . Providing feedback on adherence increases use of preventive medication by asthmatic children. Journal of Asthma2010;47(2):198‐201. ">ACTRN12607000489493</a>; <a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a> (IRF and IRF + PAD groups vs PAD and control groups); <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a> (adherence education and monitoring vs education alone); <a href="./references#CD012226-bbs2-0032" title="Kolmodin MacDonellK , NaarS , Gibson‐ScipioW , LamP , SecordE . The Detroit young adult asthma project: pilot of a technology‐based medication adherence intervention for African‐American emerging adults. Journal of Adolescent Health2016;59(4):465‐71. [DOI: 10.1016/j.jadohealth.2016.05.016] NCT01714141 . Multi‐component technology intervention for minority emerging adults with asthma. https://clinicaltrials.gov/ct2/show/NCT01714141 (accessed 21 July 2016). ">NCT01714141</a>; <a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a>; and <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a>. </p> <p>Studies that used electronic reminders alone, without an adherence feedback discussion, included <a href="./references#CD012226-bbs2-0005" title="BlackPN , GarrattE , ArandjusC , SalmonBT , SutherlandG . An inhaler with ring tones improves compliance with inhaled steroids in childhood asthma [Abstract]. American Thoracic Society International Conference; May 16‐21, 2008; Toronto. 2008:Poster #A46. ">Black 2008</a>; <a href="./references#CD012226-bbs2-0008" title="ChanAH , StewartAW , HarrisonJ , CamargoCAJr , BlackPN , MitchellEA . The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial. Lancet Respiratory Medicine2015;3(3):210‐9. ">Chan 2015</a>; <a href="./references#CD012226-bbs2-0009" title="CharlesT , QuinnD , WeatherallM , AldingtonS , BeasleyR , HoltS . An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. Journal of Allergy and Clinical Immunology2007;119(4):811‐6. ">Charles 2007</a>; <a href="./references#CD012226-bbs2-0037" title="StrandbygaardU , ThomsenSF , BackerV . A daily SMS reminder increases adherence to asthma treatment: a three‐month follow‐up study. Respiratory Medicine2010;104(2):166‐71. ">Strandbygaard 2010</a>; and <a href="./references#CD012226-bbs2-0039" title="GoossensLMA , VasbinderEC , van DenBemtPMLA , Rutten‐Van MolkenMPMH . Cost‐effectiveness of real‐time medication monitoring in children with asthma. Value in Health2014;17(7):A329. VasbinderE , GoossensL , JanssensH , deWinterB , vanDijkL , VultoA , et al. E‐monitoring of asthma therapy to improve compliance in children (E‐MATIC). European Respiratory Journal2016;46:758‐67. [DOI: 10.1183/13993003.01698‐2015] VasbinderEC , GoossensLMA , JanssensH , deWinterBCM , vanDijkL , VultoAG , et al. E‐Monitoring of asthma therapy to improve compliance in children (E‐MATIC). Pharmacoepidemiology and Drug Safety2015;24(S1):489. [DOI: 10.1002/pds] VasbinderEC , JanssensHM , Rutten‐van MolkenMP , vanDijkL , deWinterBC , deGrootRC , et al. e‐Monitoring of asthma therapy to improve compliance in children using a real‐time medication monitoring system (RTMM): the e‐MATIC study protocol. BMC Medical Informatics and Decision Making2013;13(1):38. ">Vasbinder 2015 E‐MATIC</a>. </p> <p>We classified studies in this group as non‐complex if they tested automated reminders such as text messages or an inhaler device with an audible or visual alarm system. However, if participants received tailored feedback from a healthcare professional based on adherence data acquired through electronic monitoring, we classified this intervention as complex (<a href="./references#CD012226-bbs2-0002" title="ACTRN12607000489493 . The impact of providing feedback on adherence in childhood asthma. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=82288 (first received 14 September 2007). BurgessSW , SlyPD , DevadasonSG . Providing feedback on adherence increases use of preventive medication by asthmatic children. Journal of Asthma2010;47(2):198‐201. ">ACTRN12607000489493</a>; <a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a>; <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a>; <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a>; <a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a>). Full details can be found under <a href="./references#CD012226-sec-0144" title="">Characteristics of included studies</a> and are summarised in <a href="#CD012226-tbl-0006">Table 2</a>. </p> <div class="table" id="CD012226-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Comparison 2 study characteristics: electronic trackers or reminders</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total n</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration of intervention/follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adherence measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0005" title="BlackPN , GarrattE , ArandjusC , SalmonBT , SutherlandG . An inhaler with ring tones improves compliance with inhaled steroids in childhood asthma [Abstract]. American Thoracic Society International Conference; May 16‐21, 2008; Toronto. 2008:Poster #A46. ">Black 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>New Zealand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inhaler alarm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, AQLQ, LFTs, beta‐agonist use</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0002" title="ACTRN12607000489493 . The impact of providing feedback on adherence in childhood asthma. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=82288 (first received 14 September 2007). BurgessSW , SlyPD , DevadasonSG . Providing feedback on adherence increases use of preventive medication by asthmatic children. Journal of Asthma2010;47(2):198‐201. ">ACTRN12607000489493</a> </p> <p>(2007)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence feedback during consultations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, symptoms, LFTs</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0008" title="ChanAH , StewartAW , HarrisonJ , CamargoCAJr , BlackPN , MitchellEA . The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial. Lancet Respiratory Medicine2015;3(3):210‐9. ">Chan 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>New Zealand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Audiovisual inhaler reminder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, school/work absences, ACT, Asthma Morbidity Score, exacerbations, unscheduled visits, beta‐agonist use, LFTs </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0009" title="CharlesT , QuinnD , WeatherallM , AldingtonS , BeasleyR , HoltS . An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. Journal of Allergy and Clinical Immunology2007;119(4):811‐6. ">Charles 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adolescents and adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>New Zealand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Audiovisual inhaler reminder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, ACQ, LFTs</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 GPs, 143 patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adolescents and adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inhaler reminder and feedback (IRF)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ACT, AQLQ, Hospital Anxiety and Depression Scale, Medication Adherence Report Scale, LFTs, exacerbations </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0032" title="Kolmodin MacDonellK , NaarS , Gibson‐ScipioW , LamP , SecordE . The Detroit young adult asthma project: pilot of a technology‐based medication adherence intervention for African‐American emerging adults. Journal of Adolescent Health2016;59(4):465‐71. [DOI: 10.1016/j.jadohealth.2016.05.016] NCT01714141 . Multi‐component technology intervention for minority emerging adults with asthma. https://clinicaltrials.gov/ct2/show/NCT01714141 (accessed 21 July 2016). ">NCT01714141</a> </p> <p>(2012)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Young adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Computer sessions and tailored text reminders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Asthma education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Self‐reported missed doses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, ACT, LFTs, participant satisfaction</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a> </p> <p>(2015)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence monitoring with feedback</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence monitoring but no feedback</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Clinical outcomes", adherence, LFTs, exacerbations</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a> </p> <p>(2005)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence monitoring and education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prescription refill rates, self‐reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, symptoms, night‐time awakenings, ED visits, hospitalisation, OCS courses</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0037" title="StrandbygaardU , ThomsenSF , BackerV . A daily SMS reminder increases adherence to asthma treatment: a three‐month follow‐up study. Respiratory Medicine2010;104(2):166‐71. ">Strandbygaard 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SMS (text message) adherence reminders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Dose‐count" on the Seretide was diskus</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, change in FeNO, LFTs, airway responsiveness</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0039" title="GoossensLMA , VasbinderEC , van DenBemtPMLA , Rutten‐Van MolkenMPMH . Cost‐effectiveness of real‐time medication monitoring in children with asthma. Value in Health2014;17(7):A329. VasbinderE , GoossensL , JanssensH , deWinterB , vanDijkL , VultoA , et al. E‐monitoring of asthma therapy to improve compliance in children (E‐MATIC). European Respiratory Journal2016;46:758‐67. [DOI: 10.1183/13993003.01698‐2015] VasbinderEC , GoossensLMA , JanssensH , deWinterBCM , vanDijkL , VultoAG , et al. E‐Monitoring of asthma therapy to improve compliance in children (E‐MATIC). Pharmacoepidemiology and Drug Safety2015;24(S1):489. [DOI: 10.1002/pds] VasbinderEC , JanssensHM , Rutten‐van MolkenMP , vanDijkL , deWinterBC , deGrootRC , et al. e‐Monitoring of asthma therapy to improve compliance in children using a real‐time medication monitoring system (RTMM): the e‐MATIC study protocol. BMC Medical Informatics and Decision Making2013;13(1):38. ">Vasbinder 2015 E‐MATIC</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The Netherlands</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SMS (text message) adherence reminders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, ACT, exacerbations, use of healthcare services, AQLQ, school/work absence, acceptance of e‐monitoring, economic evaluation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a> </p> <p>(2007)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2698 (34 clusters)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children and adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence education with adherence feedback</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence education alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic prescribing data/refill rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, ED visits, hospitalisation, OCS use</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACQ: Asthma Control Questionnaire; ACT: Asthma Control Test; AQLQ: Asthma Quality of Life Questionnaire; ED: emergency department; FeNO: fractional exhaled nitric oxide; ICS: inhaled corticosteroid; LFTs: lung function tests; OCS: oral corticosteroid </p> </div> </div> </section> <section id="CD012226-sec-0070"> <h6 class="title">Simplified drug regimen versus usual drug regimen (Table 3)</h6> <p>Studies that aimed to improve adherence by randomising participants to a simplified therapeutic regimen included <a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a>; <a href="./references#CD012226-bbs2-0006" title="BosleyCM , ParryDT , CochraneGM . Patient compliance with inhaled medication: does combining beta‐agonists with corticosteroids improve compliance?. European Respiratory Journal1994;7(3):504‐9. ">Bosley 1994</a>; <a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a>; and <a href="./references#CD012226-bbs2-0036" title="PriceD , RobertsonA , BullenK , RandC , HorneR , StaudingerH . Improved adherence with once‐daily versus twice‐daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open‐label study. BMC Pulmonary Medicine2010;10:1. ">Price 2010</a>. We classified all four studies as providing a non‐complex intervention.Full details can be found under <a href="./references#CD012226-sec-0144" title="">Characteristics of included studies</a> and are summarised in <a href="#CD012226-tbl-0007">Table 3</a>. </p> <div class="table" id="CD012226-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Comparison 3 study characteristics: simplified regimens</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total n</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration of intervention/follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adherence measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0006" title="BosleyCM , ParryDT , CochraneGM . Patient compliance with inhaled medication: does combining beta‐agonists with corticosteroids improve compliance?. European Respiratory Journal1994;7(3):504‐9. ">Bosley 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Combined inhaler</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Separate inhalers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, LFTs</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks/12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Twice‐daily dosing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Four‐times‐daily dosing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, LFTs, symptoms</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a> </p> <p>(2007)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>New Zealand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Combined inhaler</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Separate inhalers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, LFTs, ACQ, OCS, unscheduled visits</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0036" title="PriceD , RobertsonA , BullenK , RandC , HorneR , StaudingerH . Improved adherence with once‐daily versus twice‐daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open‐label study. BMC Pulmonary Medicine2010;10:1. ">Price 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1233</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adolescents and adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Once‐daily ICS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Twice‐daily ICS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Device counter number"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, physician assessment of response, quality of life, use of healthcare services, days of school/work missed, adverse events, worsening asthma </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACQ: Asthma Control Questionnaire; ICS: inhaled corticosteroid; LFTs: lung function tests; OCS: oral corticosteroid </p> </div> </div> </section> <section id="CD012226-sec-0071"> <h6 class="title">School‐based directly observed therapy (Table 4)</h6> <p><a href="./references#CD012226-bbs2-0013" title="GeraldLB , McClureLA , HarringtonKF , ManganJM , GibsonL , AtchisonJ , et al. Design of the supervised asthma therapy study: implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials2008;29(2):304‐10. GeraldLB , McClureLA , ManganJM , HarringtonKF , GibsonL , ErwinS , et al. Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school‐based supervised asthma therapy. Pediatrics2009;123(2):466‐74. GeraldLB , PatelK , ZhangS , McClureL . Secondhand smoke exposure and asthma morbidity among elementary school children enrolled in a clinical trial. Chest2007;132(4):461. [DOI: 10.1378/chest.132.4_MeetingAbstracts.461] McClureLA , HarringtonKF , GrahamH , GeraldLB . Internet‐based monitoring of asthma symptoms, peak flow meter readings, and absence data in a school‐based clinical trial. Clinical Trials2008;5(1):31‐7. ">Gerald 2009</a>, <a href="./references#CD012226-bbs2-0014" title="HaltermanJS , SzilagyiPG , YoosHL , ConnKM , KaczorowskiJM , HolzhauerRJ , et al. Benefits of a school‐based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Archives of Pediatric and Adolescent Medicine2004;158(5):460‐7. ">Halterman 2004</a> and <a href="./references#CD012226-bbs2-0031" title="HaltermanJS , FagnanoM , MontesG , FisherS , TremblayP , TajonR , et al. The school‐based preventive asthma care trial: results of a pilot study. Journal of Pediatrics2012;161(6):1109‐15. HaltermanJS , SauerJ , FagnanoM , MontesG , FisherS , TremblayP , et al. Working toward a sustainable system of asthma care: development of the School‐Based Preventive Asthma Care Technology (SB‐PACT) trial. Journal of Asthma2012;49(4):395‐400. NCT01175434 . School‐based preventive asthma care technology: a trial using a novel technology to improve adherence (SB‐PACT). https://clinicaltrials.gov/ct2/show/NCT01175434 (first received 16 April 2010). ">NCT01175434</a> randomised children to receive their ICS at school or usual care. <a href="./references#CD012226-bbs2-0013" title="GeraldLB , McClureLA , HarringtonKF , ManganJM , GibsonL , AtchisonJ , et al. Design of the supervised asthma therapy study: implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials2008;29(2):304‐10. GeraldLB , McClureLA , ManganJM , HarringtonKF , GibsonL , ErwinS , et al. Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school‐based supervised asthma therapy. Pediatrics2009;123(2):466‐74. GeraldLB , PatelK , ZhangS , McClureL . Secondhand smoke exposure and asthma morbidity among elementary school children enrolled in a clinical trial. Chest2007;132(4):461. [DOI: 10.1378/chest.132.4_MeetingAbstracts.461] McClureLA , HarringtonKF , GrahamH , GeraldLB . Internet‐based monitoring of asthma symptoms, peak flow meter readings, and absence data in a school‐based clinical trial. Clinical Trials2008;5(1):31‐7. ">Gerald 2009</a> and <a href="./references#CD012226-bbs2-0014" title="HaltermanJS , SzilagyiPG , YoosHL , ConnKM , KaczorowskiJM , HolzhauerRJ , et al. Benefits of a school‐based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Archives of Pediatric and Adolescent Medicine2004;158(5):460‐7. ">Halterman 2004</a> were classified as non‐complex, as the intervention was largely limited to providing school‐based ICS therapy. <a href="./references#CD012226-bbs2-0031" title="HaltermanJS , FagnanoM , MontesG , FisherS , TremblayP , TajonR , et al. The school‐based preventive asthma care trial: results of a pilot study. Journal of Pediatrics2012;161(6):1109‐15. HaltermanJS , SauerJ , FagnanoM , MontesG , FisherS , TremblayP , et al. Working toward a sustainable system of asthma care: development of the School‐Based Preventive Asthma Care Technology (SB‐PACT) trial. Journal of Asthma2012;49(4):395‐400. NCT01175434 . School‐based preventive asthma care technology: a trial using a novel technology to improve adherence (SB‐PACT). https://clinicaltrials.gov/ct2/show/NCT01175434 (first received 16 April 2010). ">NCT01175434</a> was classified as complex, as participants also underwent web‐based screening to assess children’s asthma, which generated a report that was sent to their primary care provider and was used to adjust the medication regimen. Full details can be found under <a href="./references#CD012226-sec-0144" title="">Characteristics of included studies</a> and are summarised in <a href="#CD012226-tbl-0008">Table 4</a>. </p> <div class="table" id="CD012226-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Comparison 4 study characteristics: school‐based ICS therapy</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total n</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration of intervention/follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adherence measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0013" title="GeraldLB , McClureLA , HarringtonKF , ManganJM , GibsonL , AtchisonJ , et al. Design of the supervised asthma therapy study: implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials2008;29(2):304‐10. GeraldLB , McClureLA , ManganJM , HarringtonKF , GibsonL , ErwinS , et al. Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school‐based supervised asthma therapy. Pediatrics2009;123(2):466‐74. GeraldLB , PatelK , ZhangS , McClureL . Secondhand smoke exposure and asthma morbidity among elementary school children enrolled in a clinical trial. Chest2007;132(4):461. [DOI: 10.1378/chest.132.4_MeetingAbstracts.461] McClureLA , HarringtonKF , GrahamH , GeraldLB . Internet‐based monitoring of asthma symptoms, peak flow meter readings, and absence data in a school‐based clinical trial. Clinical Trials2008;5(1):31‐7. ">Gerald 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised ICS therapy at school</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Episodes of poor asthma control, school absences, rescue medication use at school</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0014" title="HaltermanJS , SzilagyiPG , YoosHL , ConnKM , KaczorowskiJM , HolzhauerRJ , et al. Benefits of a school‐based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Archives of Pediatric and Adolescent Medicine2004;158(5):460‐7. ">Halterman 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised ICS therapy at school</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Symptom‐free days, daytime and night‐time symptoms, rescue medication use, school absences </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0031" title="HaltermanJS , FagnanoM , MontesG , FisherS , TremblayP , TajonR , et al. The school‐based preventive asthma care trial: results of a pilot study. Journal of Pediatrics2012;161(6):1109‐15. HaltermanJS , SauerJ , FagnanoM , MontesG , FisherS , TremblayP , et al. Working toward a sustainable system of asthma care: development of the School‐Based Preventive Asthma Care Technology (SB‐PACT) trial. Journal of Asthma2012;49(4):395‐400. NCT01175434 . School‐based preventive asthma care technology: a trial using a novel technology to improve adherence (SB‐PACT). https://clinicaltrials.gov/ct2/show/NCT01175434 (first received 16 April 2010). ">NCT01175434</a> </p> <p>(2010)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 8 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised ICS therapy at school</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Feasibility, symptom‐free days, numbers of days and nights with symptoms, activity limitation, rescue medication use, school absenteeism, parent sleep interruption, change in family plans due to the child’s asthma, PAQLQ, utilisation of healthcare services, FeNO </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>FeNO: fractional exhaled nitric oxide; ICS: inhaled corticosteroid; PAQLQ: Pediatric Asthma Quality of Life Questionnaire </p> </div> </div> <p>Finally, we were unable to classify several studies according to the above categories. <a href="./references#CD012226-bbs2-0007" title="BurgessSW , SlyPD , CooperDM , DevadasonSG . Novel spacer device does not improve adherence in childhood asthma. Pediatric Pulmonology2007;42(8):736‐9. ">Burgess 2007</a> used an "incentive" inhaler device (the "Funhaler") to encourage children to adhere to their inhaled medication. <a href="./references#CD012226-bbs2-0017" title="KoufopoulosJT , ConnerMT , GardnerPH , KellarI . A web‐based and mobile health social support intervention to promote adherence to inhaled asthma medications: randomized controlled trial. Journal of Medical Internet Research2016;18(6):e122. [CRS: 4900132000024092; PUBMED: 27298211] ">Koufopoulos 2016</a> trialled use on an online community of people with asthma ("AsthmaVillage") to improve adherence. </p> <p>We have provided additional details of these studies under <a href="./references#CD012226-sec-0144" title="">Characteristics of included studies</a>. </p> </section> </section> <section id="CD012226-sec-0072"> <h5 class="title">Outcomes</h5> <p>Outcomes reported were not consistent across reviews, and investigators did not always use validated scales. Almost all included studies reported some measure of adherence, usually as a percentage, with 100% showing complete adherence, but the way in which this was captured and calculated varied between studies. When possible, we extracted and presented this information in <a href="./references#CD012226-sec-0144" title="">Characteristics of included studies</a> and <a href="#CD012226-tbl-0005">Table 1</a>. The three studies in which the intervention consisted of supervised ICS therapy at school did not report adherence as an outcome (<a href="./references#CD012226-bbs2-0013" title="GeraldLB , McClureLA , HarringtonKF , ManganJM , GibsonL , AtchisonJ , et al. Design of the supervised asthma therapy study: implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials2008;29(2):304‐10. GeraldLB , McClureLA , ManganJM , HarringtonKF , GibsonL , ErwinS , et al. Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school‐based supervised asthma therapy. Pediatrics2009;123(2):466‐74. GeraldLB , PatelK , ZhangS , McClureL . Secondhand smoke exposure and asthma morbidity among elementary school children enrolled in a clinical trial. Chest2007;132(4):461. [DOI: 10.1378/chest.132.4_MeetingAbstracts.461] McClureLA , HarringtonKF , GrahamH , GeraldLB . Internet‐based monitoring of asthma symptoms, peak flow meter readings, and absence data in a school‐based clinical trial. Clinical Trials2008;5(1):31‐7. ">Gerald 2009</a>; <a href="./references#CD012226-bbs2-0014" title="HaltermanJS , SzilagyiPG , YoosHL , ConnKM , KaczorowskiJM , HolzhauerRJ , et al. Benefits of a school‐based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Archives of Pediatric and Adolescent Medicine2004;158(5):460‐7. ">Halterman 2004</a>; <a href="./references#CD012226-bbs2-0031" title="HaltermanJS , FagnanoM , MontesG , FisherS , TremblayP , TajonR , et al. The school‐based preventive asthma care trial: results of a pilot study. Journal of Pediatrics2012;161(6):1109‐15. HaltermanJS , SauerJ , FagnanoM , MontesG , FisherS , TremblayP , et al. Working toward a sustainable system of asthma care: development of the School‐Based Preventive Asthma Care Technology (SB‐PACT) trial. Journal of Asthma2012;49(4):395‐400. NCT01175434 . School‐based preventive asthma care technology: a trial using a novel technology to improve adherence (SB‐PACT). https://clinicaltrials.gov/ct2/show/NCT01175434 (first received 16 April 2010). ">NCT01175434</a>). </p> <p>Many included studies used an objective measure of adherence; this was often an electronic inhaler monitoring device. Named devices used included the "SmartInhaler" (<a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a>; <a href="./references#CD012226-bbs2-0007" title="BurgessSW , SlyPD , CooperDM , DevadasonSG . Novel spacer device does not improve adherence in childhood asthma. Pediatric Pulmonology2007;42(8):736‐9. ">Burgess 2007</a>; <a href="./references#CD012226-bbs2-0009" title="CharlesT , QuinnD , WeatherallM , AldingtonS , BeasleyR , HoltS . An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. Journal of Allergy and Clinical Immunology2007;119(4):811‐6. ">Charles 2007</a>; <a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a>); the "SmartTrack" device (<a href="./references#CD012226-bbs2-0008" title="ChanAH , StewartAW , HarrisonJ , CamargoCAJr , BlackPN , MitchellEA . The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial. Lancet Respiratory Medicine2015;3(3):210‐9. ">Chan 2015</a>; <a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a>); the "MDILog or MDILog‐II (<a href="./references#CD012226-bbs2-0004" title="BenderBG , ApterA , BogenDK , DickinsonP , FisherL , WamboldtFS , et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. Journal of the American Board of Family Medicine2010;23(2):159‐65. ">Bender 2010</a>; <a href="./references#CD012226-bbs2-0016" title="KampsJL . Improving adherence to inhaled corticosteroids in children with asthma [Dissertation]. University of Kansas, 2002. KampsJL , RapoffMA , RobertsMC , VarelaRE , BarnardM , OlsonN . Improving adherence to inhaled corticosteroids in children with asthma: a pilot of a randomized clinical trial. Children's Health Care2008;37(4):261‐77. ">Kamps 2008</a>; <a href="./references#CD012226-bbs2-0021" title="NCT00149487 . Enhancing treatment adherence in pediatric asthma with a problem solving intervention [Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma]. https://clinicaltrials.gov/ct2/show/NCT00149487 (first received 6 September 2005). NCT00149487 . Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma. clinicaltrials.gov/show/NCT00149487 (first received 6 September 2005). RohanJ , DrotarD , McNallyK , SchluchterM , RiekertK , VavrekP , et al. Adherence to pediatric asthma treatment in economically disadvantaged African‐American children and adolescents: an application of growth curve analysis. Journal of Pediatric Psychology2010;35(4):394‐404. ">NCT00149487</a>; <a href="./references#CD012226-bbs2-0022" title="AdamsCD , JosephKE , MacLarenJE , DeMoreM , KovenL , DetweilerMF , et al. Parent‐youth teamwork in pediatric asthma management [Abstract]. Journal of Allergy and Clinical Immunology2004;113(2):S159. DuncanCL , HoganMB , TienKJ , GravesMM , ChorneyJM , ZettlerMD , et al. Efficacy of a parent‐youth teamwork intervention to promote adherence in pediatric asthma. Journal of Pediatric Psychology2013;38(6):617‐28. NCT00166582 . Parent‐youth teamwork in pediatric asthma management. https://clinicaltrials.gov/show/NCT00166582 (first received 9 September 2009). ">NCT00166582</a>); the "Doser Clinical Trials" (Doser‐CT) device (<a href="./references#CD012226-bbs2-0004" title="BenderBG , ApterA , BogenDK , DickinsonP , FisherL , WamboldtFS , et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. Journal of the American Board of Family Medicine2010;23(2):159‐65. ">Bender 2010</a>; <a href="./references#CD012226-bbs2-0030" title="MosnaimG , LiH , MartinM , BelicePJ , AveryE , RyanN , et al. The use of coping peer support and mp3 technology to improve adherence to inhaled corticosteroids among low‐income minority adolescents. Journal of Allergy and Clinical Immunology2013;131(2):AB133 [478]. MosnaimG , LiH , MartinM , RichardsonD , BelicePJ , AveryE , et al. The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology: In Practice2013;1(5):485‐93. NCT01169883 . Coping peer intervention for adherence. https://clinicaltrials.gov/show/NCT01169883 (first received 23 July 2010). PowellL . The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology2013;0(5):485‐93. ">NCT01169883</a>); the "E‐haler/Adhaler" (<a href="./references#CD012226-bbs2-0039" title="GoossensLMA , VasbinderEC , van DenBemtPMLA , Rutten‐Van MolkenMPMH . Cost‐effectiveness of real‐time medication monitoring in children with asthma. Value in Health2014;17(7):A329. VasbinderE , GoossensL , JanssensH , deWinterB , vanDijkL , VultoA , et al. E‐monitoring of asthma therapy to improve compliance in children (E‐MATIC). European Respiratory Journal2016;46:758‐67. [DOI: 10.1183/13993003.01698‐2015] VasbinderEC , GoossensLMA , JanssensH , deWinterBCM , vanDijkL , VultoAG , et al. E‐Monitoring of asthma therapy to improve compliance in children (E‐MATIC). Pharmacoepidemiology and Drug Safety2015;24(S1):489. [DOI: 10.1002/pds] VasbinderEC , JanssensHM , Rutten‐van MolkenMP , vanDijkL , deWinterBC , deGrootRC , et al. e‐Monitoring of asthma therapy to improve compliance in children using a real‐time medication monitoring system (RTMM): the e‐MATIC study protocol. BMC Medical Informatics and Decision Making2013;13(1):38. ">Vasbinder 2015 E‐MATIC</a>); the "Tubuhaler Inhalation Computer (TIC)" (<a href="./references#CD012226-bbs2-0006" title="BosleyCM , ParryDT , CochraneGM . Patient compliance with inhaled medication: does combining beta‐agonists with corticosteroids improve compliance?. European Respiratory Journal1994;7(3):504‐9. ">Bosley 1994</a>); the "Diskus Adherence Monitor" (<a href="./references#CD012226-bbs2-0004" title="BenderBG , ApterA , BogenDK , DickinsonP , FisherL , WamboldtFS , et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. Journal of the American Board of Family Medicine2010;23(2):159‐65. ">Bender 2010</a>); the "MDI Chorololog" (<a href="./references#CD012226-bbs2-0035" title="OnyirimbaF , ApterA , ReisineS , LittM , McCuskerC , ConnorsM , et al. Direct clinician‐to‐patient feedback discussion of inhaled steroid use: its effect on adherence. Annals of Allergy, Asthma and Immunology2003;90(4):411‐5. ">Onyirimba 2003</a>); and the "Nebuliser Chronolog" (<a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a>). <a href="./references#CD012226-bbs2-0015" title="HartCAH , LoveAM , GibsonNA , MorganN , PatonJY . Effects of an educational intervention directed at parental beliefs and anxieties about inhaled steroid medication of adherence. American Journal of Respiratory and Critical Care Medicine2002;165:A420. ">Hart 2002</a> and <a href="./references#CD012226-bbs2-0020" title="ApterAJ , BogenDK , WangX , RandCS , McElligottS , PolskyD , et al. Intervening to improve adherence and asthma outcomes in urban adults with moderate or severe asthma [Abstract]. American Journal of Respiratory and Critical Care Medicine2011;183:A3791. ApterAJ , WangX , BogenDK , RandCS , McElligottS , PolskyD , et al. Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial. Journal of Aallergy and Clinical Immunology2011;128(3):516‐23. NCT00115323 . Comparison of two medication adherence strategies to improve asthma treatment adherence [Individualized interventions to improve asthma adherence]. https://clinicaltrials.gov/show/NCT00115323 (first received 21 June 2005). [NCT00115323] ">NCT00115323</a> report using dose‐counting devices but do not name the specific product used. <a href="./references#CD012226-bbs2-0003" title="ADERE PEDIATRIC1 . Prospective, parallel‐group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticasone 50/250 mcg (Seretide) twice a day. ADERE PROJECT (Pediatric). //www.gsk‐clinicalstudyregister.com/study/ADERE%20PEDIATRIC%201?search=compound&amp;compound=fluticasone‐propionate‐salmeterol#rs (first received 28 September 2008). ">ADERE PEDIATRIC 1</a>, <a href="./references#CD012226-bbs2-0010" title="ChatkinJM , BlancoDC , ScagliaN , WagnerMB , FritscherCC , ChatkinJ , et al. Impact of a low‐cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. Journal of Asthma2006;43(4):263‐6. ">Chatkin 2006</a>, <a href="./references#CD012226-bbs2-0036" title="PriceD , RobertsonA , BullenK , RandC , HorneR , StaudingerH . Improved adherence with once‐daily versus twice‐daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open‐label study. BMC Pulmonary Medicine2010;10:1. ">Price 2010</a>, <a href="./references#CD012226-bbs2-0037" title="StrandbygaardU , ThomsenSF , BackerV . A daily SMS reminder increases adherence to asthma treatment: a three‐month follow‐up study. Respiratory Medicine2010;104(2):166‐71. ">Strandbygaard 2010</a> and <a href="./references#CD012226-bbs2-0038" title="UlrikCS , ClaudiusBK , TammM , HarvingH , SierstedHC , BackerV , et al. Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial.[Erratum appears in Clin Respir J. 2009 Jul;3(3):185]. Clinical Respiratory Journal2009;3(3):161‐8. ">Ulrik 2009</a> report counting the doses actuated/remaining on the returned inhaler but do not describe use of a monitoring device. </p> <p>With the exception of the MDILog‐II, these devices record the time and date of inhaler actuation, and most disregard multiple actuations in a short space of time ("dose‐dumping"). The MDI‐Log‐II also includes a measure of whether the drug was inhaled via a "temperature sensitive thermistor". Data can be uploaded onto a computer (for review and discussion in some studies) but in most cases were not visible to the participant day‐to‐day. In <a href="./references#CD012226-bbs2-0039" title="GoossensLMA , VasbinderEC , van DenBemtPMLA , Rutten‐Van MolkenMPMH . Cost‐effectiveness of real‐time medication monitoring in children with asthma. Value in Health2014;17(7):A329. VasbinderE , GoossensL , JanssensH , deWinterB , vanDijkL , VultoA , et al. E‐monitoring of asthma therapy to improve compliance in children (E‐MATIC). European Respiratory Journal2016;46:758‐67. [DOI: 10.1183/13993003.01698‐2015] VasbinderEC , GoossensLMA , JanssensH , deWinterBCM , vanDijkL , VultoAG , et al. E‐Monitoring of asthma therapy to improve compliance in children (E‐MATIC). Pharmacoepidemiology and Drug Safety2015;24(S1):489. [DOI: 10.1002/pds] VasbinderEC , JanssensHM , Rutten‐van MolkenMP , vanDijkL , deWinterBC , deGrootRC , et al. e‐Monitoring of asthma therapy to improve compliance in children using a real‐time medication monitoring system (RTMM): the e‐MATIC study protocol. BMC Medical Informatics and Decision Making2013;13(1):38. ">Vasbinder 2015 E‐MATIC</a>, the device sent data back to the study database via the mobile phone network, which allowed real‐time tailoring of adherence reminder text messages for participants. Some of the devices described above (e.g. the SmartInhaler) are capable of producing audiovisual inhaler reminders; studies investigating this as an intervention disabled this function in control groups (see comparison 2). </p> <p>Remaining studies used canister weight (<a href="./references#CD012226-bbs2-0004" title="BenderBG , ApterA , BogenDK , DickinsonP , FisherL , WamboldtFS , et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. Journal of the American Board of Family Medicine2010;23(2):159‐65. ">Bender 2010</a>; <a href="./references#CD012226-bbs2-0026" title="HederosCA , JansonS , HedlinG . Group discussions with parents have long‐term positive effects on the management of asthma with good cost‐benefit. Acta Paediatrica2005;94(5):602‐8. NCT00516633 . Intervention study to improve adherence in asthma [Does improved information in the form of group discussions with parents of newly diagnosed asthmatic children lead to a better quality of life for the families, an improved adherence and better development of the lung function of the children?]. clinicaltrials.gov/show/NCT00516633 (first received 13 August 2007). ">NCT00516633</a>) or a combination of pharmacy data and self‐report (<a href="./references#CD012226-bbs2-0012" title="GallefossF , BakkePS . How does patient education and self‐management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. American Journal of Respiratory and Critical Care Medicine1999;160(6):2000‐5. GallefossF , BakkePS . Impact of patient education and self‐management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine2000;94(3):279‐87. [CRS: 4900100000008905] GallefossF , BakkePS , RsgaardPK , KjaersgaardP . Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1999;159(3):812‐7. [CENTRAL: 160267; CRS: 4900100000006265; PUBMED: 10051255] ">Gallefoss 1999</a>; <a href="./references#CD012226-bbs2-0019" title="MehuysE , VanBortelL , DeBolleL , VanTongelenI , AnnemansL , RemonJP , et al. Effectiveness of pharmacist intervention for asthma control improvement. European Respiratory Journal2008;31(4):790‐9. MehuysE , vanBortelL , deBolleL , vanTongelenI , RemonJ‐P , AnnemansL , et al. Does pharmacist intervention lead to appropriate use of asthma medication and improved asthma control? [Leidt apothekersadvies over het optimaal gebruik van astmamedicatie tot een verbetering van de astmacontrole? Een gerandomiseerde gecontroleerde studie]. Farmaceutisch Tijdschrift voor Belgie2008;85(1):1‐9. ">Mehuys 2008</a>; <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a>; <a href="./references#CD012226-bbs2-0024" title="NCT00414817 . Telephone‐based program to promote inhaled corticosteroid adherence among individuals with asthma [Phone calls to promote adherence with inhaled corticosteroids]. clinicaltrials.gov/show/NCT00414817 (first received 20 December 2006). VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of automated phone calls to support inhaled corticosteroids (ICS) adherence. American Thoracic Society International Conference; May 15‐20, 2009; San Diego. 2009:A1089 [Poster #518]. VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of health information technology to improve medication adherence. American Journal of Managed Care2011;17(12):SP79‐87. VollmerWM , XuM , FeldsteinA , SmithD , WaterburyA , RandC . Comparison of pharmacy‐based measures of medication adherence. BMC Health Services Research2012;12:155. ">NCT00414817</a>; <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a>; <a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a>; <a href="./references#CD012226-bbs2-0028" title="GambleJ , HeaneyLG . An individualised nurse‐led programme to improve adherence in patients with difficult asthma ‐ 12 month outcomes. American Journal of Respiratory and Critical Care Medicine2010;181(1):A3258. GambleJ , StevensonM , HeaneyLG . A study of a multi‐level intervention to improve non‐adherence in difficult to control asthma. Respiratory Medicine2011;105(9):1308‐15. NCT01064869 . A nurse led programme to improve adherence in difficult asthma [Evaluation of the benefits of an individualised menu driven nurse led programme to improve adherence in difficult asthma]. clinicaltrials.gov/show/NCT01064869 (first received 8 February 2010). ">NCT01064869</a>; <a href="./references#CD012226-bbs2-0029" title="LavoieK , MoullecG , BlaisL , BeauchesneM‐F , LemiereC , LabrecqueM , et al. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, nonadherent asthmatics: results from a randomized controlled pilot study [Abstract]. Chest2011;140(4):915A. LavoieKL , LemiereC , LabrecqueM , BlaisL , BeauchesneM , MoullecG , et al. The efficacy of motivational interviewing on asthma medication adherence in non‐adherent, poorly controlled asthmatics: preliminary results of the asthma control trial (ACT). Psychosomatic Medicine2011;7(3):A‐9. LavoieKL , MoullecG , LemiereC , BlaisL , LabrecqueM , BeauchesneM‐F , et al. Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial. Patient Preference and Adherence2014;8:1555‐69. NCT01132430 . Motivational interviewing for medication adherence in asthma [Impact of a motivational interviewing intervention on medication adherence in patients with asthma]. https://clinicaltrials.gov/show/NCT01132430 (first received 27 May 2010). ">NCT01132430</a>). Two studies relied on self‐report (<a href="./references#CD012226-bbs2-0017" title="KoufopoulosJT , ConnerMT , GardnerPH , KellarI . A web‐based and mobile health social support intervention to promote adherence to inhaled asthma medications: randomized controlled trial. Journal of Medical Internet Research2016;18(6):e122. [CRS: 4900132000024092; PUBMED: 27298211] ">Koufopoulos 2016</a>; <a href="./references#CD012226-bbs2-0032" title="Kolmodin MacDonellK , NaarS , Gibson‐ScipioW , LamP , SecordE . The Detroit young adult asthma project: pilot of a technology‐based medication adherence intervention for African‐American emerging adults. Journal of Adolescent Health2016;59(4):465‐71. [DOI: 10.1016/j.jadohealth.2016.05.016] NCT01714141 . Multi‐component technology intervention for minority emerging adults with asthma. https://clinicaltrials.gov/ct2/show/NCT01714141 (accessed 21 July 2016). ">NCT01714141</a>). </p> <p>The three studies that investigated school‐based therapy (<a href="./references#CD012226-bbs2-0013" title="GeraldLB , McClureLA , HarringtonKF , ManganJM , GibsonL , AtchisonJ , et al. Design of the supervised asthma therapy study: implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials2008;29(2):304‐10. GeraldLB , McClureLA , ManganJM , HarringtonKF , GibsonL , ErwinS , et al. Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school‐based supervised asthma therapy. Pediatrics2009;123(2):466‐74. GeraldLB , PatelK , ZhangS , McClureL . Secondhand smoke exposure and asthma morbidity among elementary school children enrolled in a clinical trial. Chest2007;132(4):461. [DOI: 10.1378/chest.132.4_MeetingAbstracts.461] McClureLA , HarringtonKF , GrahamH , GeraldLB . Internet‐based monitoring of asthma symptoms, peak flow meter readings, and absence data in a school‐based clinical trial. Clinical Trials2008;5(1):31‐7. ">Gerald 2009</a>; <a href="./references#CD012226-bbs2-0014" title="HaltermanJS , SzilagyiPG , YoosHL , ConnKM , KaczorowskiJM , HolzhauerRJ , et al. Benefits of a school‐based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Archives of Pediatric and Adolescent Medicine2004;158(5):460‐7. ">Halterman 2004</a>; <a href="./references#CD012226-bbs2-0031" title="HaltermanJS , FagnanoM , MontesG , FisherS , TremblayP , TajonR , et al. The school‐based preventive asthma care trial: results of a pilot study. Journal of Pediatrics2012;161(6):1109‐15. HaltermanJS , SauerJ , FagnanoM , MontesG , FisherS , TremblayP , et al. Working toward a sustainable system of asthma care: development of the School‐Based Preventive Asthma Care Technology (SB‐PACT) trial. Journal of Asthma2012;49(4):395‐400. NCT01175434 . School‐based preventive asthma care technology: a trial using a novel technology to improve adherence (SB‐PACT). https://clinicaltrials.gov/ct2/show/NCT01175434 (first received 16 April 2010). ">NCT01175434</a>) did not measure or report adherence. </p> <p>Included studies reported the following outcomes: lung function (e.g. FEV<sub>1</sub>, peak expiratory flow rate (PEFR)) (n = 15); quality of life (e.g. AQLQ) (n = 13); rescue medication use (n = 11); asthma control (e.g. ACT, Asthma Control Questionnaire (ACQ)) (n = 10); hospitalisations (n = 9); exacerbations (n = 8); asthma symptoms (n = 8); absences from school/work (n = 7); emergency department (ED) visits (n = 7); OCS use (n = 4); participant satisfaction (n = 4); use of healthcare services (n = 5); beliefs about medication (n = 3); costs (n = 3); primary care/general practitioner (GP) visits (n = 3); adverse events (n = 3); unscheduled visits to a healthcare provider (n = 3); self‐efficacy (n = 2); anxiety and depression (e.g. Hospital Anxiety and Depression Scale (HADS)) (n = 2); asthma knowledge (n = 2); fractional exhaled nitrous oxide (n = 2); asthma morbidity (n = 1); parent and adolescent conflict (n = 1); functional severity index (n = 1); episodes of poor asthma control (n = 1); inhaler technique (n = 1); feasibility (n = 1); activity limitation (n = 1); parent sleep interruption (n = 1); and change in family plans due to the child's asthma (n = 1). </p> <p>We extracted and reported only our prespecified outcomes of interest.</p> </section> </section> <section id="CD012226-sec-0073"> <h4 class="title">Excluded studies</h4> <p>After full‐text review, we excluded 52 records, which were related to 45 unique studies. The most common reason for exclusion (n = 20) was that adherence to ICS was not the primary focus of the intervention, for example, the study involved multi‐faceted asthma education or shared decision making. The second most common reason (n = 12) was that the study was a trial of different ICS types, regimens or inhaler devices, in which adherence was <i>observed and reported</i> but improved adherence was not the main intention of the intervention. Nine studies were not of appropriate design for inclusion, one study recruited a mixed disease population, one recruited participants among whom less than 50% were using ICS and one study aimed to improve treatment adherence generally in asthma, rather than ICS specifically, and did not report the proportion using ICS. A final study aimed to investigate if Symbicort Maintenance and Reliever Therapy (SMART) could improve adherence, but our outcomes of interested would have been confounded by the different drugs and doses used in each arm; therefore, we excluded this study. </p> </section> </section> <section id="CD012226-sec-0074"> <h3 class="title">Risk of bias in included studies</h3> <p>As planned, we assessed each trial according to the Cochrane 'Risk of bias' tool (<a href="#CD012226-fig-0002">Figure 2</a>). In some cases, we assessed blinding, or lack or blinding, as associated with a different level of risk, depending on the outcome in question. We have noted in the <a href="./references#CD012226-sec-0144" title="">Characteristics of included studies</a> tables when this was the case, and we factored this into our GRADE decisions for these outcomes (e.g. a study at high risk of detection bias for patient‐reported outcomes, such as quality of life, might be at lower risk for other, more objective outcomes, such as electronically monitored adherence). </p> <div class="figure" id="CD012226-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012226-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012226-sec-0075"> <h4 class="title">Allocation</h4> <p>We considered all included studies to be at low (n = 23) or unclear (n = 16) risk of bias for the random sequence generation domain. We considered the following studies to be at low risk because study authors described an accepted method of generating a random sequence (e.g. using a computer‐generated random sequence): <a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a>; <a href="./references#CD012226-bbs2-0004" title="BenderBG , ApterA , BogenDK , DickinsonP , FisherL , WamboldtFS , et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. Journal of the American Board of Family Medicine2010;23(2):159‐65. ">Bender 2010</a>; <a href="./references#CD012226-bbs2-0007" title="BurgessSW , SlyPD , CooperDM , DevadasonSG . Novel spacer device does not improve adherence in childhood asthma. Pediatric Pulmonology2007;42(8):736‐9. ">Burgess 2007</a>; <a href="./references#CD012226-bbs2-0008" title="ChanAH , StewartAW , HarrisonJ , CamargoCAJr , BlackPN , MitchellEA . The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial. Lancet Respiratory Medicine2015;3(3):210‐9. ">Chan 2015</a>; <a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a>; <a href="./references#CD012226-bbs2-0012" title="GallefossF , BakkePS . How does patient education and self‐management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. American Journal of Respiratory and Critical Care Medicine1999;160(6):2000‐5. GallefossF , BakkePS . Impact of patient education and self‐management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine2000;94(3):279‐87. [CRS: 4900100000008905] GallefossF , BakkePS , RsgaardPK , KjaersgaardP . Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1999;159(3):812‐7. [CENTRAL: 160267; CRS: 4900100000006265; PUBMED: 10051255] ">Gallefoss 1999</a>; <a href="./references#CD012226-bbs2-0013" title="GeraldLB , McClureLA , HarringtonKF , ManganJM , GibsonL , AtchisonJ , et al. Design of the supervised asthma therapy study: implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials2008;29(2):304‐10. GeraldLB , McClureLA , ManganJM , HarringtonKF , GibsonL , ErwinS , et al. Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school‐based supervised asthma therapy. Pediatrics2009;123(2):466‐74. GeraldLB , PatelK , ZhangS , McClureL . Secondhand smoke exposure and asthma morbidity among elementary school children enrolled in a clinical trial. Chest2007;132(4):461. [DOI: 10.1378/chest.132.4_MeetingAbstracts.461] McClureLA , HarringtonKF , GrahamH , GeraldLB . Internet‐based monitoring of asthma symptoms, peak flow meter readings, and absence data in a school‐based clinical trial. Clinical Trials2008;5(1):31‐7. ">Gerald 2009</a>; <a href="./references#CD012226-bbs2-0014" title="HaltermanJS , SzilagyiPG , YoosHL , ConnKM , KaczorowskiJM , HolzhauerRJ , et al. Benefits of a school‐based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Archives of Pediatric and Adolescent Medicine2004;158(5):460‐7. ">Halterman 2004</a>; <a href="./references#CD012226-bbs2-0016" title="KampsJL . Improving adherence to inhaled corticosteroids in children with asthma [Dissertation]. University of Kansas, 2002. KampsJL , RapoffMA , RobertsMC , VarelaRE , BarnardM , OlsonN . Improving adherence to inhaled corticosteroids in children with asthma: a pilot of a randomized clinical trial. Children's Health Care2008;37(4):261‐77. ">Kamps 2008</a>; <a href="./references#CD012226-bbs2-0017" title="KoufopoulosJT , ConnerMT , GardnerPH , KellarI . A web‐based and mobile health social support intervention to promote adherence to inhaled asthma medications: randomized controlled trial. Journal of Medical Internet Research2016;18(6):e122. [CRS: 4900132000024092; PUBMED: 27298211] ">Koufopoulos 2016</a>; <a href="./references#CD012226-bbs2-0019" title="MehuysE , VanBortelL , DeBolleL , VanTongelenI , AnnemansL , RemonJP , et al. Effectiveness of pharmacist intervention for asthma control improvement. European Respiratory Journal2008;31(4):790‐9. MehuysE , vanBortelL , deBolleL , vanTongelenI , RemonJ‐P , AnnemansL , et al. Does pharmacist intervention lead to appropriate use of asthma medication and improved asthma control? [Leidt apothekersadvies over het optimaal gebruik van astmamedicatie tot een verbetering van de astmacontrole? Een gerandomiseerde gecontroleerde studie]. Farmaceutisch Tijdschrift voor Belgie2008;85(1):1‐9. ">Mehuys 2008</a>; <a href="./references#CD012226-bbs2-0020" title="ApterAJ , BogenDK , WangX , RandCS , McElligottS , PolskyD , et al. Intervening to improve adherence and asthma outcomes in urban adults with moderate or severe asthma [Abstract]. American Journal of Respiratory and Critical Care Medicine2011;183:A3791. ApterAJ , WangX , BogenDK , RandCS , McElligottS , PolskyD , et al. Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial. Journal of Aallergy and Clinical Immunology2011;128(3):516‐23. NCT00115323 . Comparison of two medication adherence strategies to improve asthma treatment adherence [Individualized interventions to improve asthma adherence]. https://clinicaltrials.gov/show/NCT00115323 (first received 21 June 2005). [NCT00115323] ">NCT00115323</a>; <a href="./references#CD012226-bbs2-0022" title="AdamsCD , JosephKE , MacLarenJE , DeMoreM , KovenL , DetweilerMF , et al. Parent‐youth teamwork in pediatric asthma management [Abstract]. Journal of Allergy and Clinical Immunology2004;113(2):S159. DuncanCL , HoganMB , TienKJ , GravesMM , ChorneyJM , ZettlerMD , et al. Efficacy of a parent‐youth teamwork intervention to promote adherence in pediatric asthma. Journal of Pediatric Psychology2013;38(6):617‐28. NCT00166582 . Parent‐youth teamwork in pediatric asthma management. https://clinicaltrials.gov/show/NCT00166582 (first received 9 September 2009). ">NCT00166582</a>; <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a>; <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a>; <a href="./references#CD012226-bbs2-0029" title="LavoieK , MoullecG , BlaisL , BeauchesneM‐F , LemiereC , LabrecqueM , et al. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, nonadherent asthmatics: results from a randomized controlled pilot study [Abstract]. Chest2011;140(4):915A. LavoieKL , LemiereC , LabrecqueM , BlaisL , BeauchesneM , MoullecG , et al. The efficacy of motivational interviewing on asthma medication adherence in non‐adherent, poorly controlled asthmatics: preliminary results of the asthma control trial (ACT). Psychosomatic Medicine2011;7(3):A‐9. LavoieKL , MoullecG , LemiereC , BlaisL , LabrecqueM , BeauchesneM‐F , et al. Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial. Patient Preference and Adherence2014;8:1555‐69. NCT01132430 . Motivational interviewing for medication adherence in asthma [Impact of a motivational interviewing intervention on medication adherence in patients with asthma]. https://clinicaltrials.gov/show/NCT01132430 (first received 27 May 2010). ">NCT01132430</a>; <a href="./references#CD012226-bbs2-0030" title="MosnaimG , LiH , MartinM , BelicePJ , AveryE , RyanN , et al. The use of coping peer support and mp3 technology to improve adherence to inhaled corticosteroids among low‐income minority adolescents. Journal of Allergy and Clinical Immunology2013;131(2):AB133 [478]. MosnaimG , LiH , MartinM , RichardsonD , BelicePJ , AveryE , et al. The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology: In Practice2013;1(5):485‐93. NCT01169883 . Coping peer intervention for adherence. https://clinicaltrials.gov/show/NCT01169883 (first received 23 July 2010). PowellL . The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology2013;0(5):485‐93. ">NCT01169883</a>; <a href="./references#CD012226-bbs2-0031" title="HaltermanJS , FagnanoM , MontesG , FisherS , TremblayP , TajonR , et al. The school‐based preventive asthma care trial: results of a pilot study. Journal of Pediatrics2012;161(6):1109‐15. HaltermanJS , SauerJ , FagnanoM , MontesG , FisherS , TremblayP , et al. Working toward a sustainable system of asthma care: development of the School‐Based Preventive Asthma Care Technology (SB‐PACT) trial. Journal of Asthma2012;49(4):395‐400. NCT01175434 . School‐based preventive asthma care technology: a trial using a novel technology to improve adherence (SB‐PACT). https://clinicaltrials.gov/ct2/show/NCT01175434 (first received 16 April 2010). ">NCT01175434</a>; <a href="./references#CD012226-bbs2-0032" title="Kolmodin MacDonellK , NaarS , Gibson‐ScipioW , LamP , SecordE . The Detroit young adult asthma project: pilot of a technology‐based medication adherence intervention for African‐American emerging adults. Journal of Adolescent Health2016;59(4):465‐71. [DOI: 10.1016/j.jadohealth.2016.05.016] NCT01714141 . Multi‐component technology intervention for minority emerging adults with asthma. https://clinicaltrials.gov/ct2/show/NCT01714141 (accessed 21 July 2016). ">NCT01714141</a>; <a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a>; <a href="./references#CD012226-bbs2-0037" title="StrandbygaardU , ThomsenSF , BackerV . A daily SMS reminder increases adherence to asthma treatment: a three‐month follow‐up study. Respiratory Medicine2010;104(2):166‐71. ">Strandbygaard 2010</a>; <a href="./references#CD012226-bbs2-0039" title="GoossensLMA , VasbinderEC , van DenBemtPMLA , Rutten‐Van MolkenMPMH . Cost‐effectiveness of real‐time medication monitoring in children with asthma. Value in Health2014;17(7):A329. VasbinderE , GoossensL , JanssensH , deWinterB , vanDijkL , VultoA , et al. E‐monitoring of asthma therapy to improve compliance in children (E‐MATIC). European Respiratory Journal2016;46:758‐67. [DOI: 10.1183/13993003.01698‐2015] VasbinderEC , GoossensLMA , JanssensH , deWinterBCM , vanDijkL , VultoAG , et al. E‐Monitoring of asthma therapy to improve compliance in children (E‐MATIC). Pharmacoepidemiology and Drug Safety2015;24(S1):489. [DOI: 10.1002/pds] VasbinderEC , JanssensHM , Rutten‐van MolkenMP , vanDijkL , deWinterBC , deGrootRC , et al. e‐Monitoring of asthma therapy to improve compliance in children using a real‐time medication monitoring system (RTMM): the e‐MATIC study protocol. BMC Medical Informatics and Decision Making2013;13(1):38. ">Vasbinder 2015 E‐MATIC</a>. We were unable to make a judgement on the following studies considered at unclear risk because investigators described them as 'randomised' but provided no other details: <a href="./references#CD012226-bbs2-0002" title="ACTRN12607000489493 . The impact of providing feedback on adherence in childhood asthma. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=82288 (first received 14 September 2007). BurgessSW , SlyPD , DevadasonSG . Providing feedback on adherence increases use of preventive medication by asthmatic children. Journal of Asthma2010;47(2):198‐201. ">ACTRN12607000489493</a>; <a href="./references#CD012226-bbs2-0003" title="ADERE PEDIATRIC1 . Prospective, parallel‐group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticasone 50/250 mcg (Seretide) twice a day. ADERE PROJECT (Pediatric). //www.gsk‐clinicalstudyregister.com/study/ADERE%20PEDIATRIC%201?search=compound&amp;compound=fluticasone‐propionate‐salmeterol#rs (first received 28 September 2008). ">ADERE PEDIATRIC 1</a>; <a href="./references#CD012226-bbs2-0005" title="BlackPN , GarrattE , ArandjusC , SalmonBT , SutherlandG . An inhaler with ring tones improves compliance with inhaled steroids in childhood asthma [Abstract]. American Thoracic Society International Conference; May 16‐21, 2008; Toronto. 2008:Poster #A46. ">Black 2008</a>; <a href="./references#CD012226-bbs2-0006" title="BosleyCM , ParryDT , CochraneGM . Patient compliance with inhaled medication: does combining beta‐agonists with corticosteroids improve compliance?. European Respiratory Journal1994;7(3):504‐9. ">Bosley 1994</a>; <a href="./references#CD012226-bbs2-0010" title="ChatkinJM , BlancoDC , ScagliaN , WagnerMB , FritscherCC , ChatkinJ , et al. Impact of a low‐cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. Journal of Asthma2006;43(4):263‐6. ">Chatkin 2006</a>; <a href="./references#CD012226-bbs2-0015" title="HartCAH , LoveAM , GibsonNA , MorganN , PatonJY . Effects of an educational intervention directed at parental beliefs and anxieties about inhaled steroid medication of adherence. American Journal of Respiratory and Critical Care Medicine2002;165:A420. ">Hart 2002</a>; <a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a>; <a href="./references#CD012226-bbs2-0021" title="NCT00149487 . Enhancing treatment adherence in pediatric asthma with a problem solving intervention [Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma]. https://clinicaltrials.gov/ct2/show/NCT00149487 (first received 6 September 2005). NCT00149487 . Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma. clinicaltrials.gov/show/NCT00149487 (first received 6 September 2005). RohanJ , DrotarD , McNallyK , SchluchterM , RiekertK , VavrekP , et al. Adherence to pediatric asthma treatment in economically disadvantaged African‐American children and adolescents: an application of growth curve analysis. Journal of Pediatric Psychology2010;35(4):394‐404. ">NCT00149487</a>; <a href="./references#CD012226-bbs2-0024" title="NCT00414817 . Telephone‐based program to promote inhaled corticosteroid adherence among individuals with asthma [Phone calls to promote adherence with inhaled corticosteroids]. clinicaltrials.gov/show/NCT00414817 (first received 20 December 2006). VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of automated phone calls to support inhaled corticosteroids (ICS) adherence. American Thoracic Society International Conference; May 15‐20, 2009; San Diego. 2009:A1089 [Poster #518]. VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of health information technology to improve medication adherence. American Journal of Managed Care2011;17(12):SP79‐87. VollmerWM , XuM , FeldsteinA , SmithD , WaterburyA , RandC . Comparison of pharmacy‐based measures of medication adherence. BMC Health Services Research2012;12:155. ">NCT00414817</a>; <a href="./references#CD012226-bbs2-0026" title="HederosCA , JansonS , HedlinG . Group discussions with parents have long‐term positive effects on the management of asthma with good cost‐benefit. Acta Paediatrica2005;94(5):602‐8. NCT00516633 . Intervention study to improve adherence in asthma [Does improved information in the form of group discussions with parents of newly diagnosed asthmatic children lead to a better quality of life for the families, an improved adherence and better development of the lung function of the children?]. clinicaltrials.gov/show/NCT00516633 (first received 13 August 2007). ">NCT00516633</a>; <a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a>; <a href="./references#CD012226-bbs2-0028" title="GambleJ , HeaneyLG . An individualised nurse‐led programme to improve adherence in patients with difficult asthma ‐ 12 month outcomes. American Journal of Respiratory and Critical Care Medicine2010;181(1):A3258. GambleJ , StevensonM , HeaneyLG . A study of a multi‐level intervention to improve non‐adherence in difficult to control asthma. Respiratory Medicine2011;105(9):1308‐15. NCT01064869 . A nurse led programme to improve adherence in difficult asthma [Evaluation of the benefits of an individualised menu driven nurse led programme to improve adherence in difficult asthma]. clinicaltrials.gov/show/NCT01064869 (first received 8 February 2010). ">NCT01064869</a>; <a href="./references#CD012226-bbs2-0033" title="NCT02413528 . Pilot study of a mobile asthma adherence intervention [Pilot study of a mobile intervention to increase adherence to asthma medication among adolescents]. https://clinicaltrials.gov/show/NCT02413528 (first received 7 April 2015). ">NCT02413528</a>; <a href="./references#CD012226-bbs2-0035" title="OnyirimbaF , ApterA , ReisineS , LittM , McCuskerC , ConnorsM , et al. Direct clinician‐to‐patient feedback discussion of inhaled steroid use: its effect on adherence. Annals of Allergy, Asthma and Immunology2003;90(4):411‐5. ">Onyirimba 2003</a>; <a href="./references#CD012226-bbs2-0036" title="PriceD , RobertsonA , BullenK , RandC , HorneR , StaudingerH . Improved adherence with once‐daily versus twice‐daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open‐label study. BMC Pulmonary Medicine2010;10:1. ">Price 2010</a>; <a href="./references#CD012226-bbs2-0038" title="UlrikCS , ClaudiusBK , TammM , HarvingH , SierstedHC , BackerV , et al. Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial.[Erratum appears in Clin Respir J. 2009 Jul;3(3):185]. Clinical Respiratory Journal2009;3(3):161‐8. ">Ulrik 2009</a>. </p> <p>Only 14 included studies (<a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a>; <a href="./references#CD012226-bbs2-0002" title="ACTRN12607000489493 . The impact of providing feedback on adherence in childhood asthma. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=82288 (first received 14 September 2007). BurgessSW , SlyPD , DevadasonSG . Providing feedback on adherence increases use of preventive medication by asthmatic children. Journal of Asthma2010;47(2):198‐201. ">ACTRN12607000489493</a>; <a href="./references#CD012226-bbs2-0008" title="ChanAH , StewartAW , HarrisonJ , CamargoCAJr , BlackPN , MitchellEA . The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial. Lancet Respiratory Medicine2015;3(3):210‐9. ">Chan 2015</a>; <a href="./references#CD012226-bbs2-0009" title="CharlesT , QuinnD , WeatherallM , AldingtonS , BeasleyR , HoltS . An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. Journal of Allergy and Clinical Immunology2007;119(4):811‐6. ">Charles 2007</a>; <a href="./references#CD012226-bbs2-0013" title="GeraldLB , McClureLA , HarringtonKF , ManganJM , GibsonL , AtchisonJ , et al. Design of the supervised asthma therapy study: implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials2008;29(2):304‐10. GeraldLB , McClureLA , ManganJM , HarringtonKF , GibsonL , ErwinS , et al. Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school‐based supervised asthma therapy. Pediatrics2009;123(2):466‐74. GeraldLB , PatelK , ZhangS , McClureL . Secondhand smoke exposure and asthma morbidity among elementary school children enrolled in a clinical trial. Chest2007;132(4):461. [DOI: 10.1378/chest.132.4_MeetingAbstracts.461] McClureLA , HarringtonKF , GrahamH , GeraldLB . Internet‐based monitoring of asthma symptoms, peak flow meter readings, and absence data in a school‐based clinical trial. Clinical Trials2008;5(1):31‐7. ">Gerald 2009</a>; <a href="./references#CD012226-bbs2-0014" title="HaltermanJS , SzilagyiPG , YoosHL , ConnKM , KaczorowskiJM , HolzhauerRJ , et al. Benefits of a school‐based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Archives of Pediatric and Adolescent Medicine2004;158(5):460‐7. ">Halterman 2004</a>; <a href="./references#CD012226-bbs2-0019" title="MehuysE , VanBortelL , DeBolleL , VanTongelenI , AnnemansL , RemonJP , et al. Effectiveness of pharmacist intervention for asthma control improvement. European Respiratory Journal2008;31(4):790‐9. MehuysE , vanBortelL , deBolleL , vanTongelenI , RemonJ‐P , AnnemansL , et al. Does pharmacist intervention lead to appropriate use of asthma medication and improved asthma control? [Leidt apothekersadvies over het optimaal gebruik van astmamedicatie tot een verbetering van de astmacontrole? Een gerandomiseerde gecontroleerde studie]. Farmaceutisch Tijdschrift voor Belgie2008;85(1):1‐9. ">Mehuys 2008</a>; <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a>; <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a>; <a href="./references#CD012226-bbs2-0029" title="LavoieK , MoullecG , BlaisL , BeauchesneM‐F , LemiereC , LabrecqueM , et al. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, nonadherent asthmatics: results from a randomized controlled pilot study [Abstract]. Chest2011;140(4):915A. LavoieKL , LemiereC , LabrecqueM , BlaisL , BeauchesneM , MoullecG , et al. The efficacy of motivational interviewing on asthma medication adherence in non‐adherent, poorly controlled asthmatics: preliminary results of the asthma control trial (ACT). Psychosomatic Medicine2011;7(3):A‐9. LavoieKL , MoullecG , LemiereC , BlaisL , LabrecqueM , BeauchesneM‐F , et al. Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial. Patient Preference and Adherence2014;8:1555‐69. NCT01132430 . Motivational interviewing for medication adherence in asthma [Impact of a motivational interviewing intervention on medication adherence in patients with asthma]. https://clinicaltrials.gov/show/NCT01132430 (first received 27 May 2010). ">NCT01132430</a>; <a href="./references#CD012226-bbs2-0031" title="HaltermanJS , FagnanoM , MontesG , FisherS , TremblayP , TajonR , et al. The school‐based preventive asthma care trial: results of a pilot study. Journal of Pediatrics2012;161(6):1109‐15. HaltermanJS , SauerJ , FagnanoM , MontesG , FisherS , TremblayP , et al. Working toward a sustainable system of asthma care: development of the School‐Based Preventive Asthma Care Technology (SB‐PACT) trial. Journal of Asthma2012;49(4):395‐400. NCT01175434 . School‐based preventive asthma care technology: a trial using a novel technology to improve adherence (SB‐PACT). https://clinicaltrials.gov/ct2/show/NCT01175434 (first received 16 April 2010). ">NCT01175434</a>; <a href="./references#CD012226-bbs2-0032" title="Kolmodin MacDonellK , NaarS , Gibson‐ScipioW , LamP , SecordE . The Detroit young adult asthma project: pilot of a technology‐based medication adherence intervention for African‐American emerging adults. Journal of Adolescent Health2016;59(4):465‐71. [DOI: 10.1016/j.jadohealth.2016.05.016] NCT01714141 . Multi‐component technology intervention for minority emerging adults with asthma. https://clinicaltrials.gov/ct2/show/NCT01714141 (accessed 21 July 2016). ">NCT01714141</a>; <a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a>; <a href="./references#CD012226-bbs2-0039" title="GoossensLMA , VasbinderEC , van DenBemtPMLA , Rutten‐Van MolkenMPMH . Cost‐effectiveness of real‐time medication monitoring in children with asthma. Value in Health2014;17(7):A329. VasbinderE , GoossensL , JanssensH , deWinterB , vanDijkL , VultoA , et al. E‐monitoring of asthma therapy to improve compliance in children (E‐MATIC). European Respiratory Journal2016;46:758‐67. [DOI: 10.1183/13993003.01698‐2015] VasbinderEC , GoossensLMA , JanssensH , deWinterBCM , vanDijkL , VultoAG , et al. E‐Monitoring of asthma therapy to improve compliance in children (E‐MATIC). Pharmacoepidemiology and Drug Safety2015;24(S1):489. [DOI: 10.1002/pds] VasbinderEC , JanssensHM , Rutten‐van MolkenMP , vanDijkL , deWinterBC , deGrootRC , et al. e‐Monitoring of asthma therapy to improve compliance in children using a real‐time medication monitoring system (RTMM): the e‐MATIC study protocol. BMC Medical Informatics and Decision Making2013;13(1):38. ">Vasbinder 2015 E‐MATIC</a>) described the method of allocation concealment adequately to be considered at low risk of bias in this domain. Accepted methods included use of sequentially numbered, sealed, opaque envelopes. We considered one study (<a href="./references#CD012226-bbs2-0022" title="AdamsCD , JosephKE , MacLarenJE , DeMoreM , KovenL , DetweilerMF , et al. Parent‐youth teamwork in pediatric asthma management [Abstract]. Journal of Allergy and Clinical Immunology2004;113(2):S159. DuncanCL , HoganMB , TienKJ , GravesMM , ChorneyJM , ZettlerMD , et al. Efficacy of a parent‐youth teamwork intervention to promote adherence in pediatric asthma. Journal of Pediatric Psychology2013;38(6):617‐28. NCT00166582 . Parent‐youth teamwork in pediatric asthma management. https://clinicaltrials.gov/show/NCT00166582 (first received 9 September 2009). ">NCT00166582</a>) to be at high risk because the sequence was available to the research assistant who recruited participants. We judged the remaining 24 studies to be at unclear risk, as investigators did not describe methods used to conceal allocation (<a href="./references#CD012226-bbs2-0003" title="ADERE PEDIATRIC1 . Prospective, parallel‐group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticasone 50/250 mcg (Seretide) twice a day. ADERE PROJECT (Pediatric). //www.gsk‐clinicalstudyregister.com/study/ADERE%20PEDIATRIC%201?search=compound&amp;compound=fluticasone‐propionate‐salmeterol#rs (first received 28 September 2008). ">ADERE PEDIATRIC 1</a>; <a href="./references#CD012226-bbs2-0004" title="BenderBG , ApterA , BogenDK , DickinsonP , FisherL , WamboldtFS , et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. Journal of the American Board of Family Medicine2010;23(2):159‐65. ">Bender 2010</a>; <a href="./references#CD012226-bbs2-0005" title="BlackPN , GarrattE , ArandjusC , SalmonBT , SutherlandG . An inhaler with ring tones improves compliance with inhaled steroids in childhood asthma [Abstract]. American Thoracic Society International Conference; May 16‐21, 2008; Toronto. 2008:Poster #A46. ">Black 2008</a>; <a href="./references#CD012226-bbs2-0006" title="BosleyCM , ParryDT , CochraneGM . Patient compliance with inhaled medication: does combining beta‐agonists with corticosteroids improve compliance?. European Respiratory Journal1994;7(3):504‐9. ">Bosley 1994</a>; <a href="./references#CD012226-bbs2-0007" title="BurgessSW , SlyPD , CooperDM , DevadasonSG . Novel spacer device does not improve adherence in childhood asthma. Pediatric Pulmonology2007;42(8):736‐9. ">Burgess 2007</a>; <a href="./references#CD012226-bbs2-0010" title="ChatkinJM , BlancoDC , ScagliaN , WagnerMB , FritscherCC , ChatkinJ , et al. Impact of a low‐cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. Journal of Asthma2006;43(4):263‐6. ">Chatkin 2006</a>; <a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a>; <a href="./references#CD012226-bbs2-0012" title="GallefossF , BakkePS . How does patient education and self‐management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. American Journal of Respiratory and Critical Care Medicine1999;160(6):2000‐5. GallefossF , BakkePS . Impact of patient education and self‐management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine2000;94(3):279‐87. [CRS: 4900100000008905] GallefossF , BakkePS , RsgaardPK , KjaersgaardP . Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1999;159(3):812‐7. [CENTRAL: 160267; CRS: 4900100000006265; PUBMED: 10051255] ">Gallefoss 1999</a>; <a href="./references#CD012226-bbs2-0015" title="HartCAH , LoveAM , GibsonNA , MorganN , PatonJY . Effects of an educational intervention directed at parental beliefs and anxieties about inhaled steroid medication of adherence. American Journal of Respiratory and Critical Care Medicine2002;165:A420. ">Hart 2002</a>; <a href="./references#CD012226-bbs2-0016" title="KampsJL . Improving adherence to inhaled corticosteroids in children with asthma [Dissertation]. University of Kansas, 2002. KampsJL , RapoffMA , RobertsMC , VarelaRE , BarnardM , OlsonN . Improving adherence to inhaled corticosteroids in children with asthma: a pilot of a randomized clinical trial. Children's Health Care2008;37(4):261‐77. ">Kamps 2008</a>; <a href="./references#CD012226-bbs2-0017" title="KoufopoulosJT , ConnerMT , GardnerPH , KellarI . A web‐based and mobile health social support intervention to promote adherence to inhaled asthma medications: randomized controlled trial. Journal of Medical Internet Research2016;18(6):e122. [CRS: 4900132000024092; PUBMED: 27298211] ">Koufopoulos 2016</a>; <a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a>; <a href="./references#CD012226-bbs2-0020" title="ApterAJ , BogenDK , WangX , RandCS , McElligottS , PolskyD , et al. Intervening to improve adherence and asthma outcomes in urban adults with moderate or severe asthma [Abstract]. American Journal of Respiratory and Critical Care Medicine2011;183:A3791. ApterAJ , WangX , BogenDK , RandCS , McElligottS , PolskyD , et al. Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial. Journal of Aallergy and Clinical Immunology2011;128(3):516‐23. NCT00115323 . Comparison of two medication adherence strategies to improve asthma treatment adherence [Individualized interventions to improve asthma adherence]. https://clinicaltrials.gov/show/NCT00115323 (first received 21 June 2005). [NCT00115323] ">NCT00115323</a>; <a href="./references#CD012226-bbs2-0021" title="NCT00149487 . Enhancing treatment adherence in pediatric asthma with a problem solving intervention [Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma]. https://clinicaltrials.gov/ct2/show/NCT00149487 (first received 6 September 2005). NCT00149487 . Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma. clinicaltrials.gov/show/NCT00149487 (first received 6 September 2005). RohanJ , DrotarD , McNallyK , SchluchterM , RiekertK , VavrekP , et al. Adherence to pediatric asthma treatment in economically disadvantaged African‐American children and adolescents: an application of growth curve analysis. Journal of Pediatric Psychology2010;35(4):394‐404. ">NCT00149487</a>; <a href="./references#CD012226-bbs2-0024" title="NCT00414817 . Telephone‐based program to promote inhaled corticosteroid adherence among individuals with asthma [Phone calls to promote adherence with inhaled corticosteroids]. clinicaltrials.gov/show/NCT00414817 (first received 20 December 2006). VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of automated phone calls to support inhaled corticosteroids (ICS) adherence. American Thoracic Society International Conference; May 15‐20, 2009; San Diego. 2009:A1089 [Poster #518]. VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of health information technology to improve medication adherence. American Journal of Managed Care2011;17(12):SP79‐87. VollmerWM , XuM , FeldsteinA , SmithD , WaterburyA , RandC . Comparison of pharmacy‐based measures of medication adherence. BMC Health Services Research2012;12:155. ">NCT00414817</a>; <a href="./references#CD012226-bbs2-0026" title="HederosCA , JansonS , HedlinG . Group discussions with parents have long‐term positive effects on the management of asthma with good cost‐benefit. Acta Paediatrica2005;94(5):602‐8. NCT00516633 . Intervention study to improve adherence in asthma [Does improved information in the form of group discussions with parents of newly diagnosed asthmatic children lead to a better quality of life for the families, an improved adherence and better development of the lung function of the children?]. clinicaltrials.gov/show/NCT00516633 (first received 13 August 2007). ">NCT00516633</a>; <a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a>; <a href="./references#CD012226-bbs2-0028" title="GambleJ , HeaneyLG . An individualised nurse‐led programme to improve adherence in patients with difficult asthma ‐ 12 month outcomes. American Journal of Respiratory and Critical Care Medicine2010;181(1):A3258. GambleJ , StevensonM , HeaneyLG . A study of a multi‐level intervention to improve non‐adherence in difficult to control asthma. Respiratory Medicine2011;105(9):1308‐15. NCT01064869 . A nurse led programme to improve adherence in difficult asthma [Evaluation of the benefits of an individualised menu driven nurse led programme to improve adherence in difficult asthma]. clinicaltrials.gov/show/NCT01064869 (first received 8 February 2010). ">NCT01064869</a>; <a href="./references#CD012226-bbs2-0030" title="MosnaimG , LiH , MartinM , BelicePJ , AveryE , RyanN , et al. The use of coping peer support and mp3 technology to improve adherence to inhaled corticosteroids among low‐income minority adolescents. Journal of Allergy and Clinical Immunology2013;131(2):AB133 [478]. MosnaimG , LiH , MartinM , RichardsonD , BelicePJ , AveryE , et al. The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology: In Practice2013;1(5):485‐93. NCT01169883 . Coping peer intervention for adherence. https://clinicaltrials.gov/show/NCT01169883 (first received 23 July 2010). PowellL . The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology2013;0(5):485‐93. ">NCT01169883</a>; <a href="./references#CD012226-bbs2-0033" title="NCT02413528 . Pilot study of a mobile asthma adherence intervention [Pilot study of a mobile intervention to increase adherence to asthma medication among adolescents]. https://clinicaltrials.gov/show/NCT02413528 (first received 7 April 2015). ">NCT02413528</a>; <a href="./references#CD012226-bbs2-0035" title="OnyirimbaF , ApterA , ReisineS , LittM , McCuskerC , ConnorsM , et al. Direct clinician‐to‐patient feedback discussion of inhaled steroid use: its effect on adherence. Annals of Allergy, Asthma and Immunology2003;90(4):411‐5. ">Onyirimba 2003</a>; <a href="./references#CD012226-bbs2-0036" title="PriceD , RobertsonA , BullenK , RandC , HorneR , StaudingerH . Improved adherence with once‐daily versus twice‐daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open‐label study. BMC Pulmonary Medicine2010;10:1. ">Price 2010</a>; <a href="./references#CD012226-bbs2-0037" title="StrandbygaardU , ThomsenSF , BackerV . A daily SMS reminder increases adherence to asthma treatment: a three‐month follow‐up study. Respiratory Medicine2010;104(2):166‐71. ">Strandbygaard 2010</a>; <a href="./references#CD012226-bbs2-0038" title="UlrikCS , ClaudiusBK , TammM , HarvingH , SierstedHC , BackerV , et al. Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial.[Erratum appears in Clin Respir J. 2009 Jul;3(3):185]. Clinical Respiratory Journal2009;3(3):161‐8. ">Ulrik 2009</a>). </p> </section> <section id="CD012226-sec-0076"> <h4 class="title">Blinding</h4> <p>Owing to the nature of the intervention, blinding of participants and personnel was not possible in most trials, and we judged 34 of the 39 included studies to be to be at overall high risk of performance bias. We judged two studies (<a href="./references#CD012226-bbs2-0006" title="BosleyCM , ParryDT , CochraneGM . Patient compliance with inhaled medication: does combining beta‐agonists with corticosteroids improve compliance?. European Respiratory Journal1994;7(3):504‐9. ">Bosley 1994</a>; <a href="./references#CD012226-bbs2-0010" title="ChatkinJM , BlancoDC , ScagliaN , WagnerMB , FritscherCC , ChatkinJ , et al. Impact of a low‐cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. Journal of Asthma2006;43(4):263‐6. ">Chatkin 2006</a>) to be at low risk of performance bias. <a href="./references#CD012226-bbs2-0006" title="BosleyCM , ParryDT , CochraneGM . Patient compliance with inhaled medication: does combining beta‐agonists with corticosteroids improve compliance?. European Respiratory Journal1994;7(3):504‐9. ">Bosley 1994</a> measured only outcomes of lung function and electronically monitored adherence, which are more objective outcomes and therefore are less likely to be susceptible to performance bias. In addition, participants were unaware that they were being monitored. Similarly, <a href="./references#CD012226-bbs2-0010" title="ChatkinJM , BlancoDC , ScagliaN , WagnerMB , FritscherCC , ChatkinJ , et al. Impact of a low‐cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. Journal of Asthma2006;43(4):263‐6. ">Chatkin 2006</a> did not describe blinding but reported only the outcome of electronically monitored adherence. We assessed three studies (<a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a>; <a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a>; <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a>) to be at unclear risk of performance bias. <a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a> did not describe procedures used to mask participants or personnel, and although some outcomes were more objective and were less prone to bias, others, including asthma symptoms, were more at risk. Therefore, we judged this study to be at unclear risk overall. Similarly, for <a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a>, participants were unaware that the main outcome of interest was adherence and they were monitored covertly, but other outcomes, such as ACQ, were at greater risk of bias. Finally, <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a> randomised healthcare practitioners rather than individuals. Practitioners were aware of their group allocation, and it is unclear how this knowledge may have influenced adherence of their patients in ways unintended by the intervention itself. </p> <p>Many of the outcomes of interest in this review are patient reported (e.g. asthma control, quality of life), and the unblinded participant is often the outcome assessor. We therefore judged 29 of the included studies to be at high risk of bias in the outcome assessment domain. We judged six studies to be at low risk (<a href="./references#CD012226-bbs2-0006" title="BosleyCM , ParryDT , CochraneGM . Patient compliance with inhaled medication: does combining beta‐agonists with corticosteroids improve compliance?. European Respiratory Journal1994;7(3):504‐9. ">Bosley 1994</a>; <a href="./references#CD012226-bbs2-0010" title="ChatkinJM , BlancoDC , ScagliaN , WagnerMB , FritscherCC , ChatkinJ , et al. Impact of a low‐cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. Journal of Asthma2006;43(4):263‐6. ">Chatkin 2006</a>; <a href="./references#CD012226-bbs2-0024" title="NCT00414817 . Telephone‐based program to promote inhaled corticosteroid adherence among individuals with asthma [Phone calls to promote adherence with inhaled corticosteroids]. clinicaltrials.gov/show/NCT00414817 (first received 20 December 2006). VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of automated phone calls to support inhaled corticosteroids (ICS) adherence. American Thoracic Society International Conference; May 15‐20, 2009; San Diego. 2009:A1089 [Poster #518]. VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of health information technology to improve medication adherence. American Journal of Managed Care2011;17(12):SP79‐87. VollmerWM , XuM , FeldsteinA , SmithD , WaterburyA , RandC . Comparison of pharmacy‐based measures of medication adherence. BMC Health Services Research2012;12:155. ">NCT00414817</a>; <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a>; <a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a>; <a href="./references#CD012226-bbs2-0030" title="MosnaimG , LiH , MartinM , BelicePJ , AveryE , RyanN , et al. The use of coping peer support and mp3 technology to improve adherence to inhaled corticosteroids among low‐income minority adolescents. Journal of Allergy and Clinical Immunology2013;131(2):AB133 [478]. MosnaimG , LiH , MartinM , RichardsonD , BelicePJ , AveryE , et al. The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology: In Practice2013;1(5):485‐93. NCT01169883 . Coping peer intervention for adherence. https://clinicaltrials.gov/show/NCT01169883 (first received 23 July 2010). PowellL . The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology2013;0(5):485‐93. ">NCT01169883</a>). We made this judgement because the outcomes measured were objective and were unlikely to be influenced by outcome assessors' knowledge of group allocation (e.g. usage of healthcare services from medical records, data from electronic monitoring devices), and for some specific measures, studies described masking outcome assessors to group allocation. We judged the remaining four studies (<a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a>; <a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a>; <a href="./references#CD012226-bbs2-0029" title="LavoieK , MoullecG , BlaisL , BeauchesneM‐F , LemiereC , LabrecqueM , et al. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, nonadherent asthmatics: results from a randomized controlled pilot study [Abstract]. Chest2011;140(4):915A. LavoieKL , LemiereC , LabrecqueM , BlaisL , BeauchesneM , MoullecG , et al. The efficacy of motivational interviewing on asthma medication adherence in non‐adherent, poorly controlled asthmatics: preliminary results of the asthma control trial (ACT). Psychosomatic Medicine2011;7(3):A‐9. LavoieKL , MoullecG , LemiereC , BlaisL , LabrecqueM , BeauchesneM‐F , et al. Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial. Patient Preference and Adherence2014;8:1555‐69. NCT01132430 . Motivational interviewing for medication adherence in asthma [Impact of a motivational interviewing intervention on medication adherence in patients with asthma]. https://clinicaltrials.gov/show/NCT01132430 (first received 27 May 2010). ">NCT01132430</a>; <a href="./references#CD012226-bbs2-0033" title="NCT02413528 . Pilot study of a mobile asthma adherence intervention [Pilot study of a mobile intervention to increase adherence to asthma medication among adolescents]. https://clinicaltrials.gov/show/NCT02413528 (first received 7 April 2015). ">NCT02413528</a>) to be at unclear risk of bias. <a href="./references#CD012226-bbs2-0029" title="LavoieK , MoullecG , BlaisL , BeauchesneM‐F , LemiereC , LabrecqueM , et al. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, nonadherent asthmatics: results from a randomized controlled pilot study [Abstract]. Chest2011;140(4):915A. LavoieKL , LemiereC , LabrecqueM , BlaisL , BeauchesneM , MoullecG , et al. The efficacy of motivational interviewing on asthma medication adherence in non‐adherent, poorly controlled asthmatics: preliminary results of the asthma control trial (ACT). Psychosomatic Medicine2011;7(3):A‐9. LavoieKL , MoullecG , LemiereC , BlaisL , LabrecqueM , BeauchesneM‐F , et al. Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial. Patient Preference and Adherence2014;8:1555‐69. NCT01132430 . Motivational interviewing for medication adherence in asthma [Impact of a motivational interviewing intervention on medication adherence in patients with asthma]. https://clinicaltrials.gov/show/NCT01132430 (first received 27 May 2010). ">NCT01132430</a> included a mixture of outcomes objectively assessed by a blinded outcome assessor and patient‐reported outcomes, so overall we judged this study to be at unclear risk. Similarly, <a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a> and <a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a> included a mix of objective outcomes and patient‐reported outcomes. <a href="./references#CD012226-bbs2-0033" title="NCT02413528 . Pilot study of a mobile asthma adherence intervention [Pilot study of a mobile intervention to increase adherence to asthma medication among adolescents]. https://clinicaltrials.gov/show/NCT02413528 (first received 7 April 2015). ">NCT02413528</a> reported very minimal details, so we could not make a judgement. </p> </section> <section id="CD012226-sec-0077"> <h4 class="title">Incomplete outcome data</h4> <p>We judged 18 studies to be at low risk of attrition bias; drop‐out was low and balanced, and withdrawn participants were adequately described (<a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a>; <a href="./references#CD012226-bbs2-0002" title="ACTRN12607000489493 . The impact of providing feedback on adherence in childhood asthma. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=82288 (first received 14 September 2007). BurgessSW , SlyPD , DevadasonSG . Providing feedback on adherence increases use of preventive medication by asthmatic children. Journal of Asthma2010;47(2):198‐201. ">ACTRN12607000489493</a>; <a href="./references#CD012226-bbs2-0004" title="BenderBG , ApterA , BogenDK , DickinsonP , FisherL , WamboldtFS , et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. Journal of the American Board of Family Medicine2010;23(2):159‐65. ">Bender 2010</a>; <a href="./references#CD012226-bbs2-0007" title="BurgessSW , SlyPD , CooperDM , DevadasonSG . Novel spacer device does not improve adherence in childhood asthma. Pediatric Pulmonology2007;42(8):736‐9. ">Burgess 2007</a>; <a href="./references#CD012226-bbs2-0008" title="ChanAH , StewartAW , HarrisonJ , CamargoCAJr , BlackPN , MitchellEA . The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial. Lancet Respiratory Medicine2015;3(3):210‐9. ">Chan 2015</a>; <a href="./references#CD012226-bbs2-0014" title="HaltermanJS , SzilagyiPG , YoosHL , ConnKM , KaczorowskiJM , HolzhauerRJ , et al. Benefits of a school‐based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Archives of Pediatric and Adolescent Medicine2004;158(5):460‐7. ">Halterman 2004</a>; <a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a>; <a href="./references#CD012226-bbs2-0022" title="AdamsCD , JosephKE , MacLarenJE , DeMoreM , KovenL , DetweilerMF , et al. Parent‐youth teamwork in pediatric asthma management [Abstract]. Journal of Allergy and Clinical Immunology2004;113(2):S159. DuncanCL , HoganMB , TienKJ , GravesMM , ChorneyJM , ZettlerMD , et al. Efficacy of a parent‐youth teamwork intervention to promote adherence in pediatric asthma. Journal of Pediatric Psychology2013;38(6):617‐28. NCT00166582 . Parent‐youth teamwork in pediatric asthma management. https://clinicaltrials.gov/show/NCT00166582 (first received 9 September 2009). ">NCT00166582</a>; <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a>; <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a>; <a href="./references#CD012226-bbs2-0026" title="HederosCA , JansonS , HedlinG . Group discussions with parents have long‐term positive effects on the management of asthma with good cost‐benefit. Acta Paediatrica2005;94(5):602‐8. NCT00516633 . Intervention study to improve adherence in asthma [Does improved information in the form of group discussions with parents of newly diagnosed asthmatic children lead to a better quality of life for the families, an improved adherence and better development of the lung function of the children?]. clinicaltrials.gov/show/NCT00516633 (first received 13 August 2007). ">NCT00516633</a>; <a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a>; <a href="./references#CD012226-bbs2-0029" title="LavoieK , MoullecG , BlaisL , BeauchesneM‐F , LemiereC , LabrecqueM , et al. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, nonadherent asthmatics: results from a randomized controlled pilot study [Abstract]. Chest2011;140(4):915A. LavoieKL , LemiereC , LabrecqueM , BlaisL , BeauchesneM , MoullecG , et al. The efficacy of motivational interviewing on asthma medication adherence in non‐adherent, poorly controlled asthmatics: preliminary results of the asthma control trial (ACT). Psychosomatic Medicine2011;7(3):A‐9. LavoieKL , MoullecG , LemiereC , BlaisL , LabrecqueM , BeauchesneM‐F , et al. Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial. Patient Preference and Adherence2014;8:1555‐69. NCT01132430 . Motivational interviewing for medication adherence in asthma [Impact of a motivational interviewing intervention on medication adherence in patients with asthma]. https://clinicaltrials.gov/show/NCT01132430 (first received 27 May 2010). ">NCT01132430</a>; <a href="./references#CD012226-bbs2-0030" title="MosnaimG , LiH , MartinM , BelicePJ , AveryE , RyanN , et al. The use of coping peer support and mp3 technology to improve adherence to inhaled corticosteroids among low‐income minority adolescents. Journal of Allergy and Clinical Immunology2013;131(2):AB133 [478]. MosnaimG , LiH , MartinM , RichardsonD , BelicePJ , AveryE , et al. The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology: In Practice2013;1(5):485‐93. NCT01169883 . Coping peer intervention for adherence. https://clinicaltrials.gov/show/NCT01169883 (first received 23 July 2010). PowellL . The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology2013;0(5):485‐93. ">NCT01169883</a>; <a href="./references#CD012226-bbs2-0031" title="HaltermanJS , FagnanoM , MontesG , FisherS , TremblayP , TajonR , et al. The school‐based preventive asthma care trial: results of a pilot study. Journal of Pediatrics2012;161(6):1109‐15. HaltermanJS , SauerJ , FagnanoM , MontesG , FisherS , TremblayP , et al. Working toward a sustainable system of asthma care: development of the School‐Based Preventive Asthma Care Technology (SB‐PACT) trial. Journal of Asthma2012;49(4):395‐400. NCT01175434 . School‐based preventive asthma care technology: a trial using a novel technology to improve adherence (SB‐PACT). https://clinicaltrials.gov/ct2/show/NCT01175434 (first received 16 April 2010). ">NCT01175434</a>; <a href="./references#CD012226-bbs2-0032" title="Kolmodin MacDonellK , NaarS , Gibson‐ScipioW , LamP , SecordE . The Detroit young adult asthma project: pilot of a technology‐based medication adherence intervention for African‐American emerging adults. Journal of Adolescent Health2016;59(4):465‐71. [DOI: 10.1016/j.jadohealth.2016.05.016] NCT01714141 . Multi‐component technology intervention for minority emerging adults with asthma. https://clinicaltrials.gov/ct2/show/NCT01714141 (accessed 21 July 2016). ">NCT01714141</a>; <a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a>; <a href="./references#CD012226-bbs2-0036" title="PriceD , RobertsonA , BullenK , RandC , HorneR , StaudingerH . Improved adherence with once‐daily versus twice‐daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open‐label study. BMC Pulmonary Medicine2010;10:1. ">Price 2010</a>). We judged 11 studies to be at high risk, usually owing to high and/or unbalanced drop‐out from study arms (<a href="./references#CD012226-bbs2-0003" title="ADERE PEDIATRIC1 . Prospective, parallel‐group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticasone 50/250 mcg (Seretide) twice a day. ADERE PROJECT (Pediatric). //www.gsk‐clinicalstudyregister.com/study/ADERE%20PEDIATRIC%201?search=compound&amp;compound=fluticasone‐propionate‐salmeterol#rs (first received 28 September 2008). ">ADERE PEDIATRIC 1</a>; <a href="./references#CD012226-bbs2-0006" title="BosleyCM , ParryDT , CochraneGM . Patient compliance with inhaled medication: does combining beta‐agonists with corticosteroids improve compliance?. European Respiratory Journal1994;7(3):504‐9. ">Bosley 1994</a>; <a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a>; <a href="./references#CD012226-bbs2-0013" title="GeraldLB , McClureLA , HarringtonKF , ManganJM , GibsonL , AtchisonJ , et al. Design of the supervised asthma therapy study: implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials2008;29(2):304‐10. GeraldLB , McClureLA , ManganJM , HarringtonKF , GibsonL , ErwinS , et al. Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school‐based supervised asthma therapy. Pediatrics2009;123(2):466‐74. GeraldLB , PatelK , ZhangS , McClureL . Secondhand smoke exposure and asthma morbidity among elementary school children enrolled in a clinical trial. Chest2007;132(4):461. [DOI: 10.1378/chest.132.4_MeetingAbstracts.461] McClureLA , HarringtonKF , GrahamH , GeraldLB . Internet‐based monitoring of asthma symptoms, peak flow meter readings, and absence data in a school‐based clinical trial. Clinical Trials2008;5(1):31‐7. ">Gerald 2009</a>; <a href="./references#CD012226-bbs2-0016" title="KampsJL . Improving adherence to inhaled corticosteroids in children with asthma [Dissertation]. University of Kansas, 2002. KampsJL , RapoffMA , RobertsMC , VarelaRE , BarnardM , OlsonN . Improving adherence to inhaled corticosteroids in children with asthma: a pilot of a randomized clinical trial. Children's Health Care2008;37(4):261‐77. ">Kamps 2008</a>; <a href="./references#CD012226-bbs2-0017" title="KoufopoulosJT , ConnerMT , GardnerPH , KellarI . A web‐based and mobile health social support intervention to promote adherence to inhaled asthma medications: randomized controlled trial. Journal of Medical Internet Research2016;18(6):e122. [CRS: 4900132000024092; PUBMED: 27298211] ">Koufopoulos 2016</a>; <a href="./references#CD012226-bbs2-0019" title="MehuysE , VanBortelL , DeBolleL , VanTongelenI , AnnemansL , RemonJP , et al. Effectiveness of pharmacist intervention for asthma control improvement. European Respiratory Journal2008;31(4):790‐9. MehuysE , vanBortelL , deBolleL , vanTongelenI , RemonJ‐P , AnnemansL , et al. Does pharmacist intervention lead to appropriate use of asthma medication and improved asthma control? [Leidt apothekersadvies over het optimaal gebruik van astmamedicatie tot een verbetering van de astmacontrole? Een gerandomiseerde gecontroleerde studie]. Farmaceutisch Tijdschrift voor Belgie2008;85(1):1‐9. ">Mehuys 2008</a>; <a href="./references#CD012226-bbs2-0021" title="NCT00149487 . Enhancing treatment adherence in pediatric asthma with a problem solving intervention [Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma]. https://clinicaltrials.gov/ct2/show/NCT00149487 (first received 6 September 2005). NCT00149487 . Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma. clinicaltrials.gov/show/NCT00149487 (first received 6 September 2005). RohanJ , DrotarD , McNallyK , SchluchterM , RiekertK , VavrekP , et al. Adherence to pediatric asthma treatment in economically disadvantaged African‐American children and adolescents: an application of growth curve analysis. Journal of Pediatric Psychology2010;35(4):394‐404. ">NCT00149487</a>; <a href="./references#CD012226-bbs2-0028" title="GambleJ , HeaneyLG . An individualised nurse‐led programme to improve adherence in patients with difficult asthma ‐ 12 month outcomes. American Journal of Respiratory and Critical Care Medicine2010;181(1):A3258. GambleJ , StevensonM , HeaneyLG . A study of a multi‐level intervention to improve non‐adherence in difficult to control asthma. Respiratory Medicine2011;105(9):1308‐15. NCT01064869 . A nurse led programme to improve adherence in difficult asthma [Evaluation of the benefits of an individualised menu driven nurse led programme to improve adherence in difficult asthma]. clinicaltrials.gov/show/NCT01064869 (first received 8 February 2010). ">NCT01064869</a>; <a href="./references#CD012226-bbs2-0035" title="OnyirimbaF , ApterA , ReisineS , LittM , McCuskerC , ConnorsM , et al. Direct clinician‐to‐patient feedback discussion of inhaled steroid use: its effect on adherence. Annals of Allergy, Asthma and Immunology2003;90(4):411‐5. ">Onyirimba 2003</a>; <a href="./references#CD012226-bbs2-0039" title="GoossensLMA , VasbinderEC , van DenBemtPMLA , Rutten‐Van MolkenMPMH . Cost‐effectiveness of real‐time medication monitoring in children with asthma. Value in Health2014;17(7):A329. VasbinderE , GoossensL , JanssensH , deWinterB , vanDijkL , VultoA , et al. E‐monitoring of asthma therapy to improve compliance in children (E‐MATIC). European Respiratory Journal2016;46:758‐67. [DOI: 10.1183/13993003.01698‐2015] VasbinderEC , GoossensLMA , JanssensH , deWinterBCM , vanDijkL , VultoAG , et al. E‐Monitoring of asthma therapy to improve compliance in children (E‐MATIC). Pharmacoepidemiology and Drug Safety2015;24(S1):489. [DOI: 10.1002/pds] VasbinderEC , JanssensHM , Rutten‐van MolkenMP , vanDijkL , deWinterBC , deGrootRC , et al. e‐Monitoring of asthma therapy to improve compliance in children using a real‐time medication monitoring system (RTMM): the e‐MATIC study protocol. BMC Medical Informatics and Decision Making2013;13(1):38. ">Vasbinder 2015 E‐MATIC</a>). We judged another 10 studies to be at unclear risk, usually because drop‐outs were not adequately described to allow a judgement (<a href="./references#CD012226-bbs2-0005" title="BlackPN , GarrattE , ArandjusC , SalmonBT , SutherlandG . An inhaler with ring tones improves compliance with inhaled steroids in childhood asthma [Abstract]. American Thoracic Society International Conference; May 16‐21, 2008; Toronto. 2008:Poster #A46. ">Black 2008</a>; <a href="./references#CD012226-bbs2-0009" title="CharlesT , QuinnD , WeatherallM , AldingtonS , BeasleyR , HoltS . An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. Journal of Allergy and Clinical Immunology2007;119(4):811‐6. ">Charles 2007</a>; <a href="./references#CD012226-bbs2-0010" title="ChatkinJM , BlancoDC , ScagliaN , WagnerMB , FritscherCC , ChatkinJ , et al. Impact of a low‐cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. Journal of Asthma2006;43(4):263‐6. ">Chatkin 2006</a>; <a href="./references#CD012226-bbs2-0012" title="GallefossF , BakkePS . How does patient education and self‐management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. American Journal of Respiratory and Critical Care Medicine1999;160(6):2000‐5. GallefossF , BakkePS . Impact of patient education and self‐management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine2000;94(3):279‐87. [CRS: 4900100000008905] GallefossF , BakkePS , RsgaardPK , KjaersgaardP . Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1999;159(3):812‐7. [CENTRAL: 160267; CRS: 4900100000006265; PUBMED: 10051255] ">Gallefoss 1999</a>; <a href="./references#CD012226-bbs2-0015" title="HartCAH , LoveAM , GibsonNA , MorganN , PatonJY . Effects of an educational intervention directed at parental beliefs and anxieties about inhaled steroid medication of adherence. American Journal of Respiratory and Critical Care Medicine2002;165:A420. ">Hart 2002</a>; <a href="./references#CD012226-bbs2-0020" title="ApterAJ , BogenDK , WangX , RandCS , McElligottS , PolskyD , et al. Intervening to improve adherence and asthma outcomes in urban adults with moderate or severe asthma [Abstract]. American Journal of Respiratory and Critical Care Medicine2011;183:A3791. ApterAJ , WangX , BogenDK , RandCS , McElligottS , PolskyD , et al. Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial. Journal of Aallergy and Clinical Immunology2011;128(3):516‐23. NCT00115323 . Comparison of two medication adherence strategies to improve asthma treatment adherence [Individualized interventions to improve asthma adherence]. https://clinicaltrials.gov/show/NCT00115323 (first received 21 June 2005). [NCT00115323] ">NCT00115323</a>; <a href="./references#CD012226-bbs2-0024" title="NCT00414817 . Telephone‐based program to promote inhaled corticosteroid adherence among individuals with asthma [Phone calls to promote adherence with inhaled corticosteroids]. clinicaltrials.gov/show/NCT00414817 (first received 20 December 2006). VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of automated phone calls to support inhaled corticosteroids (ICS) adherence. American Thoracic Society International Conference; May 15‐20, 2009; San Diego. 2009:A1089 [Poster #518]. VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of health information technology to improve medication adherence. American Journal of Managed Care2011;17(12):SP79‐87. VollmerWM , XuM , FeldsteinA , SmithD , WaterburyA , RandC . Comparison of pharmacy‐based measures of medication adherence. BMC Health Services Research2012;12:155. ">NCT00414817</a>; <a href="./references#CD012226-bbs2-0033" title="NCT02413528 . Pilot study of a mobile asthma adherence intervention [Pilot study of a mobile intervention to increase adherence to asthma medication among adolescents]. https://clinicaltrials.gov/show/NCT02413528 (first received 7 April 2015). ">NCT02413528</a>; <a href="./references#CD012226-bbs2-0037" title="StrandbygaardU , ThomsenSF , BackerV . A daily SMS reminder increases adherence to asthma treatment: a three‐month follow‐up study. Respiratory Medicine2010;104(2):166‐71. ">Strandbygaard 2010</a>; <a href="./references#CD012226-bbs2-0038" title="UlrikCS , ClaudiusBK , TammM , HarvingH , SierstedHC , BackerV , et al. Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial.[Erratum appears in Clin Respir J. 2009 Jul;3(3):185]. Clinical Respiratory Journal2009;3(3):161‐8. ">Ulrik 2009</a>). </p> </section> <section id="CD012226-sec-0078"> <h4 class="title">Selective reporting</h4> <p>We judged five trials to be at low risk of reporting bias. We were able to identify a prepublished protocol or prospective trial registration and found that all stated outcomes of interest were appropriately reported (<a href="./references#CD012226-bbs2-0008" title="ChanAH , StewartAW , HarrisonJ , CamargoCAJr , BlackPN , MitchellEA . The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial. Lancet Respiratory Medicine2015;3(3):210‐9. ">Chan 2015</a>; <a href="./references#CD012226-bbs2-0020" title="ApterAJ , BogenDK , WangX , RandCS , McElligottS , PolskyD , et al. Intervening to improve adherence and asthma outcomes in urban adults with moderate or severe asthma [Abstract]. American Journal of Respiratory and Critical Care Medicine2011;183:A3791. ApterAJ , WangX , BogenDK , RandCS , McElligottS , PolskyD , et al. Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial. Journal of Aallergy and Clinical Immunology2011;128(3):516‐23. NCT00115323 . Comparison of two medication adherence strategies to improve asthma treatment adherence [Individualized interventions to improve asthma adherence]. https://clinicaltrials.gov/show/NCT00115323 (first received 21 June 2005). [NCT00115323] ">NCT00115323</a>; <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a>; <a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a>; <a href="./references#CD012226-bbs2-0039" title="GoossensLMA , VasbinderEC , van DenBemtPMLA , Rutten‐Van MolkenMPMH . Cost‐effectiveness of real‐time medication monitoring in children with asthma. Value in Health2014;17(7):A329. VasbinderE , GoossensL , JanssensH , deWinterB , vanDijkL , VultoA , et al. E‐monitoring of asthma therapy to improve compliance in children (E‐MATIC). European Respiratory Journal2016;46:758‐67. [DOI: 10.1183/13993003.01698‐2015] VasbinderEC , GoossensLMA , JanssensH , deWinterBCM , vanDijkL , VultoAG , et al. E‐Monitoring of asthma therapy to improve compliance in children (E‐MATIC). Pharmacoepidemiology and Drug Safety2015;24(S1):489. [DOI: 10.1002/pds] VasbinderEC , JanssensHM , Rutten‐van MolkenMP , vanDijkL , deWinterBC , deGrootRC , et al. e‐Monitoring of asthma therapy to improve compliance in children using a real‐time medication monitoring system (RTMM): the e‐MATIC study protocol. BMC Medical Informatics and Decision Making2013;13(1):38. ">Vasbinder 2015 E‐MATIC</a>). We judged 15 studies to be at high risk of selective reporting. Reasons included that the study was identified only as a conference abstract with minimal details, that key outcomes were reported only narratively or in a way that prevented meta‐analysis or that we noted an important deviation between protocol/registration and published results (<a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a>; <a href="./references#CD012226-bbs2-0003" title="ADERE PEDIATRIC1 . Prospective, parallel‐group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticasone 50/250 mcg (Seretide) twice a day. ADERE PROJECT (Pediatric). //www.gsk‐clinicalstudyregister.com/study/ADERE%20PEDIATRIC%201?search=compound&amp;compound=fluticasone‐propionate‐salmeterol#rs (first received 28 September 2008). ">ADERE PEDIATRIC 1</a>; <a href="./references#CD012226-bbs2-0005" title="BlackPN , GarrattE , ArandjusC , SalmonBT , SutherlandG . An inhaler with ring tones improves compliance with inhaled steroids in childhood asthma [Abstract]. American Thoracic Society International Conference; May 16‐21, 2008; Toronto. 2008:Poster #A46. ">Black 2008</a>; <a href="./references#CD012226-bbs2-0010" title="ChatkinJM , BlancoDC , ScagliaN , WagnerMB , FritscherCC , ChatkinJ , et al. Impact of a low‐cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. Journal of Asthma2006;43(4):263‐6. ">Chatkin 2006</a>; <a href="./references#CD012226-bbs2-0012" title="GallefossF , BakkePS . How does patient education and self‐management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. American Journal of Respiratory and Critical Care Medicine1999;160(6):2000‐5. GallefossF , BakkePS . Impact of patient education and self‐management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine2000;94(3):279‐87. [CRS: 4900100000008905] GallefossF , BakkePS , RsgaardPK , KjaersgaardP . Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1999;159(3):812‐7. [CENTRAL: 160267; CRS: 4900100000006265; PUBMED: 10051255] ">Gallefoss 1999</a>; <a href="./references#CD012226-bbs2-0013" title="GeraldLB , McClureLA , HarringtonKF , ManganJM , GibsonL , AtchisonJ , et al. Design of the supervised asthma therapy study: implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials2008;29(2):304‐10. GeraldLB , McClureLA , ManganJM , HarringtonKF , GibsonL , ErwinS , et al. Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school‐based supervised asthma therapy. Pediatrics2009;123(2):466‐74. GeraldLB , PatelK , ZhangS , McClureL . Secondhand smoke exposure and asthma morbidity among elementary school children enrolled in a clinical trial. Chest2007;132(4):461. [DOI: 10.1378/chest.132.4_MeetingAbstracts.461] McClureLA , HarringtonKF , GrahamH , GeraldLB . Internet‐based monitoring of asthma symptoms, peak flow meter readings, and absence data in a school‐based clinical trial. Clinical Trials2008;5(1):31‐7. ">Gerald 2009</a>; <a href="./references#CD012226-bbs2-0015" title="HartCAH , LoveAM , GibsonNA , MorganN , PatonJY . Effects of an educational intervention directed at parental beliefs and anxieties about inhaled steroid medication of adherence. American Journal of Respiratory and Critical Care Medicine2002;165:A420. ">Hart 2002</a>; <a href="./references#CD012226-bbs2-0016" title="KampsJL . Improving adherence to inhaled corticosteroids in children with asthma [Dissertation]. University of Kansas, 2002. KampsJL , RapoffMA , RobertsMC , VarelaRE , BarnardM , OlsonN . Improving adherence to inhaled corticosteroids in children with asthma: a pilot of a randomized clinical trial. Children's Health Care2008;37(4):261‐77. ">Kamps 2008</a>; <a href="./references#CD012226-bbs2-0017" title="KoufopoulosJT , ConnerMT , GardnerPH , KellarI . A web‐based and mobile health social support intervention to promote adherence to inhaled asthma medications: randomized controlled trial. Journal of Medical Internet Research2016;18(6):e122. [CRS: 4900132000024092; PUBMED: 27298211] ">Koufopoulos 2016</a>; <a href="./references#CD012226-bbs2-0021" title="NCT00149487 . Enhancing treatment adherence in pediatric asthma with a problem solving intervention [Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma]. https://clinicaltrials.gov/ct2/show/NCT00149487 (first received 6 September 2005). NCT00149487 . Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma. clinicaltrials.gov/show/NCT00149487 (first received 6 September 2005). RohanJ , DrotarD , McNallyK , SchluchterM , RiekertK , VavrekP , et al. Adherence to pediatric asthma treatment in economically disadvantaged African‐American children and adolescents: an application of growth curve analysis. Journal of Pediatric Psychology2010;35(4):394‐404. ">NCT00149487</a>; <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a>; <a href="./references#CD012226-bbs2-0024" title="NCT00414817 . Telephone‐based program to promote inhaled corticosteroid adherence among individuals with asthma [Phone calls to promote adherence with inhaled corticosteroids]. clinicaltrials.gov/show/NCT00414817 (first received 20 December 2006). VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of automated phone calls to support inhaled corticosteroids (ICS) adherence. American Thoracic Society International Conference; May 15‐20, 2009; San Diego. 2009:A1089 [Poster #518]. VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of health information technology to improve medication adherence. American Journal of Managed Care2011;17(12):SP79‐87. VollmerWM , XuM , FeldsteinA , SmithD , WaterburyA , RandC . Comparison of pharmacy‐based measures of medication adherence. BMC Health Services Research2012;12:155. ">NCT00414817</a>; <a href="./references#CD012226-bbs2-0026" title="HederosCA , JansonS , HedlinG . Group discussions with parents have long‐term positive effects on the management of asthma with good cost‐benefit. Acta Paediatrica2005;94(5):602‐8. NCT00516633 . Intervention study to improve adherence in asthma [Does improved information in the form of group discussions with parents of newly diagnosed asthmatic children lead to a better quality of life for the families, an improved adherence and better development of the lung function of the children?]. clinicaltrials.gov/show/NCT00516633 (first received 13 August 2007). ">NCT00516633</a>; <a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a>; <a href="./references#CD012226-bbs2-0038" title="UlrikCS , ClaudiusBK , TammM , HarvingH , SierstedHC , BackerV , et al. Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial.[Erratum appears in Clin Respir J. 2009 Jul;3(3):185]. Clinical Respiratory Journal2009;3(3):161‐8. ">Ulrik 2009</a>). We judged the remaining 18 studies to be at unclear risk, primarily because we were unable to identify a prepublished protocol or prospective trial registration. </p> </section> <section id="CD012226-sec-0079"> <h4 class="title">Other potential sources of bias</h4> <p>We did not note any additional potential sources of bias in any included studies.</p> </section> </section> <section id="CD012226-sec-0080"> <h3 class="title" id="CD012226-sec-0080">Effects of interventions</h3> <p>See: <a href="./full#CD012226-tbl-0001"><b>Summary of findings for the main comparison</b> Adherence education compared with controls for asthma</a>; <a href="./full#CD012226-tbl-0002"><b>Summary of findings 2</b> Electronic trackers or reminders (± feedback) compared with controls for asthma</a>; <a href="./full#CD012226-tbl-0003"><b>Summary of findings 3</b> Simplified compared with usual regimens for asthma</a>; <a href="./full#CD012226-tbl-0004"><b>Summary of findings 4</b> School‐based ICS therapy compared with home therapy for asthma</a> </p> <section id="CD012226-sec-0081"> <h4 class="title">Comparison 1. Adherence education versus controls</h4> <section id="CD012226-sec-0082"> <h5 class="title">Adherence</h5> <p>Our primary analysis of adherence included only studies that used an objective electronic monitor to measure adherence. Mean adherence for those receiving adherence education was 20% better than for those in the control group (<a href="./references#CD012226-fig-0004" title="">Analysis 1.1</a>; mean difference (MD) 20.13, 95% confidence interval (CI) 7.52 to 32.74; 280 participants; five studies; low‐quality evidence). A benefit favouring adherence education is seen when studies using both objective and subjective measures are included, but the effect is attenuated (<a href="./references#CD012226-fig-0005" title="">Analysis 1.2</a>; MD 11.59, 95% CI 3.72 to 19.46; 1693 participants; 10 studies; low‐quality evidence). </p> <p>We noted great variation between individual study results in both analyses (I<sup>2</sup> = 81% and 88%, respectively), and concerns about effects of performance bias and selection bias reduced our confidence in the results. We created a funnel plot to look for evidence of publication bias (<a href="#CD012226-fig-0003">Figure 3</a>) and found none. </p> <div class="figure" id="CD012226-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Adherence education vs controls, outcome: 1.2 % Adherence (all measures)." data-id="CD012226-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Adherence education vs controls, outcome: 1.2 % Adherence (all measures). </p> </div> </div> </div> <p>One larger study (<a href="./references#CD012226-bbs2-0010" title="ChatkinJM , BlancoDC , ScagliaN , WagnerMB , FritscherCC , ChatkinJ , et al. Impact of a low‐cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. Journal of Asthma2006;43(4):263‐6. ">Chatkin 2006</a>) dichotomised participants into those who achieved greater than 85% adherence and those who did not; results showed benefit of the educational intervention (<a href="./references#CD012226-fig-0006" title="">Analysis 1.3</a>; odds ratio (OR) 2.68, 95% CI 1.61 to 4.46; 271 participants; one study). </p> <p>A test for subgroup differences between interventions judged to be 'complex' (i.e. multi‐faceted) and interventions offering simpler forms of education detected no differences between the two types of interventions (I<sup>2</sup> = 0%), but it should be noted that we classified as 'simple' only one study using objective measures. Testing suggested no important differences between studies of adults, studies of adults and adolescents and studies of children (<a href="./references#CD012226-fig-0029" title="">Analysis 5.1</a>) when all measures of adherence were considered. If the same subgroup analysis is performed only on studies using objective measures, only one study in the child subgroup remains; although this analysis suggests that the intervention is more effective in children, we interpret this finding with extreme caution. We planned a subgroup analysis based on the recipient of the intervention, but this was not necessary, as all interventions were delivered to adults or children with asthma or their parents. </p> </section> <section id="CD012226-sec-0083"> <h5 class="title">Exacerbations requiring OCS</h5> <p>It was not possible to discern with certainly whether education had an effect on the odds that a patient would need oral steroids for an exacerbation (OR 1.82, 95% CI 0.99 to 3.36; 349 participants; three studies; I<sup>2</sup> = 10%; low‐quality evidence). The point estimate lay in favour of control, but confidence intervals around the pooled estimate showed no differences between groups (<a href="./references#CD012226-fig-0007" title="">Analysis 1.4</a>). We downgraded the evidence for risk of bias and for imprecision. We did not perform subgroup analyses on this primary outcome because we identified too few studies and we did not observe significant heterogeneity in the analysis. </p> <p>Three other studies (<a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a>; <a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a>; <a href="./references#CD012226-bbs2-0028" title="GambleJ , HeaneyLG . An individualised nurse‐led programme to improve adherence in patients with difficult asthma ‐ 12 month outcomes. American Journal of Respiratory and Critical Care Medicine2010;181(1):A3258. GambleJ , StevensonM , HeaneyLG . A study of a multi‐level intervention to improve non‐adherence in difficult to control asthma. Respiratory Medicine2011;105(9):1308‐15. NCT01064869 . A nurse led programme to improve adherence in difficult asthma [Evaluation of the benefits of an individualised menu driven nurse led programme to improve adherence in difficult asthma]. clinicaltrials.gov/show/NCT01064869 (first received 8 February 2010). ">NCT01064869</a>) reported the mean number of exacerbations per person over six or 12 months, but the data were skewed so we did not pool the results. <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a> reported a significant reduction in OCS use (incident rate ratio 0.83; 95% CI 0.73 to 0.95; P = 0.008) when both intervention groups were compared with the control group. Conversely, <a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a> reported increased oral steroid use in the intervention group over the 24 months of the study (mean (standard error (SE)) oral steroid bursts per person per year 0.21 (0.18) in the control group and 0.27 (0.23) in the intervention group; P = 0.05). <a href="./references#CD012226-bbs2-0028" title="GambleJ , HeaneyLG . An individualised nurse‐led programme to improve adherence in patients with difficult asthma ‐ 12 month outcomes. American Journal of Respiratory and Critical Care Medicine2010;181(1):A3258. GambleJ , StevensonM , HeaneyLG . A study of a multi‐level intervention to improve non‐adherence in difficult to control asthma. Respiratory Medicine2011;105(9):1308‐15. NCT01064869 . A nurse led programme to improve adherence in difficult asthma [Evaluation of the benefits of an individualised menu driven nurse led programme to improve adherence in difficult asthma]. clinicaltrials.gov/show/NCT01064869 (first received 8 February 2010). ">NCT01064869</a> reported a small reduction in courses of oral steroids at 12‐month follow‐up in the intervention group compared with the control group, but this finding was not significant (mean (standard deviation (SD)) 1.7 (1.1) in the intervention group and 2.0 (1.4) in the control group; P = 0.41). </p> </section> <section id="CD012226-sec-0084"> <h5 class="title">Asthma control</h5> <p>Studies used the Asthma Control Questionnaire (<a href="./references#CD012226-bbs2-0004" title="BenderBG , ApterA , BogenDK , DickinsonP , FisherL , WamboldtFS , et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. Journal of the American Board of Family Medicine2010;23(2):159‐65. ">Bender 2010</a>; <a href="./references#CD012226-bbs2-0020" title="ApterAJ , BogenDK , WangX , RandCS , McElligottS , PolskyD , et al. Intervening to improve adherence and asthma outcomes in urban adults with moderate or severe asthma [Abstract]. American Journal of Respiratory and Critical Care Medicine2011;183:A3791. ApterAJ , WangX , BogenDK , RandCS , McElligottS , PolskyD , et al. Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial. Journal of Aallergy and Clinical Immunology2011;128(3):516‐23. NCT00115323 . Comparison of two medication adherence strategies to improve asthma treatment adherence [Individualized interventions to improve asthma adherence]. https://clinicaltrials.gov/show/NCT00115323 (first received 21 June 2005). [NCT00115323] ">NCT00115323</a>; <a href="./references#CD012226-bbs2-0028" title="GambleJ , HeaneyLG . An individualised nurse‐led programme to improve adherence in patients with difficult asthma ‐ 12 month outcomes. American Journal of Respiratory and Critical Care Medicine2010;181(1):A3258. GambleJ , StevensonM , HeaneyLG . A study of a multi‐level intervention to improve non‐adherence in difficult to control asthma. Respiratory Medicine2011;105(9):1308‐15. NCT01064869 . A nurse led programme to improve adherence in difficult asthma [Evaluation of the benefits of an individualised menu driven nurse led programme to improve adherence in difficult asthma]. clinicaltrials.gov/show/NCT01064869 (first received 8 February 2010). ">NCT01064869</a>; <a href="./references#CD012226-bbs2-0029" title="LavoieK , MoullecG , BlaisL , BeauchesneM‐F , LemiereC , LabrecqueM , et al. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, nonadherent asthmatics: results from a randomized controlled pilot study [Abstract]. Chest2011;140(4):915A. LavoieKL , LemiereC , LabrecqueM , BlaisL , BeauchesneM , MoullecG , et al. The efficacy of motivational interviewing on asthma medication adherence in non‐adherent, poorly controlled asthmatics: preliminary results of the asthma control trial (ACT). Psychosomatic Medicine2011;7(3):A‐9. LavoieKL , MoullecG , LemiereC , BlaisL , LabrecqueM , BeauchesneM‐F , et al. Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial. Patient Preference and Adherence2014;8:1555‐69. NCT01132430 . Motivational interviewing for medication adherence in asthma [Impact of a motivational interviewing intervention on medication adherence in patients with asthma]. https://clinicaltrials.gov/show/NCT01132430 (first received 27 May 2010). ">NCT01132430</a>) and the Asthma Control Test (<a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a>; <a href="./references#CD012226-bbs2-0019" title="MehuysE , VanBortelL , DeBolleL , VanTongelenI , AnnemansL , RemonJP , et al. Effectiveness of pharmacist intervention for asthma control improvement. European Respiratory Journal2008;31(4):790‐9. MehuysE , vanBortelL , deBolleL , vanTongelenI , RemonJ‐P , AnnemansL , et al. Does pharmacist intervention lead to appropriate use of asthma medication and improved asthma control? [Leidt apothekersadvies over het optimaal gebruik van astmamedicatie tot een verbetering van de astmacontrole? Een gerandomiseerde gecontroleerde studie]. Farmaceutisch Tijdschrift voor Belgie2008;85(1):1‐9. ">Mehuys 2008</a>; <a href="./references#CD012226-bbs2-0029" title="LavoieK , MoullecG , BlaisL , BeauchesneM‐F , LemiereC , LabrecqueM , et al. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, nonadherent asthmatics: results from a randomized controlled pilot study [Abstract]. Chest2011;140(4):915A. LavoieKL , LemiereC , LabrecqueM , BlaisL , BeauchesneM , MoullecG , et al. The efficacy of motivational interviewing on asthma medication adherence in non‐adherent, poorly controlled asthmatics: preliminary results of the asthma control trial (ACT). Psychosomatic Medicine2011;7(3):A‐9. LavoieKL , MoullecG , LemiereC , BlaisL , LabrecqueM , BeauchesneM‐F , et al. Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial. Patient Preference and Adherence2014;8:1555‐69. NCT01132430 . Motivational interviewing for medication adherence in asthma [Impact of a motivational interviewing intervention on medication adherence in patients with asthma]. https://clinicaltrials.gov/show/NCT01132430 (first received 27 May 2010). ">NCT01132430</a>) as validated measures of asthma control (<a href="./references#CD012226-fig-0008" title="">Analysis 1.5</a>) and reported no differences between adherence education and control on the ACQ (MD ‐0.03, 95% CI ‐0.49 to 0.43; 455 participants; four studies; I<sup>2</sup> = 38%; moderate‐quality evidence) nor on the ACT (MD 0.30, 95% CI ‐0.82 to 1.43; 333 participants; three studies; I<sup>2</sup> = 40%; moderate‐quality evidence). We noted some variation in study results, but our confidence in these results was mainly reduced by risk of performance and detection bias. Upper and lower confidence limits for both estimates fell within the minimal clinically important differences (MCIDs) for the scales (0.5 point for the ACQ and 3 points for the ACT), so we did not consider the evidence imprecise. It was not possible to perform subgroup analyses on this primary outcome because we identified too few studies and we did not observe substantial heterogeneity in the analysis. </p> </section> <section id="CD012226-sec-0085"> <h5 class="title">Unscheduled visits</h5> <p>Studies reported unscheduled visits inconsistently as hospital visits, ED visits or GP visits, and this made the estimate difficult to interpret (<a href="./references#CD012226-fig-0009" title="">Analysis 1.6</a>). The pooled estimate lay predominantly in favour of adherence education, but the effect was imprecise and the upper confidence limit crossed the line of no difference (OR 0.48, 95% CI 0.19 to 1.19; 688 participants; four studies; I<sup>2</sup> = 59%). We considered evidence for this outcome to be of very low quality owing to risk of bias, inconsistency between study results, imprecision and variation in the way unscheduled visits were defined. Also, effects presented separately suggest possible benefit of adherence education for ED and GP visits, but we did not set out to assess these outcomes separately, so this must be interpreted with caution. </p> <p>Three other studies (<a href="./references#CD012226-bbs2-0012" title="GallefossF , BakkePS . How does patient education and self‐management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. American Journal of Respiratory and Critical Care Medicine1999;160(6):2000‐5. GallefossF , BakkePS . Impact of patient education and self‐management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine2000;94(3):279‐87. [CRS: 4900100000008905] GallefossF , BakkePS , RsgaardPK , KjaersgaardP . Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1999;159(3):812‐7. [CENTRAL: 160267; CRS: 4900100000006265; PUBMED: 10051255] ">Gallefoss 1999</a>; <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a>; <a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a>) reported the mean number of unscheduled visits per person, but the data were skewed so we have not presented a mean difference. <a href="./references#CD012226-bbs2-0012" title="GallefossF , BakkePS . How does patient education and self‐management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. American Journal of Respiratory and Critical Care Medicine1999;160(6):2000‐5. GallefossF , BakkePS . Impact of patient education and self‐management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine2000;94(3):279‐87. [CRS: 4900100000008905] GallefossF , BakkePS , RsgaardPK , KjaersgaardP . Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1999;159(3):812‐7. [CENTRAL: 160267; CRS: 4900100000006265; PUBMED: 10051255] ">Gallefoss 1999</a> reported a reduction in the mean (SD) number of GP consultations in the intervention group compared with the control group: 0.7 (2.0) versus 2.6 (3.6); P &lt; 0.001. <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a> also reported a significant reduction in the number of ED visits in the intervention group (incident rate ratio 0.88; 95% CI 0.78 to 0.99; P = 0.03), <a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a> reported ED and after‐hours visits but did not detect a significant between‐group difference for either outcome (P = 0.23 and P = 0.12, respectively). </p> </section> <section id="CD012226-sec-0086"> <h5 class="title">Absence from work/school</h5> <p>Two studies reported rates of absenteeism per person over 12 months (<a href="./references#CD012226-bbs2-0012" title="GallefossF , BakkePS . How does patient education and self‐management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. American Journal of Respiratory and Critical Care Medicine1999;160(6):2000‐5. GallefossF , BakkePS . Impact of patient education and self‐management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine2000;94(3):279‐87. [CRS: 4900100000008905] GallefossF , BakkePS , RsgaardPK , KjaersgaardP . Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1999;159(3):812‐7. [CENTRAL: 160267; CRS: 4900100000006265; PUBMED: 10051255] ">Gallefoss 1999</a>) or 18 months (<a href="./references#CD012226-bbs2-0026" title="HederosCA , JansonS , HedlinG . Group discussions with parents have long‐term positive effects on the management of asthma with good cost‐benefit. Acta Paediatrica2005;94(5):602‐8. NCT00516633 . Intervention study to improve adherence in asthma [Does improved information in the form of group discussions with parents of newly diagnosed asthmatic children lead to a better quality of life for the families, an improved adherence and better development of the lung function of the children?]. clinicaltrials.gov/show/NCT00516633 (first received 13 August 2007). ">NCT00516633</a>). The mean number of absence days per person in <a href="./references#CD012226-bbs2-0012" title="GallefossF , BakkePS . How does patient education and self‐management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. American Journal of Respiratory and Critical Care Medicine1999;160(6):2000‐5. GallefossF , BakkePS . Impact of patient education and self‐management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine2000;94(3):279‐87. [CRS: 4900100000008905] GallefossF , BakkePS , RsgaardPK , KjaersgaardP . Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1999;159(3):812‐7. [CENTRAL: 160267; CRS: 4900100000006265; PUBMED: 10051255] ">Gallefoss 1999</a> was eight in the adherence education group (n = 25) and 26 in the control group (n = 24), but standard deviations were 32 and 70 days, respectively, suggesting that the data were heavily skewed. Consequently, we did not consider it appropriate or useful to analyse the data for a mean difference. The other study reporting this outcome (<a href="./references#CD012226-bbs2-0026" title="HederosCA , JansonS , HedlinG . Group discussions with parents have long‐term positive effects on the management of asthma with good cost‐benefit. Acta Paediatrica2005;94(5):602‐8. NCT00516633 . Intervention study to improve adherence in asthma [Does improved information in the form of group discussions with parents of newly diagnosed asthmatic children lead to a better quality of life for the families, an improved adherence and better development of the lung function of the children?]. clinicaltrials.gov/show/NCT00516633 (first received 13 August 2007). ">NCT00516633</a>) observed a mean of 2.1 days in the adherence education group (n = 32) and 3.9 days in the control group (n = 28); the P value for this difference as reported in the paper was 0.08. </p> </section> <section id="CD012226-sec-0087"> <h5 class="title">Quality of life</h5> <p>Results showed no difference between adherence education and control on the Asthma Quality of Life Questionnaire (<a href="./references#CD012226-fig-0010" title="">Analysis 1.7</a>; MD 0.01, 95% CI ‐0.20 to 0.23; 734 participants; six studies; I<sup>2</sup> = 34%; moderate‐quality). Upper and lower confidence limits fell within the 0.5 MCID for the scale, so we did not downgrade for imprecision. We had concerns regarding performance and detection bias because the scale is self‐rated. </p> </section> <section id="CD012226-sec-0088"> <h5 class="title">All adverse events</h5> <p>No studies measured or reported adverse events other than the need for oral steroids or unscheduled visits, which have already been considered. </p> </section> <section id="CD012226-sec-0089"> <h5 class="title">Comparison 1 sensitivity analyses</h5> <p>No unpublished data were included in the analyses, so we found that this sensitivity analysis was not necessary. </p> <p>Only one study in the objective % adherence outcome was rated at high risk for either of the selection bias domains, and results without this study showed a slightly smaller pooled effect than was evident in the main analysis (MD 16.23, 95% CI 3.86 to 28.60). No studies in the 'Exacerbation requiring OCS' or 'Asthma control' analyses were at high risk in either of the selection bias domains. </p> <p><a href="./references#CD012226-bbs2-0019" title="MehuysE , VanBortelL , DeBolleL , VanTongelenI , AnnemansL , RemonJP , et al. Effectiveness of pharmacist intervention for asthma control improvement. European Respiratory Journal2008;31(4):790‐9. MehuysE , vanBortelL , deBolleL , vanTongelenI , RemonJ‐P , AnnemansL , et al. Does pharmacist intervention lead to appropriate use of asthma medication and improved asthma control? [Leidt apothekersadvies over het optimaal gebruik van astmamedicatie tot een verbetering van de astmacontrole? Een gerandomiseerde gecontroleerde studie]. Farmaceutisch Tijdschrift voor Belgie2008;85(1):1‐9. ">Mehuys 2008</a> and <a href="./references#CD012226-bbs2-0012" title="GallefossF , BakkePS . How does patient education and self‐management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. American Journal of Respiratory and Critical Care Medicine1999;160(6):2000‐5. GallefossF , BakkePS . Impact of patient education and self‐management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine2000;94(3):279‐87. [CRS: 4900100000008905] GallefossF , BakkePS , RsgaardPK , KjaersgaardP . Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1999;159(3):812‐7. [CENTRAL: 160267; CRS: 4900100000006265; PUBMED: 10051255] ">Gallefoss 1999</a> were the only Comparison 1 studies in which not all participants were taking an ICS at baseline (although proportions were between 89.5% and 97% in each group). <a href="./references#CD012226-bbs2-0019" title="MehuysE , VanBortelL , DeBolleL , VanTongelenI , AnnemansL , RemonJP , et al. Effectiveness of pharmacist intervention for asthma control improvement. European Respiratory Journal2008;31(4):790‐9. MehuysE , vanBortelL , deBolleL , vanTongelenI , RemonJ‐P , AnnemansL , et al. Does pharmacist intervention lead to appropriate use of asthma medication and improved asthma control? [Leidt apothekersadvies over het optimaal gebruik van astmamedicatie tot een verbetering van de astmacontrole? Een gerandomiseerde gecontroleerde studie]. Farmaceutisch Tijdschrift voor Belgie2008;85(1):1‐9. ">Mehuys 2008</a> did not contribute to the objective % adherence outcome, as researchers did not measure adherence using an electronic monitor. Both studies contributed to 'Exacerbations requiring OCS' and their exclusion left just the two <a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a> comparisons (PAD vs control and IRF + PAD vs IRF) in the analysis. The point estimate favours control over education (OR 3.44, 95% CI 1.35 to 8.81; 131 participants; one study), but results were reported by a single small study and should be interpreted with caution. <a href="./references#CD012226-bbs2-0019" title="MehuysE , VanBortelL , DeBolleL , VanTongelenI , AnnemansL , RemonJP , et al. Effectiveness of pharmacist intervention for asthma control improvement. European Respiratory Journal2008;31(4):790‐9. MehuysE , vanBortelL , deBolleL , vanTongelenI , RemonJ‐P , AnnemansL , et al. Does pharmacist intervention lead to appropriate use of asthma medication and improved asthma control? [Leidt apothekersadvies over het optimaal gebruik van astmamedicatie tot een verbetering van de astmacontrole? Een gerandomiseerde gecontroleerde studie]. Farmaceutisch Tijdschrift voor Belgie2008;85(1):1‐9. ">Mehuys 2008</a> contributed to the ACT analysis, but our conclusions did not change when we excluded this study (MD 0.72, 95% CI ‐0.58 to 2.02). </p> <p>As described previously, instead of excluding studies that did not measure adherence objectively in a sensitivity analysis, we have presented this as our main analysis (<a href="./references#CD012226-fig-0004" title="">Analysis 1.1</a>). </p> </section> </section> <section id="CD012226-sec-0090"> <h4 class="title">Comparison 2. Electronic trackers or reminders versus controls</h4> <section id="CD012226-sec-0091"> <h5 class="title">Adherence</h5> <p>As for Comparison 1, our primary analysis of adherence included only studies that used an objective electronic monitor to measure adherence. Mean adherence of those using electronic trackers or reminders was 20% better than mean adherence of those in the control group (<a href="./references#CD012226-fig-0011" title="">Analysis 2.1</a>; MD 19.86, 95% CI 14.47 to 25.26; 555 participants; six studies; I<sup>2</sup> = 34%; moderate‐quality evidence). As with Comparison 1, our confidence in the estimate was reduced by possible performance and selection bias. Pooling studies using any measure of adherence had little impact on the estimate, but greater inconsistency was evident (MD 18.41, 95% CI 11.82 to 25.00; 762 participants; eight studies; I<sup>2</sup> = 66%; low‐quality evidence). </p> <p>Subgroup analyses for the objectively measured adherence outcome provides weak evidence that inhaler reminders combined with individual feedback may be more effective than inhaler reminders alone (test for subgroup difference: I<sup>2</sup>= 65.2%; P = 0.09; <a href="./references#CD012226-fig-0011" title="">Analysis 2.1</a>). The test for subgroup differences between interventions judged to be 'complex' (i.e. multi‐faceted) and simpler interventions also provides weak evidence that complex interventions may be more effective, but this effect was seen only when the analysis was limited to studies using objective measures of adherence (I<sup>2</sup> = 65.2%; P = 0.09; <a href="./references#CD012226-fig-0030" title="">Analysis 5.2</a>). Testing also suggested no important differences between studies of adults (or adults and adolescents) and children (I<sup>2</sup> = 0%; <a href="./references#CD012226-fig-0031" title="">Analysis 5.3</a>). As with Comparison 1, the subgroup analysis based on the recipient of the intervention was not necessary, as all interventions were delivered to adults or children with asthma or their parents. </p> <p>Three other studies reported data about adherence that could not be pooled with data from studies reporting % adherence. Data from <a href="./references#CD012226-bbs2-0008" title="ChanAH , StewartAW , HarrisonJ , CamargoCAJr , BlackPN , MitchellEA . The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial. Lancet Respiratory Medicine2015;3(3):210‐9. ">Chan 2015</a> were skewed and were reported as medians; this study showed large benefit of an audiovisual inhaler reminder, with an intervention median adherence of 84% (10th to 90th percentile 54 to 96; N = 110) compared with a control median adherence of 30% (10th to 90th percentile 8 to 68; N = 110). <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a>, a large cluster study, reported adherence as a refill rate and showed similar results between groups (21.3 in the feedback group (SE 2.5), 23.2 in the control group (SE 2,2)). <a href="./references#CD012226-bbs2-0032" title="Kolmodin MacDonellK , NaarS , Gibson‐ScipioW , LamP , SecordE . The Detroit young adult asthma project: pilot of a technology‐based medication adherence intervention for African‐American emerging adults. Journal of Adolescent Health2016;59(4):465‐71. [DOI: 10.1016/j.jadohealth.2016.05.016] NCT01714141 . Multi‐component technology intervention for minority emerging adults with asthma. https://clinicaltrials.gov/ct2/show/NCT01714141 (accessed 21 July 2016). ">NCT01714141</a> collected adherence data in several ways from a self‐report questionnaire, none of which were comparable with those of other studies; scores generally favoured the treatment group. </p> </section> <section id="CD012226-sec-0092"> <h5 class="title">Exacerbations requiring OCS</h5> <p>It was not possible to say with certainty whether electronic trackers or reminders improved the odds of needing oral steroids for an exacerbation (OR 0.72, 95% CI 0.37 to 1.39; 3063 participants; four studies; I<sup>2</sup> = 60%; very low‐quality evidence). Confidence limits included important benefit in one direction and important harm in the other (<a href="./references#CD012226-fig-0013" title="">Analysis 2.3</a>). We downgraded the evidence further for risk of bias and inconsistency. </p> <p>Again, as with the first comparison, we did not perform subgroup analyses on this primary outcome because we identified too few studies. Similarly, some studies (<a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a>; <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a>; <a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a>; <a href="./references#CD012226-bbs2-0039" title="GoossensLMA , VasbinderEC , van DenBemtPMLA , Rutten‐Van MolkenMPMH . Cost‐effectiveness of real‐time medication monitoring in children with asthma. Value in Health2014;17(7):A329. VasbinderE , GoossensL , JanssensH , deWinterB , vanDijkL , VultoA , et al. E‐monitoring of asthma therapy to improve compliance in children (E‐MATIC). European Respiratory Journal2016;46:758‐67. [DOI: 10.1183/13993003.01698‐2015] VasbinderEC , GoossensLMA , JanssensH , deWinterBCM , vanDijkL , VultoAG , et al. E‐Monitoring of asthma therapy to improve compliance in children (E‐MATIC). Pharmacoepidemiology and Drug Safety2015;24(S1):489. [DOI: 10.1002/pds] VasbinderEC , JanssensHM , Rutten‐van MolkenMP , vanDijkL , deWinterBC , deGrootRC , et al. e‐Monitoring of asthma therapy to improve compliance in children using a real‐time medication monitoring system (RTMM): the e‐MATIC study protocol. BMC Medical Informatics and Decision Making2013;13(1):38. ">Vasbinder 2015 E‐MATIC</a>) reported the mean number of exacerbations per person over a period of time and the data were skewed, so we did not consider a mean difference to be a valid measure for comparison. <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a> reported no difference between the adherence monitoring with feedback group and the asthma education group for oral steroid use (P = 0.32). Similarly, <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a> reported oral steroid use and found no clear benefit of adherence feedback over usual care (P = 0.277). <a href="./references#CD012226-bbs2-0039" title="GoossensLMA , VasbinderEC , van DenBemtPMLA , Rutten‐Van MolkenMPMH . Cost‐effectiveness of real‐time medication monitoring in children with asthma. Value in Health2014;17(7):A329. VasbinderE , GoossensL , JanssensH , deWinterB , vanDijkL , VultoA , et al. E‐monitoring of asthma therapy to improve compliance in children (E‐MATIC). European Respiratory Journal2016;46:758‐67. [DOI: 10.1183/13993003.01698‐2015] VasbinderEC , GoossensLMA , JanssensH , deWinterBCM , vanDijkL , VultoAG , et al. E‐Monitoring of asthma therapy to improve compliance in children (E‐MATIC). Pharmacoepidemiology and Drug Safety2015;24(S1):489. [DOI: 10.1002/pds] VasbinderEC , JanssensHM , Rutten‐van MolkenMP , vanDijkL , deWinterBC , deGrootRC , et al. e‐Monitoring of asthma therapy to improve compliance in children using a real‐time medication monitoring system (RTMM): the e‐MATIC study protocol. BMC Medical Informatics and Decision Making2013;13(1):38. ">Vasbinder 2015 E‐MATIC</a> reported exacerbations as requiring OCS, an ED visit or hospitalisation and reported no advantage of the text messaging intervention over control (P = 0.432). Finally, <a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a> adjusted the analysis to account for the skew and found that children receiving adherence feedback had fewer exacerbations per 100 days compared with controls (rate ratio 0.23, 95% CI 0.08 to 0.64). </p> </section> <section id="CD012226-sec-0093"> <h5 class="title">Asthma control</h5> <p>Studies used the Asthma Control Questionnaire (<a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a>; <a href="./references#CD012226-bbs2-0037" title="StrandbygaardU , ThomsenSF , BackerV . A daily SMS reminder increases adherence to asthma treatment: a three‐month follow‐up study. Respiratory Medicine2010;104(2):166‐71. ">Strandbygaard 2010</a>) or the Asthma Control Test (<a href="./references#CD012226-bbs2-0008" title="ChanAH , StewartAW , HarrisonJ , CamargoCAJr , BlackPN , MitchellEA . The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial. Lancet Respiratory Medicine2015;3(3):210‐9. ">Chan 2015</a>; <a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a>; <a href="./references#CD012226-bbs2-0032" title="Kolmodin MacDonellK , NaarS , Gibson‐ScipioW , LamP , SecordE . The Detroit young adult asthma project: pilot of a technology‐based medication adherence intervention for African‐American emerging adults. Journal of Adolescent Health2016;59(4):465‐71. [DOI: 10.1016/j.jadohealth.2016.05.016] NCT01714141 . Multi‐component technology intervention for minority emerging adults with asthma. https://clinicaltrials.gov/ct2/show/NCT01714141 (accessed 21 July 2016). ">NCT01714141</a>; <a href="./references#CD012226-bbs2-0039" title="GoossensLMA , VasbinderEC , van DenBemtPMLA , Rutten‐Van MolkenMPMH . Cost‐effectiveness of real‐time medication monitoring in children with asthma. Value in Health2014;17(7):A329. VasbinderE , GoossensL , JanssensH , deWinterB , vanDijkL , VultoA , et al. E‐monitoring of asthma therapy to improve compliance in children (E‐MATIC). European Respiratory Journal2016;46:758‐67. [DOI: 10.1183/13993003.01698‐2015] VasbinderEC , GoossensLMA , JanssensH , deWinterBCM , vanDijkL , VultoAG , et al. E‐Monitoring of asthma therapy to improve compliance in children (E‐MATIC). Pharmacoepidemiology and Drug Safety2015;24(S1):489. [DOI: 10.1002/pds] VasbinderEC , JanssensHM , Rutten‐van MolkenMP , vanDijkL , deWinterBC , deGrootRC , et al. e‐Monitoring of asthma therapy to improve compliance in children using a real‐time medication monitoring system (RTMM): the e‐MATIC study protocol. BMC Medical Informatics and Decision Making2013;13(1):38. ">Vasbinder 2015 E‐MATIC</a>) as validated measures of asthma control (<a href="./references#CD012226-fig-0014" title="">Analysis 2.4</a>). Results did not show an important difference between reminders/trackers and controls on the ACQ (MD 0.24, 95% CI ‐0.29 to 0.78; 109 participants; two studies; I<sup>2</sup> = 0%; low‐quality evidence) nor on the ACT (MD 0.74, 95% CI ‐0.20 to 1.69; 596 participants; four studies; I<sup>2</sup> = 47%; low‐quality evidence). The upper limit for the ACQ estimate includes the MCID for the scale (0.5), so trackers and reminders could have an important effect on this measure of asthma control; we downgraded the evidence for imprecision for this reason. We noted some variation between ACT results, but confidence limits fell below the 3 point MCID for the scale, so we did not consider the estimate imprecise. </p> <p>It was not possible to perform subgroup analyses on this primary outcome because we identified too few studies and we did not observe significant heterogeneity in the analysis. </p> </section> <section id="CD012226-sec-0094"> <h5 class="title">Unscheduled visits</h5> <p>Some studies reported unscheduled visits as ED visits and some as hospital visits (<a href="./references#CD012226-fig-0015" title="">Analysis 2.5</a>); we did not pool the two because <a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a> reported both. It was not possible to say with certainly whether electronic trackers or reminders reduced the odds of unscheduled visits to the ED (OR 1.14, 95% CI 0.88 to 1.47; 2918 participants; two studies; I<sup>2</sup> = 0%; moderate‐quality evidence) or to the hospital (OR 0.97, 95% CI 0.53 to 1.78; 2865 participants; two studies; I<sup>2</sup> = 0%; not graded), as the estimates were imprecise. </p> <p><a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a> reported data that could be analysed as rate ratios (<a href="./references#CD012226-fig-0016" title="">Analysis 2.6</a>) and showed a reduction in hospital visits (rate ratio 4.38, 95% CI 1.46 to 13.14) but not in GP or ED visits (rate ratio 1.15, 95% CI 0.83 to 1.59). </p> </section> <section id="CD012226-sec-0095"> <h5 class="title">Absence from work/school</h5> <p><a href="./references#CD012226-bbs2-0008" title="ChanAH , StewartAW , HarrisonJ , CamargoCAJr , BlackPN , MitchellEA . The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial. Lancet Respiratory Medicine2015;3(3):210‐9. ">Chan 2015</a> reported that the number of parents taking at least one absence favoured controls but results were imprecise (<a href="./references#CD012226-fig-0017" title="">Analysis 2.7</a>; OR 1.42, 95% CI 0.82 to 2.47; low‐quality evidence). We considered evidence for the outcome to be of low quality owing to imprecision and risk of bias. <a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a> reported absences per 100 child days that favoured reminders, but results were imprecise (<a href="./references#CD012226-fig-0018" title="">Analysis 2.8</a>; rate ratio 1.16, 95% CI 0.97 to 1.39; evidence quality not graded). </p> </section> <section id="CD012226-sec-0096"> <h5 class="title">Quality of life</h5> <p>Studies reported no difference between electronic trackers or reminders and controls on the Asthma Quality of Life Questionnaire (MD ‐0.03, 95% CI ‐0.20 to 0.13; 369 participants; four studies; I<sup>2</sup> = 0%; moderate‐quality evidence). Upper and lower confidence limits lay well within the 0.5 point MCID for the scale, so we did not consider the effect imprecise, although we had the usual concerns related to risk of bias. </p> </section> <section id="CD012226-sec-0097"> <h5 class="title">All adverse events</h5> <p>Only <a href="./references#CD012226-bbs2-0039" title="GoossensLMA , VasbinderEC , van DenBemtPMLA , Rutten‐Van MolkenMPMH . Cost‐effectiveness of real‐time medication monitoring in children with asthma. Value in Health2014;17(7):A329. VasbinderE , GoossensL , JanssensH , deWinterB , vanDijkL , VultoA , et al. E‐monitoring of asthma therapy to improve compliance in children (E‐MATIC). European Respiratory Journal2016;46:758‐67. [DOI: 10.1183/13993003.01698‐2015] VasbinderEC , GoossensLMA , JanssensH , deWinterBCM , vanDijkL , VultoAG , et al. E‐Monitoring of asthma therapy to improve compliance in children (E‐MATIC). Pharmacoepidemiology and Drug Safety2015;24(S1):489. [DOI: 10.1002/pds] VasbinderEC , JanssensHM , Rutten‐van MolkenMP , vanDijkL , deWinterBC , deGrootRC , et al. e‐Monitoring of asthma therapy to improve compliance in children using a real‐time medication monitoring system (RTMM): the e‐MATIC study protocol. BMC Medical Informatics and Decision Making2013;13(1):38. ">Vasbinder 2015 E‐MATIC</a> measured and reported adverse events; this study reported serious adverse events of any cause and observed none in either group. </p> </section> <section id="CD012226-sec-0098"> <h5 class="title">Comparison 2 sensitivity analyses</h5> <p>No unpublished data contributed to any of the three primary outcomes, so this sensitivity analysis was not necessary. Similarly, we rated no contributing studies at high risk of selection bias, so this was also not necessary. </p> <p>Before the study commenced, not all participants in <a href="./references#CD012226-bbs2-0037" title="StrandbygaardU , ThomsenSF , BackerV . A daily SMS reminder increases adherence to asthma treatment: a three‐month follow‐up study. Respiratory Medicine2010;104(2):166‐71. ">Strandbygaard 2010</a> were taking an ICS (59%), but all were taking an ICS at the start of the study. Excluding this study made little difference in the objective % adherence analysis (MD 20.62, 95% CI 14.30 to 26.95) but greatly decreased the precision of the ACQ analysis (MD 0.19, 95% CI ‐1.37 to 1.75). This study did not contribute to exacerbations requiring oral steroids. </p> <p>As for Comparison 1, instead of excluding studies that did not measure adherence objectively in a sensitivity analysis, we have presented this as our main analysis (<a href="./references#CD012226-fig-0011" title="">Analysis 2.1</a>). </p> </section> </section> <section id="CD012226-sec-0099"> <h4 class="title">Comparison 3. Simplified versus usual drug regimens</h4> <section id="CD012226-sec-0100"> <h5 class="title">Adherence</h5> <p>All three studies contributing to this outcome assessed adherence using an objective measure. Adherence was 4% better with simplified drug regimens than with usual drug regimens (<a href="./references#CD012226-fig-0004" title="">Analysis 1.1</a>; MD 4.02, 95% CI 1.88 to 6.16; 1310 participants; three studies; I<sup>2</sup> = 0%). We downgraded the evidence only for risk of bias and rated it as moderate quality. The effect is difficult to interpret as two studies compared combined versus separate inhalers (<a href="./references#CD012226-bbs2-0006" title="BosleyCM , ParryDT , CochraneGM . Patient compliance with inhaled medication: does combining beta‐agonists with corticosteroids improve compliance?. European Respiratory Journal1994;7(3):504‐9. ">Bosley 1994</a>; <a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a>), and one study compared once‐daily versus twice‐daily dosing (<a href="./references#CD012226-bbs2-0036" title="PriceD , RobertsonA , BullenK , RandC , HorneR , StaudingerH . Improved adherence with once‐daily versus twice‐daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open‐label study. BMC Pulmonary Medicine2010;10:1. ">Price 2010</a>). </p> <p>Adherence data in <a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a> could not be combined with those from other studies. Twice‐daily and four‐times‐daily groups in <a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a> took a similar mean number of correct daily inhalations. Data from the same study showing the percentage of days with missed inhalations favoured twice daily but were skewed (twice daily 36.8%, SD 48.3; four times daily 57.1%, SD 49.6). </p> </section> <section id="CD012226-sec-0101"> <h5 class="title">Exacerbations requiring OCS</h5> <p>It was not possible to tell whether simplifying drug regimens had an effect on exacerbations, as only one study of 16 people reported this outcome (<a href="./references#CD012226-fig-0021" title="">Analysis 3.2</a>; OR 2.33, 95% CI 0.17 to 32.58; low‐quality evidence). This study compared twice‐daily treatment versus treatment given four times daily (<a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a>). </p> </section> <section id="CD012226-sec-0102"> <h5 class="title">Asthma control</h5> <p>One study (<a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a>) comparing combined inhalers (simplified regimen) versus separate inhalers showed no difference between regimens on the ACQ (MD ‐0.03, 95% CI ‐0.34 to 0.28; 103 participants; one study). Both confidence limits fell within the 0.5 MCID for the ACQ, so we did not downgrade for imprecision. We had the usual concerns regarding risk of bias through lack of blinding, so we rated the evidence as moderate quality. </p> </section> <section id="CD012226-sec-0103"> <h5 class="title">Unscheduled visits</h5> <p><a href="./references#CD012226-bbs2-0036" title="PriceD , RobertsonA , BullenK , RandC , HorneR , StaudingerH . Improved adherence with once‐daily versus twice‐daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open‐label study. BMC Pulmonary Medicine2010;10:1. ">Price 2010</a> did not show benefit of once‐daily dosing (simplified regimen) versus twice‐daily dosing for unscheduled visits (<a href="./references#CD012226-fig-0023" title="">Analysis 3.4</a>; OR 1.17, 95% CI 0.72 to 1.90; 1037 participants; one study; low‐quality evidence). The effect lay close to no difference, and confidence limits showed important benefit in one direction and important harm in the other; we downgraded the evidence for this imprecision and for risk of bias. </p> </section> <section id="CD012226-sec-0104"> <h5 class="title">Absence from work/school</h5> <p>On the basis of data from one study (<a href="./references#CD012226-bbs2-0036" title="PriceD , RobertsonA , BullenK , RandC , HorneR , StaudingerH . Improved adherence with once‐daily versus twice‐daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open‐label study. BMC Pulmonary Medicine2010;10:1. ">Price 2010</a>), it was, again, not possible to tell whether once‐daily dosing (simplified regimen) showed benefit for this outcome compared with twice‐daily dosing; only one study reported this, and confidence intervals included important benefit and harm (<a href="./references#CD012226-fig-0024" title="">Analysis 3.5</a>; OR 0.93, 95% CI 0.37 to 2.30; low‐quality evidence). </p> </section> <section id="CD012226-sec-0105"> <h5 class="title">Quality of life</h5> <p>One study comparing once‐daily dosing (simplified) versus twice‐daily dosing (<a href="./references#CD012226-bbs2-0036" title="PriceD , RobertsonA , BullenK , RandC , HorneR , StaudingerH . Improved adherence with once‐daily versus twice‐daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open‐label study. BMC Pulmonary Medicine2010;10:1. ">Price 2010</a>) reported quality of life on the Therapeutics Group Asthma Short Form (<a href="./references#CD012226-fig-0025" title="">Analysis 3.6</a>); the lower confidence limit crossed the line of no effect, so we were not confident in the estimate (MD 6.00, 95% CI ‐0.76 to 12.76; 1037 participants; low‐quality evidence). The scale ranges from 1 to 100, and we could find no information on an agreed MCID. </p> </section> <section id="CD012226-sec-0106"> <h5 class="title">All adverse events</h5> <p><a href="./references#CD012226-bbs2-0036" title="PriceD , RobertsonA , BullenK , RandC , HorneR , StaudingerH . Improved adherence with once‐daily versus twice‐daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open‐label study. BMC Pulmonary Medicine2010;10:1. ">Price 2010</a> reported adverse events and observed fewer in the simplified regimens group (once‐daily dose) than in the control group (twice‐daily dose), but confidence intervals included no difference (OR 0.76, 95% CI 0.56 to 1.04; low‐quality evidence). We downgraded the evidence for imprecision and for risk of performance bias. </p> </section> <section id="CD012226-sec-0107"> <h5 class="title">Comparison 3 subgroup and sensitivity analyses</h5> <p>We did not perform any subgroup analyses for this comparison as we included no more than three studies in any single analysis. None of the sensitivity analyses were necessary because we located no unpublished data, no contributing studies were at high risk of selection bias and all used objective measures of adherence. </p> </section> </section> <section id="CD012226-sec-0108"> <h4 class="title">Comparison 4. School‐based ICS therapy versus control</h4> <p>The three studies performing this comparison provided no data for adherence, exacerbations requiring OCS, asthma control or adverse events. <a href="./references#CD012226-bbs2-0013" title="GeraldLB , McClureLA , HarringtonKF , ManganJM , GibsonL , AtchisonJ , et al. Design of the supervised asthma therapy study: implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials2008;29(2):304‐10. GeraldLB , McClureLA , ManganJM , HarringtonKF , GibsonL , ErwinS , et al. Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school‐based supervised asthma therapy. Pediatrics2009;123(2):466‐74. GeraldLB , PatelK , ZhangS , McClureL . Secondhand smoke exposure and asthma morbidity among elementary school children enrolled in a clinical trial. Chest2007;132(4):461. [DOI: 10.1378/chest.132.4_MeetingAbstracts.461] McClureLA , HarringtonKF , GrahamH , GeraldLB . Internet‐based monitoring of asthma symptoms, peak flow meter readings, and absence data in a school‐based clinical trial. Clinical Trials2008;5(1):31‐7. ">Gerald 2009</a> reported a composite measure of episodes of poor asthma control (EPAC), which we could not combine with any other measures. We identified too few studies to consider any of the planned subgroup or sensitivity analyses, but we have presented below data that could be analysed. </p> <section id="CD012226-sec-0109"> <h5 class="title">Unscheduled visits</h5> <p>Two studies reported unscheduled visits, but the data could not be combined. <a href="./references#CD012226-bbs2-0014" title="HaltermanJS , SzilagyiPG , YoosHL , ConnKM , KaczorowskiJM , HolzhauerRJ , et al. Benefits of a school‐based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Archives of Pediatric and Adolescent Medicine2004;158(5):460‐7. ">Halterman 2004</a> reported that 18 of 89 children in the intervention group and 26 of 91 in the control group had three or more visits over 10 months. <a href="./references#CD012226-bbs2-0031" title="HaltermanJS , FagnanoM , MontesG , FisherS , TremblayP , TajonR , et al. The school‐based preventive asthma care trial: results of a pilot study. Journal of Pediatrics2012;161(6):1109‐15. HaltermanJS , SauerJ , FagnanoM , MontesG , FisherS , TremblayP , et al. Working toward a sustainable system of asthma care: development of the School‐Based Preventive Asthma Care Technology (SB‐PACT) trial. Journal of Asthma2012;49(4):395‐400. NCT01175434 . School‐based preventive asthma care technology: a trial using a novel technology to improve adherence (SB‐PACT). https://clinicaltrials.gov/ct2/show/NCT01175434 (first received 16 April 2010). ">NCT01175434</a> reported that 9 of 48 children in the intervention group and 11 51 in the control group had one or more unscheduled visits over six to eight months. </p> <p>Both studies reported the number of people who had one or more hospitalisations for any cause during the study; confidence intervals showed an important benefit in either direction, so it was not possible to say whether school‐based ICS has a beneficial effect (OR 0.58, 95% CI 0.16 to 2.05; 279 participants; two studies; I<sup>2</sup> = 0%; low‐quality evidence). </p> </section> <section id="CD012226-sec-0110"> <h5 class="title">Absence from work/school</h5> <p><a href="./references#CD012226-bbs2-0014" title="HaltermanJS , SzilagyiPG , YoosHL , ConnKM , KaczorowskiJM , HolzhauerRJ , et al. Benefits of a school‐based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Archives of Pediatric and Adolescent Medicine2004;158(5):460‐7. ">Halterman 2004</a> reported mean absences per child over the 10‐month study: 6.8 absences (SD 9.5) for the intervention group and 8.8 days (SD 8.8) for the control group. <a href="./references#CD012226-bbs2-0031" title="HaltermanJS , FagnanoM , MontesG , FisherS , TremblayP , TajonR , et al. The school‐based preventive asthma care trial: results of a pilot study. Journal of Pediatrics2012;161(6):1109‐15. HaltermanJS , SauerJ , FagnanoM , MontesG , FisherS , TremblayP , et al. Working toward a sustainable system of asthma care: development of the School‐Based Preventive Asthma Care Technology (SB‐PACT) trial. Journal of Asthma2012;49(4):395‐400. NCT01175434 . School‐based preventive asthma care technology: a trial using a novel technology to improve adherence (SB‐PACT). https://clinicaltrials.gov/ct2/show/NCT01175434 (first received 16 April 2010). ">NCT01175434</a> reported a mean of 0.37 absences (SD 0.7) in the intervention group over two weeks and 0.85 (SD 1.3) in the control group. Both sets of data were skewed and were not suitable for combination in a mean difference analysis. </p> </section> <section id="CD012226-sec-0111"> <h5 class="title">Quality of life</h5> <p>The same two studies reported results of the Paediatric Asthma Quality of Life Questionnaire (PAQLQ). A statistically significant effect favoured giving ICS at school, but the upper end of the confidence limit lay under the 0.5 MCID for the scale, so the difference is unlikely to be clinically important (MD 0.25, 95% CI 0.01 to 0.49; 279 participants; two studies; I<sup>2</sup> = 0%; moderate‐quality evidence). </p> </section> <section id="CD012226-sec-0112"> <h5 class="title">Adverse events</h5> <p><a href="./references#CD012226-bbs2-0031" title="HaltermanJS , FagnanoM , MontesG , FisherS , TremblayP , TajonR , et al. The school‐based preventive asthma care trial: results of a pilot study. Journal of Pediatrics2012;161(6):1109‐15. HaltermanJS , SauerJ , FagnanoM , MontesG , FisherS , TremblayP , et al. Working toward a sustainable system of asthma care: development of the School‐Based Preventive Asthma Care Technology (SB‐PACT) trial. Journal of Asthma2012;49(4):395‐400. NCT01175434 . School‐based preventive asthma care technology: a trial using a novel technology to improve adherence (SB‐PACT). https://clinicaltrials.gov/ct2/show/NCT01175434 (first received 16 April 2010). ">NCT01175434</a> reported that no one in the intervention group (n = 48) and no one in the control group (n = 51) had any adverse events. </p> </section> </section> <section id="CD012226-sec-0113"> <h4 class="title">Unclassified studies</h4> <p>We were unable to classify <a href="./references#CD012226-bbs2-0017" title="KoufopoulosJT , ConnerMT , GardnerPH , KellarI . A web‐based and mobile health social support intervention to promote adherence to inhaled asthma medications: randomized controlled trial. Journal of Medical Internet Research2016;18(6):e122. [CRS: 4900132000024092; PUBMED: 27298211] ">Koufopoulos 2016</a> and <a href="./references#CD012226-bbs2-0007" title="BurgessSW , SlyPD , CooperDM , DevadasonSG . Novel spacer device does not improve adherence in childhood asthma. Pediatric Pulmonology2007;42(8):736‐9. ">Burgess 2007</a>, as both tested interventions that did not fit into any of our four main categories. </p> <p><a href="./references#CD012226-bbs2-0007" title="BurgessSW , SlyPD , CooperDM , DevadasonSG . Novel spacer device does not improve adherence in childhood asthma. Pediatric Pulmonology2007;42(8):736‐9. ">Burgess 2007</a> reported that a novel spacer device, the 'Funhaler', did not improve adherence to ICS in children over the 12‐week study period. End of follow‐up median adherence (range) was 46% (2% to 100%) in the intervention group and 53% (0 to 100%) in the control (Aerochamber) group. Investigators measured adherence with a SmartInhaler. Study authors reported the number of children experiencing an exacerbation requiring an OCS: 11 of 24 in the intervention group and 6 of 20 in the control group. </p> <p><a href="./references#CD012226-bbs2-0017" title="KoufopoulosJT , ConnerMT , GardnerPH , KellarI . A web‐based and mobile health social support intervention to promote adherence to inhaled asthma medications: randomized controlled trial. Journal of Medical Internet Research2016;18(6):e122. [CRS: 4900132000024092; PUBMED: 27298211] ">Koufopoulos 2016</a> investigated whether an online asthma community ("AsthmaVillage") can improve self‐reported adherence, measured on the Simplified Medication Adherence Questionnaire (SMAQ). Results show that the control group reported better adherence to ICS during the study period and control group participants were more likely to use the online diary than those in the AsthmaVillage group. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012226-sec-0114" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012226-sec-0114"></div> <section id="CD012226-sec-0115"> <h3 class="title" id="CD012226-sec-0115">Summary of main results</h3> <p>This review found 39 eligible parallel randomised controlled trials (RCTs), 28 of which (n = 16,303) contributed data to at least one meta‐analysis. Eighteen studies included only children, 20 included adults and/or adolescents and one recruited individuals of all ages; all participants had asthma and a vast majority were using an inhaled corticosteroid (ICS) at baseline. Follow‐up of analysed studies ranged from two months to two years (median six months). Trials were conducted mainly in high‐income countries. Outcomes reported were not consistent across reviews, and investigators did not always use validated scales. Almost all included studies reported some measure of adherence, usually as a percentage, but the way in which this information was captured and calculated varied between studies. Studies were generally at low or unclear risk of selection bias and at high risk of bias associated with blinding (although this varied by outcome). Review authors considered around half of these studies to be at high risk for attrition bias and selective outcome reporting. </p> <p>Studies were classified into four comparisons by consensus: adherence education versus control (20 studies); electronic trackers or reminders versus control (11 studies); simplified drug regimens versus usual drug regimens (four studies); and school‐based directly observed therapy (three studies). Two multi‐arm studies appeared in two comparisons (<a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a>; <a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a>), and two studies were described separately (<a href="./references#CD012226-bbs2-0007" title="BurgessSW , SlyPD , CooperDM , DevadasonSG . Novel spacer device does not improve adherence in childhood asthma. Pediatric Pulmonology2007;42(8):736‐9. ">Burgess 2007</a>; <a href="./references#CD012226-bbs2-0017" title="KoufopoulosJT , ConnerMT , GardnerPH , KellarI . A web‐based and mobile health social support intervention to promote adherence to inhaled asthma medications: randomized controlled trial. Journal of Medical Internet Research2016;18(6):e122. [CRS: 4900132000024092; PUBMED: 27298211] ">Koufopoulos 2016</a>). </p> <p>All pooled results for adherence education, electronic trackers or reminders and simplified regimens led to better adherence than for controls, both when adherence was measured objectively and when all measures were considered. However, our confidence in the evidence was reduced by risk of bias and inconsistency. When measured objectively (e.g. using a dose counter), adherence education showed 20% benefit over controls (95% confidence interval (CI) 7.52 to 32.74; five studies; low‐quality evidence), and the effect was attenuated to 12% when all measures were considered. Electronic trackers or reminders led to 20% (18% if all measures were included) better adherence than for controls (95% CI 14.47 to 25.26; six studies; low‐quality evidence). Simplified regimens led to 4% better adherence than usual care (95% CI 1.88 to 6.16; three studies; moderate‐quality evidence), but the effect is difficult to interpret, as two studies compared combined versus separate inhalers (<a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a>; <a href="./references#CD012226-bbs2-0006" title="BosleyCM , ParryDT , CochraneGM . Patient compliance with inhaled medication: does combining beta‐agonists with corticosteroids improve compliance?. European Respiratory Journal1994;7(3):504‐9. ">Bosley 1994</a>) and one study compared once‐daily versus twice‐daily dosing (<a href="./references#CD012226-bbs2-0036" title="PriceD , RobertsonA , BullenK , RandC , HorneR , StaudingerH . Improved adherence with once‐daily versus twice‐daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open‐label study. BMC Pulmonary Medicine2010;10:1. ">Price 2010</a>). When we were able to conduct subgroup analyses, we found that 'complex' or multi‐faceted educational interventions were not statistically better than simpler interventions, but weak evidence suggested that complex interventions involving adherence reminders and feedback may be more effective than simpler interventions within this comparison. Similarly, weak evidence from subgroup analysis suggested that combining reminders with feedback is more effective than using reminders alone. Overall, results for adults and children were similar. </p> <p>Improvements in adherence were inconsistently translated into observable benefit for clinical outcomes, with some studies reporting a reduction in usage of healthcare services or courses of oral steroids favouring the intervention, and other studies reporting the opposite, or no difference. None of the pooled analyses showed clear benefit for exacerbations requiring an oral corticosteroid (OCS) (evidence of low quality), unscheduled visits (evidence of very low to moderate quality), asthma control or quality of life (evidence for both of low to moderate quality). School or work absence data were mostly skewed and were difficult to interpret (evidence of low quality, when graded), and most studies did not report adverse events. </p> <p>Studies investigating the possible benefit of administering an ICS at school did not measure adherence, exacerbations requiring OCS, asthma control or adverse events. One study showed fewer unscheduled visits, and another found no difference; data could not be combined. </p> </section> <section id="CD012226-sec-0116"> <h3 class="title" id="CD012226-sec-0116">Overall completeness and applicability of evidence</h3> <p>The findings of this review appear to support the premise that interventions specifically intended to improve adherence to ICS are effective in improving percent adherence in both adults and children. However, a wide range of interventions have been used in the included studies, and even within the four comparisons, interventions are variable. We cannot be sure to what extent improvement in adherence was a result of the intervention itself, rather than a result of participation in a trial in which the stated aim was to improve adherence (the "Hawthorne effect" (<a href="./references#CD012226-bbs2-0131" title="McCambridgeJ , WittonJ , ElbourneDR . Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. Journal of Clinical Epidemiology2014;67(3):267–77. ">McCambridge 2014</a>)). Indeed, in many trials all participants showed improvement in several outcomes, irrespective of the group to which they were assigned. In some included trials, participants' adherence was covertly monitored to minimise the impact of performance bias, but participants would likely have been aware of the overall aims of the trial nonetheless. In addition, many of the interventions, especially in Comparison 1, would require considerable investment of resources and in a budget‐constrained healthcare system would be unlikely to be widely adopted. All three considerations limit the applicability of review findings to a real‐world setting. </p> <p>Although all three of the comparisons that measured percentage adherence demonstrated improvement (albeit with low to moderate confidence), it is not always clear whether this was a clinically meaningful improvement, with no established minimal clinically important difference for this outcome. Studies have suggested that median ICS adherence to maintain asthma control is in excess of 80% (<a href="./references#CD012226-bbs2-0129" title="LasmarL , CamargosP , ChampsNS , FonsecaMT , FontesMJ , IbiapinaC . Adherence rate to inhaled corticosteroids and their impact on asthma control. Allergy2009;64:784–9. ">Lasmar 2009</a>). It may have been helpful for interpretation if more trialists had prespecified what they considered to be 'acceptable' adherence, for example, greater than 80%, and had dichotomised participants into those achieving this level of adherence and those not achieving it. The clinical applicability and usefulness of observed improvements in percent adherence could be further disputed by observation of an inconsistent impact on clinical outcomes such as asthma control, quality of life or exacerbations. Most participants, despite improvements in percent adherence, may not have reached the 'threshold' necessary for discernible clinical improvement (Comparisons 1 and 2), or baseline/control group adherence was already at a high level (Comparison 3), thus allowing little room for discernible improvement (<a href="./full#CD012226-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD012226-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD012226-tbl-0003">summary of findings Table 3</a>). It must be noted that very few studies specifically measured or reported adverse events beyond asthma‐related events such as exacerbations. Therefore, we cannot comment on the safety of the interventions studied. </p> <p>Objectvely measured adherence would generally be considered more reliable than patient‐reported measures or pharmacy data. In a post hoc decision, we presented objectively measured adherence as our main adherence analysis. It came as a surprise that in Comparison 1, limiting the analysis to objectively measured adherence resulted in a greater effect size. One possible explanation for this is that when participants were asked to self‐report and had received an educational intervention, they were able to make a more realistic assessment of their adherence than were participants in the control group, who may have consciously or unconsciously inflated their adherences rates. This could have resulted in an underestimation of the effect of the intervention. </p> <p>Our protocol clearly stated that we would include only studies for which adherence to ICS was the main aim of the trial. This resulted in the exclusion of many studies for which adherence education was just one component of a broader asthma education or self‐management education intervention. This may have led to the exclusion of potentially informative studies; however, their inclusion would have further hampered interpretation, as it would be almost impossible to be sure which element of the intervention had led to observed clinical benefit. <a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a> included a comparison (four‐times‐daily dosing) that is not relevant in current practice, but we did not state that we would exclude 'historical' comparisons, and this study was not combined with any other study in a meta‐analysis. </p> <p>Some included studies specifically targeted people with poorly controlled asthma, those known to have suboptimal adherence levels or those in especially high‐risk groups, such as adolescents. We did not plan to analyse such trials separately from those that recruited a more general asthma population. It may have been illuminating to do so, as it is conceivable that these groups would benefit most from a potentially resource‐consuming intervention and could be therefore be targeted in a real‐world setting. </p> <p>We were not able to carry out all of our planned subgroup analyses, and our subgrouping by complexity may have imposed some limitations. This was inevitably a subjective judgement, although we involved all three review authors in the assessment and revised three of our classifications after peer review. Some of the included studies provided only a brief description of the intervention, which also hampered our confidence in our classification. Although subgroup analysis did not provide strong evidence that more complex interventions are more effective than less complex interventions, a different classification process may have led to different conclusions. </p> </section> <section id="CD012226-sec-0117"> <h3 class="title" id="CD012226-sec-0117">Quality of the evidence</h3> <p>Studies were generally at low or unclear risk of selection bias, but we downgraded many of the analyses for inherent risk of bias associated with studies of behavioural interventions that cannot be blinded. To some extent, performance and detection biases varied by outcome, and by the nature of interventions within a given comparison, but we agreed that performance biases can be present even for more objective outcomes (such as unscheduled visits or exacerbations) because people who know they are receiving the intervention, or know they are not, might be more or less likely to visit their doctor or report a negative outcome. Lack of blinding was a problem especially for self‐rated outcomes such as asthma control and quality of life and may have affected how participants, study investigators and healthcare professionals behaved in each group, producing a more indirect effect on other, more objective outcomes, including adherence itself. Thus, our confidence in many of the outcomes was reduced by risk of bias, especially when we had additional concerns about attrition or uncertainties about the selection process. </p> <p>Inconsistency between study results tended to be more of an issue for adherence, and this may be explained at least in part by methodological differences such as measurements used and length of the study, or by differences in the underlying populations. Subgroup analyses generally did not help to explain observed heterogeneity. Most studies showed better adherence in the intervention group, but some outliers showed an effect close to no difference or in the opposite direction, which reduced our confidence in the findings. </p> <p>Dichotomous analyses of fairly rare events such as exacerbations and unscheduled visits tended to be limited by imprecision. For these outcomes, confidence intervals stretched from an important benefit of the intervention to a possible benefit of controls, which prevented firm conclusions. </p> <p>Indirectness of evidence was less of an issue in this evidence base, as we applied eligibility criteria stringently. In only a couple of instances, indirectness in the measurement of an outcome reduced our confidence in the effect (absences and unscheduled visits in Comparison 1). Similarly, we did not detect or strongly suspect publication bias for any outcomes. </p> </section> <section id="CD012226-sec-0118"> <h3 class="title" id="CD012226-sec-0118">Potential biases in the review process</h3> <p>As much as possible, we carried out this review as presented in the published protocol (<a href="./references#CD012226-bbs2-0146" title="KewKM , NormansellR , StovoldE . Interventions to improve adherence to inhaled steroids for asthma. Cochrane Database of Systematic Reviews2016, Issue 6. [DOI: 10.1002/14651858.CD012226] ">Kew 2016</a>) and recorded deviations from it under <a href="#CD012226-sec-0142">Differences between protocol and review</a>. We could not perform planned subgroup or sensitivity analyses on some outcomes because studies were too few or fell into a single subgroup. </p> <p>We did not attempt to contact study authors for additional outcome data or risk of bias clarification owing to the number of studies identified. Therefore, we may have overstated the uncertainty in risk of bias, particularly as related to allocation concealment. Published reports may not have provided unpublished data that were not included in the meta‐analyses. However, it is unlikely that eligible studies were missed by the searches conducted because they covered multiple sources and were sifted in duplicate. </p> <p>We could not anticipate all the ways in which intervention groups and control groups would differ across studies; as a result, our post hoc classification of studies into four comparisons could have introduced bias. It is conceivable that a different classification system may have yielded different results. </p> </section> <section id="CD012226-sec-0119"> <h3 class="title" id="CD012226-sec-0119">Agreements and disagreements with other studies or reviews</h3> <p>Several recent reviews have investigated adherence interventions in people with chronic diseases, such as asthma. Both <a href="./references#CD012226-bbs2-0120" title="Ershad SarabiR , SadoughiF , Jamshidi OrakR , BahaadinbeigyK . The effectiveness of mobile phone text messaging in improving medication adherence for patients with chronic diseases: a systematic review. Iranian Red Crescent Medical Journal2016;18(5):e25183. [CRS: 4900132000036191] ">Ershad 2016</a> and <a href="./references#CD012226-bbs2-0145" title="YasminF , BanuB , ZakirSM , SauerbornR , AliL , SouaresA . Positive influence of short message service and voice call interventions on adherence and health outcomes in case of chronic disease care: a systematic review. BMC Medical Informatics and Decision Making2016;16:46. [CRS: 4900132000036196] ">Yasmin 2016</a> examined the effectiveness of text messaging interventions for people with chronic disease. <a href="./references#CD012226-bbs2-0120" title="Ershad SarabiR , SadoughiF , Jamshidi OrakR , BahaadinbeigyK . The effectiveness of mobile phone text messaging in improving medication adherence for patients with chronic diseases: a systematic review. Iranian Red Crescent Medical Journal2016;18(5):e25183. [CRS: 4900132000036191] ">Ershad 2016</a> presented a narrative review that included six asthma studies. In keeping with our review, these review authors found that text messaging was effective in promoting adherence among different patient populations, although three of the asthma studies showed no differences between groups in adherence to treatment. <a href="./references#CD012226-bbs2-0145" title="YasminF , BanuB , ZakirSM , SauerbornR , AliL , SouaresA . Positive influence of short message service and voice call interventions on adherence and health outcomes in case of chronic disease care: a systematic review. BMC Medical Informatics and Decision Making2016;16:46. [CRS: 4900132000036196] ">Yasmin 2016</a> included two asthma studies of text message and voice call interactions. These review authors concluded that people with chronic disease showed improvement in adherence, but review authors did not see a significant impact on clinical outcomes, which is consistent with our findings. In addition, these review authors found variation in types of interventions provided and outcome measurements assessed, which made it difficult to draw firm conclusions, and cost‐effectiveness remains questionable. <a href="./references#CD012226-bbs2-0103" title="Anglada‐MartinezH , Riu‐ViladomsG , Martin‐CondeM , Rovira‐IllamolaM , Sotoca‐MomblonaJM , Codina‐JaneC . Does mHealth increase adherence to medication? Results of a systematic review. International Journal of Clinical Practice2014;69(1):9‐32. [CRS: 4900132000036192] ">Anglada‐Martinez 2014</a> reviewed m‐health interventions proposed to increase medication adherence and concluded that studies provided mixed evidence of the benefits of these interventions, probably because of variation in study methods. We also encountered problems with between‐study heterogeneity. </p> <p><a href="./references#CD012226-bbs2-0124" title="HallRL , WillgossT , HumphreyLJ , KongsøJH . The effect of medical device dose‐memory functions on patients' adherence to treatment, confidence, and disease self‐management. Patient Preference and Adherence2014;8:775‐88. [CRS: 4900132000036185] ">Hall 2014</a> considered effects of medical device dose memory functions on medication adherence and included one study on asthma medication adherence. These review authors found evidence of benefit for these device functions in terms of medication adherence and patient confidence in managing their condition. We did not attempt to extract outcomes related to participant confidence or self‐efficacy. <a href="./references#CD012226-bbs2-0144" title="WuYP , PaiAL . Health care provider‐delivered adherence promotion interventions: a meta‐analysis. Pediatrics2014;133(6):e1698‐707. [CRS: 4900132000036181] ">Wu 2014</a> reviewed adherence interventions delivered by healthcare providers and included 23 studies of people with asthma, most of whom were children. Review authors found that interventions delivered by a healthcare provider improved adherence and recommended that future reviews should focus on particular patient populations and adherence behaviours. They planned to perform subgroup analyses based on the identified recipient of the intervention but were unable to do so, as all interventions were delivered directly to study participants. </p> <p>Recent reviews of adherence interventions among asthma populations show a similar picture. <a href="./references#CD012226-bbs2-0117" title="DibelloK , BoyarK , AbrenicaS , Sandford WorralP . The effectiveness of text messaging programs on adherence to treatment regimens among adults aged 18 to 45 years diagnosed with asthma: a systematic review. JBI Database of Systematic Reviews and Implementation Report2014;12(4):485‐32. [CRS: 4900132000036180] ">Dibello 2014</a> brought together trials of text messaging services aimed at adults 18 to 45 years of age. Review authors found that adherence improved and noted some impact on control and lung function. However, they were not able to perform a meta‐analysis because of heterogeneity. <a href="./references#CD012226-bbs2-0140" title="TranN , CoffmanJM , SuminoK , CabanaMD . Patient reminder systems and asthma medication adherence: a systematic review. Journal of Asthma2014;51(5):536‐43. [CRS: 4900132000036172] ">Tran 2014</a> reviewed studies of patient reminder systems. These review authors were not able to pool the data but concluded, "All studies in our analysis suggest that reminder systems increase patient medication adherence, but none documented improved clinical outcomes". </p> <p><a href="./references#CD012226-bbs2-0111" title="BårnesCB , UlrikSC . Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respiratory Care2015;60(3):455‐68. ">Bårnes 2015</a> provides a wide‐ranging review of adherence in asthma and includes studies on adherence levels and effects of poor adherence, as well as studies of interventions aimed at improving adherence. In the intervention studies, review authors found mixed results, with most studies showing improved adherence, although this did not always translate to improvement in other outcomes. </p> <p>The results of our review of interventions to improve adherence in asthma are consistent with the findings of other reviews examining asthma populations and the broader category of chronic disease, as described. We found that adherence rates increased, but that the impact on clinical outcomes was unclear, and our conclusions must be considered in the light of variation across studies. Our review differs in that we have drawn different types of interventions together into a single review that focuses on people with asthma rather than on a broader category of chronic disease, and, when appropriate, we have been able to pool study results. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012226-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012226-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012226-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Adherence education vs controls, outcome: 1.2 % Adherence (all measures)." data-id="CD012226-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Adherence education vs controls, outcome: 1.2 % Adherence (all measures). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Adherence education versus controls, Outcome 1 % Adherence (objective measures)." data-id="CD012226-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Adherence education versus controls, Outcome 1 % Adherence (objective measures). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Adherence education versus controls, Outcome 2 % Adherence (all measures)." data-id="CD012226-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Adherence education versus controls, Outcome 2 % Adherence (all measures).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Adherence education versus controls, Outcome 3 &gt; 85% adherence." data-id="CD012226-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Adherence education versus controls, Outcome 3 &gt; 85% adherence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Adherence education versus controls, Outcome 4 Exacerbations requiring OCS (people with 1 or more)." data-id="CD012226-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Adherence education versus controls, Outcome 4 Exacerbations requiring OCS (people with 1 or more). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Adherence education versus controls, Outcome 5 Asthma control." data-id="CD012226-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Adherence education versus controls, Outcome 5 Asthma control.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Adherence education versus controls, Outcome 6 Unsheduled visits to a healthcare provider (people with 1 or more)." data-id="CD012226-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Adherence education versus controls, Outcome 6 Unsheduled visits to a healthcare provider (people with 1 or more). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Adherence education versus controls, Outcome 7 Quality of life (AQLQ)." data-id="CD012226-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Adherence education versus controls, Outcome 7 Quality of life (AQLQ).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 1 % Adherence (objective measures)." data-id="CD012226-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 1 % Adherence (objective measures). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 2 % Adherence (all measures)." data-id="CD012226-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 2 % Adherence (all measures). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 3 Exacerbations requiring OCS (people with at least 1)." data-id="CD012226-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 3 Exacerbations requiring OCS (people with at least 1). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 4 Asthma control." data-id="CD012226-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 4 Asthma control. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 5 Unscheduled visits to a healthcare provider." data-id="CD012226-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 5 Unscheduled visits to a healthcare provider. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 6 Unscheduled visits to a healthcare provider." data-id="CD012226-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 6 Unscheduled visits to a healthcare provider. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 7 Absenteeism." data-id="CD012226-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 7 Absenteeism. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 8 Absenteeism." data-id="CD012226-fig-0018" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 8 Absenteeism. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 9 Quality of life (AQLQ)." data-id="CD012226-fig-0019" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Electronic trackers or reminders (± feedback) versus controls, Outcome 9 Quality of life (AQLQ). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Simplified versus usual regimens, Outcome 1 % Adherence." data-id="CD012226-fig-0020" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Simplified versus usual regimens, Outcome 1 % Adherence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Simplified versus usual regimens, Outcome 2 Exacerbations requiring OCS." data-id="CD012226-fig-0021" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Simplified versus usual regimens, Outcome 2 Exacerbations requiring OCS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Simplified versus usual regimens, Outcome 3 Asthma control (ACQ)." data-id="CD012226-fig-0022" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Simplified versus usual regimens, Outcome 3 Asthma control (ACQ).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Simplified versus usual regimens, Outcome 4 Unscheduled visits." data-id="CD012226-fig-0023" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Simplified versus usual regimens, Outcome 4 Unscheduled visits.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Simplified versus usual regimens, Outcome 5 Absence from work/school." data-id="CD012226-fig-0024" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Simplified versus usual regimens, Outcome 5 Absence from work/school.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Simplified versus usual regimens, Outcome 6 Quality of life (ITG‐ASF % change from baseline)." data-id="CD012226-fig-0025" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Simplified versus usual regimens, Outcome 6 Quality of life (ITG‐ASF % change from baseline). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Simplified versus usual regimens, Outcome 7 All adverse events." data-id="CD012226-fig-0026" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Simplified versus usual regimens, Outcome 7 All adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 School‐based ICS therapy versus controls, Outcome 1 Unscheduled visits (1 or more hospitalisations for any cause)." data-id="CD012226-fig-0027" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 School‐based ICS therapy versus controls, Outcome 1 Unscheduled visits (1 or more hospitalisations for any cause). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 School‐based ICS therapy versus controls, Outcome 2 Quality of life (PAQLQ)." data-id="CD012226-fig-0028" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 School‐based ICS therapy versus controls, Outcome 2 Quality of life (PAQLQ).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Subgroup analyses for % adherence, Outcome 1 Comparison 1. Children vs adults." data-id="CD012226-fig-0029" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Subgroup analyses for % adherence, Outcome 1 Comparison 1. Children vs adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Subgroup analyses for % adherence, Outcome 2 Comparison 2. Complex vs simple interventions." data-id="CD012226-fig-0030" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Subgroup analyses for % adherence, Outcome 2 Comparison 2. Complex vs simple interventions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012226-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/urn:x-wiley:14651858:media:CD012226:CD012226-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_t/tCD012226-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Subgroup analyses for % adherence, Outcome 3 Comparison 2. Children vs adults." data-id="CD012226-fig-0031" src="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Subgroup analyses for % adherence, Outcome 3 Comparison 2. Children vs adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/media/CDSR/CD012226/image_n/nCD012226-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012226-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Adherence education compared with controls for asthma</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Adherence education compared with controls for asthma</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> asthma<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> adherence education<br/> <b>Comparison:</b> control group (no education) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="2" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with controls</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with adherence education</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>% Adherence</b> </p> <p>WMD of follow‐up 71.7 weeks (all studies)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Objective measures</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean adherence in the control group was <b>46.7%</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean adherence with adherence education was <b>20.13% higher</b> (7.52 higher to 32.74 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>280</p> <p>(5 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only studies in which adherence was measured with an electronic monitor</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>All measures</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean adherence in the control group was <b>57.1%</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean adherence with adherence education was <b>11.59% higher</b> (3.72 higher to 19.46 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1693<br/> (10 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Exacerbations requiring OCS</b> </p> <p>(people with 1 or more)</p> <p>WMD of follow‐up 30.8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>149 per 1000</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>242 per 1000</b> </p> <p>(148 to 370)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.82<br/> (0.99 to 3.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>349<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Asthma control (ACQ)</b> </p> <p>WMD of follow‐up 28.5 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean ACQ score was <b>1.52</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean score with adherence education was <b>0.03 better</b> (0.49 better to 0.43 worse) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>455<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>a,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates better control. Scale 0 to 6. MCID 0.5</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Asthma control (ACT)</b> </p> <p>WMD of follow‐up 29.5 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean ACT score was <b>18.88</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean score with adherence education was <b>0.30 better</b> <br/> (1.43 better to 0.82 worse) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>333<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>a,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicates better control. Scale 5 to 25. MCID 3</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Unsheduled visits to a healthcare provider</b> </p> <p>(people with 1 or more)</p> <p>WMD of follow‐up 67.2 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>159 per 1000</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>83 per 1000</b> <br/> (35 to 184) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.48<br/> (0.19 to 1.19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>688<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>a,b,d,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Includes visits to ED, GP, hospital for any cause</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Absenteeism</b> </p> <p>WMD of follow‐up 63.3 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>We did not perform an analysis of absences because the data were heavily skewed</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>109<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not graded</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Quality of life (AQLQ)</b> </p> <p>WMD of follow‐up 27.4 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean AQLQ score was <b>5</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean score with adherence education was <b>0.01 better</b> (0.20 worse to 0.23 better) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>734<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>a,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicates better QOL. Scale 1 to 7. MCID 0.5</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <br/> ACQ: Asthma Control Questionnaire; ACT: Asthma Control Test; AQLQ: Asthma Quality of Life Questionnaire; CI: confidence interval; ED: emergency department; GP: general practitioner; MCID: minimal clinically important difference; OCS: oral corticosteroid; OR: odds ratio; QOL: quality of life; RCT: randomised controlled trial; WMD: weighted mean duration </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to the estimate of effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of effect but may be substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>a</sup>Downgraded once primarily owing to risk of bias from open‐label trials and some concerns regarding attrition bias, selective reporting and selection bias (‐1 risk of bias) </p> <p><sup>b</sup>Downgraded once owing to inconsistency between study results (‐1 inconsistency) </p> <p><sup>c</sup>Funnel plot examined; no clear evidence of publication bias (no downgrade for publication bias) </p> <p><sup>d</sup>Confidence intervals include no difference and/or potential important harm or benefit of the intervention (‐1 imprecision) </p> <p><sup>e</sup>Confidence intervals fall within the established MCID for this scale (no downgrade for imprecision) </p> <p><sup>f</sup>Studies contributing to this analysis reported different types of unscheduled visits and some recorded visits for any cause rather than asthma alone (‐1 indirectness) </p> <p><sup>g</sup>Unclear how absenteeism was defined or reported, and different participants may have different thresholds for missing work or school. One study was conducted in children and the other in adults. Combined, this makes the outcome hard to interpret </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Adherence education compared with controls for asthma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012226-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Electronic trackers or reminders (± feedback) compared with controls for asthma</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Electronic trackers or reminders (</b> ±<b>feedback) compared with controls for asthma</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> asthma<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> electronic trackers or reminders (± feedback)<br/> <b>Comparison:</b> control group </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="2" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with controls</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with electronic trackers or reminders (± feedback)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>% Adherence</b> </p> <p>WMD of follow‐up 47.6 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Objective measures only</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean adherence in the control group was <b>53.27%</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean adherence was <b>19.86% higher</b> (14.47 higher to 25.26 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>555</p> <p>(6 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only studies in which adherence was measured with an electronic monitor</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>All measures</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean adherence in the control group was <b>56.06%</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean adherence with trackers was <b>18.41% higher</b> (11.82 higher to 25.00 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>762</p> <p>(8 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Exacerbations requiring OCS</b> </p> <p>(people with at least 1)</p> <p>WMD of follow‐up 48.6 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>218 per 1000</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>169 per 1000</b> <br/> (94 to 280) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.72<br/> (0.37 to 1.39) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3063<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY <b>LOW</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Asthma control (ACQ)</b> </p> <p>WMD of follow‐up 43.0 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean ACQ score in the control group was <b>0.89</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean score with trackers or reminders was <b>0.24 better</b> (0.29 worse to 0.78 better) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>109<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates better control. Scale 0 to 6. MCID 0.5</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Asthma control (ACT)</b> </p> <p>WMD of follow‐up 34.0 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean ACT score in the control group was <b>20.04</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean score with trackers or reminders was <b>0.74 better</b> (0.20 worse to 1.69 better) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>596<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,b,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicates better control. Scale 5 to 25. MCID 3</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Unscheduled healthcare visits to a healthcare provider (ED)</b> </p> <p>WMD of follow‐up 50.0 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>84 per 1000</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95 per 1000</b> <br/> (75 to 119) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.14<br/> (0.88 to 1.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2918<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two studies (n = 2865) also reported hospitalisations. OR 0.97 (0.53 to 1.78)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Absenteeism</b> </p> <p>(people with at least 1 absence)</p> <p>Follow‐up 26 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>327 per 1000</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>409 per 1000</b> <br/> (285 to 546) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.42<br/> (0.82 to 2.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>220<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>c,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Quality of life (AQLQ)</b> </p> <p>WMD of follow‐up 36.8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean AQLQ score in the control group was <b>5.15</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean score with trackers or reminders was <b>0.03 worse</b> (0.13 better to 0.20 worse) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>369<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>a,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicated better QOL. Scale 1 to 7. MCID 0.5</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> ACQ: Asthma Control Questionnaire; ACT: Asthma Control Test; AQLQ: Asthma Quality of Life Questionnaire; CI: confidence interval; ED: emergency department; MCID: minimal clinically important difference; OCS: oral corticosteroid; OR: odds ratio; QOL: quality of life; RCT: randomised controlled trial; WMD: weighted mean duration </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to the estimate of effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of effect but may be substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>a</sup>Downgraded once primarily owing to risk of bias from open‐label trials and some concerns regarding attrition bias, selective reporting and selection bias (‐1 risk of bias) </p> <p><sup>b</sup>Downgraded once for inconsistency between study results (‐1 inconsistency) </p> <p><sup>c</sup>Confidence intervals include no difference and potential important harm and benefit of the intervention (‐1 imprecision) </p> <p><sup>d</sup>Confidence intervals fall within the MCID for this scale (no downgrade for imprecision) </p> <p><sup>e</sup>Downgraded once owing to risk of performance and detection bias (‐1 risk of bias) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Electronic trackers or reminders (± feedback) compared with controls for asthma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012226-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Simplified compared with usual regimens for asthma</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Simplified compared with usual regimens for asthma</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> asthma<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> simplified regimens<br/> <b>Comparison:</b> usual regimens </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with usual regimens</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with simplified regimens</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>% Adherence (objective measures)</b> </p> <p>WMD of follow‐up 12.9 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean adherence in the control group was <b>86.73%</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean adherence with simplified regimens was <b>4.02%</b> higher<br/> (1.88 higher to 6.16 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1310<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only studies in which adherence was measured with an electronic monitor</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Exacerbations requiring OCS</b> </p> <p>People with 1 or more</p> <p>Follow‐up 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>125 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> <br/> (24 to 823) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 2.33<br/> (0.17 to 32.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asthma control (ACQ)</b> </p> <p>Follow‐up 24 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean ACQ score in the control group was <b>0.89</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean score with simplified regimens was <b>0.03 better</b> (0.34 better to 0.28 worse) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>MODERATE</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates better control. Scale 0 to 6. MCID 0.5</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unscheduled visits</b> </p> <p>Follow‐up 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>63 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>72 per 1000</b> <br/> (46 to 113) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.17<br/> (0.72 to 1.90) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1037<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Absence from work/school</b> </p> <p>Follow‐up 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> <br/> (7 to 43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.93<br/> (0.37 to 2.30) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1037<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in quality of life (ITG‐ASF)</b> </p> <p>Follow‐up 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change in quality of life in the control group was <b>14</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change with simplified regimens was <b>6 points better</b> <br/> (0.76 worse to 12.76 better) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1037<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicates better QOL. Range 0 to 100. MCID not known</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All adverse events</b> </p> <p>Follow‐up 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>175 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>139 per 1000</b> <br/> (106 to 181) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.76<br/> (0.56 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1233<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> ACQ: Asthma Control Questionnaire; CI: confidence interval; ITG‐ASF: Integrated Therapeutics Group ‐ Asthma Short Form; MCID: minimal clinically important difference; OCS: oral corticosteroid; OR: odds ratio; QOL: quality of life; RCT: randomised controlled trial; WMD: weighted mean duration </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to the estimate of effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of effect but may be substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded once primarily owing to lack of blinding and some concerns regarding attrition bias, selective reporting and selection bias (‐1 risk of bias) </p> <p><sup>b</sup>One very small trial resulting in very wide confidence intervals (‐2 imprecision) </p> <p><sup>c</sup>Although confidence intervals fall within the MCID, only one study contributed to this outcome (‐1 imprecision) </p> <p><sup>d</sup>Confidence intervals include both important potential harm and benefit of the intervention (‐1 imprecision) </p> <p><sup>e</sup>Confidence intervals do not exclude no difference (‐1 imprecision) </p> <p><sup>f</sup>Confidence intervals range from no difference to an important benefit of simplified regimens (‐1 imprecision) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Simplified compared with usual regimens for asthma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012226-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">School‐based ICS therapy compared with home therapy for asthma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>School‐based ICS therapy compared with home therapy for asthma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> children with asthma </p> <p><b>Settings:</b> school </p> <p><b>Intervention:</b> ICS given at school </p> <p><b>Comparison:</b> ICS given at home </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>School‐based ICS therapy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unscheduled visits</b> </p> <p>1 or more hospitalisations for any cause</p> <p>WMD of follow‐up 35.8 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b> <br/> (8 to 96) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.58 (0.16 to 2.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>279<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>LOW</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life (PACQLQ)</b> </p> <p>1 to 7; higher is better</p> <p>WMD of follow‐up 35.8 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean PAQLQ score in the control group was <b>6.31</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean score in the intervention groups was<br/> <b>0.25 higher</b> (0.01 to 0.49 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>279<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝</p> <p><b>MODERATE</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> <p>Follow‐up 30 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>No events observed in either arm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not graded</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> CI: confidence interval; ICS: inhaled corticosteroid; OR: odds ratio; PAQLQ: Paediatric Asthma Quality of Life Questionnaire; RCT: randomised controlled trial; WMD: weighted mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>No data could be meta‐analysed for adherence, exacerbations requiring OCS, asthma control or absenteeism. Some data are presented narratively in the review </p> <p><sup>a</sup>Both contributing studies considered at high risk for performance and detection bias </p> <p><sup>b</sup>Confidence intervals include both potential harm and benefit of the intervention </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">School‐based ICS therapy compared with home therapy for asthma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012226-tbl-0005"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Comparison 1 study characteristics: adherence education</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID ("first received" date for clinical trials registries)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total n</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration of intervention/follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adherence measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0020" title="ApterAJ , BogenDK , WangX , RandCS , McElligottS , PolskyD , et al. Intervening to improve adherence and asthma outcomes in urban adults with moderate or severe asthma [Abstract]. American Journal of Respiratory and Critical Care Medicine2011;183:A3791. ApterAJ , WangX , BogenDK , RandCS , McElligottS , PolskyD , et al. Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial. Journal of Aallergy and Clinical Immunology2011;128(3):516‐23. NCT00115323 . Comparison of two medication adherence strategies to improve asthma treatment adherence [Individualized interventions to improve asthma adherence]. https://clinicaltrials.gov/show/NCT00115323 (first received 21 June 2005). [NCT00115323] ">NCT00115323</a> </p> <p>(2005)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13/26 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Problem‐solving intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Asthma education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, AQLQ, ACQ, LFTs, hospitalisation,</p> <p>ED visits, participant satisfaction</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0004" title="BenderBG , ApterA , BogenDK , DickinsonP , FisherL , WamboldtFS , et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. Journal of the American Board of Family Medicine2010;23(2):159‐65. ">Bender 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interactive voice response intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor or canister weight</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, AQLQ, ACT, Beliefs about</p> <p>Medication Questionnaire</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0027" title="BenderBG , CvietusaP , GoodrichG , LoweCR , NuanesH , ShetterlyS , et al. A 24‐month randomized, controlled trial of an automated speech recognition program to improve adherence in pediatric asthma. Journal of Allergy and Clinical Immunology2014;133(2 Suppl):AB166. BenderBG , CvietusaPJ , GoodrichGK , LoweR , NuanesHA , RandC , et al. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatrics2015;169(4):317‐23. NCT00958932 . Telecommunication enhanced asthma management. clinicaltrials.gov/show/NCT00958932 (first received 13 August 2009). [NCT00958932] ">NCT00958932</a> </p> <p>(2009)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Telephone speech recognition intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total ICS supplied/total prescribed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, beta‐agonist use, OCS use, primary care, ED and out of hours visits, hospitalisations, participant satisfaction </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0010" title="ChatkinJM , BlancoDC , ScagliaN , WagnerMB , FritscherCC , ChatkinJ , et al. Impact of a low‐cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. Journal of Asthma2006;43(4):263‐6. ">Chatkin 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adolescents and adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Brazil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Telephone counselling</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ususal care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Number of inhalations recorded on the disks"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0021" title="NCT00149487 . Enhancing treatment adherence in pediatric asthma with a problem solving intervention [Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma]. https://clinicaltrials.gov/ct2/show/NCT00149487 (first received 6 September 2005). NCT00149487 . Randomized controlled trial of problem solving intervention to enhance treatment adherence in pediatric asthma. clinicaltrials.gov/show/NCT00149487 (first received 6 September 2005). RohanJ , DrotarD , McNallyK , SchluchterM , RiekertK , VavrekP , et al. Adherence to pediatric asthma treatment in economically disadvantaged African‐American children and adolescents: an application of growth curve analysis. Journal of Pediatric Psychology2010;35(4):394‐404. ">NCT00149487</a> </p> <p>(2005)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17 weeks/1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Problem‐solving intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Family‐based intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, symptoms, use of healthcare services, reliever medication use</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0022" title="AdamsCD , JosephKE , MacLarenJE , DeMoreM , KovenL , DetweilerMF , et al. Parent‐youth teamwork in pediatric asthma management [Abstract]. Journal of Allergy and Clinical Immunology2004;113(2):S159. DuncanCL , HoganMB , TienKJ , GravesMM , ChorneyJM , ZettlerMD , et al. Efficacy of a parent‐youth teamwork intervention to promote adherence in pediatric asthma. Journal of Pediatric Psychology2013;38(6):617‐28. NCT00166582 . Parent‐youth teamwork in pediatric asthma management. https://clinicaltrials.gov/show/NCT00166582 (first received 9 September 2009). ">NCT00166582</a> </p> <p>(2009)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Team work intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Asthma education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, Parent‐Adolescent Conflict Questionnaire, Functional Severity Index, LFTs, Consumer Satisfaction Survey </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 GPs, 143 patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adolescents and adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Personalised adherence discussion (PAD)</p> <p>PAD + inhaler reminder feedback (IRF)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ACT, AQLQ, Hospital Anxiety and Depression Scale, Medication Adherence Report Scale, LFTs, exacerbations </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0012" title="GallefossF , BakkePS . How does patient education and self‐management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. American Journal of Respiratory and Critical Care Medicine1999;160(6):2000‐5. GallefossF , BakkePS . Impact of patient education and self‐management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine2000;94(3):279‐87. [CRS: 4900100000008905] GallefossF , BakkePS , RsgaardPK , KjaersgaardP . Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1999;159(3):812‐7. [CENTRAL: 160267; CRS: 4900100000006265; PUBMED: 10051255] ">Gallefoss 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Norway</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Asthma education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prescribed doses/dispensed doses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, GP visits, absenteeism, days in hospital</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0028" title="GambleJ , HeaneyLG . An individualised nurse‐led programme to improve adherence in patients with difficult asthma ‐ 12 month outcomes. American Journal of Respiratory and Critical Care Medicine2010;181(1):A3258. GambleJ , StevensonM , HeaneyLG . A study of a multi‐level intervention to improve non‐adherence in difficult to control asthma. Respiratory Medicine2011;105(9):1308‐15. NCT01064869 . A nurse led programme to improve adherence in difficult asthma [Evaluation of the benefits of an individualised menu driven nurse led programme to improve adherence in difficult asthma]. clinicaltrials.gov/show/NCT01064869 (first received 8 February 2010). ">NCT01064869</a> </p> <p>(2010)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks/1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported, but mean age suggests adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Northern Ireland</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nurse‐led psychoeducation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ususal care (difficult asthma service)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percent of prescriptions refilled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, OCS, beta‐agonist use, hospital admissions, LFTs, ACQ, AQLQ, Hospital Anxiety and Despression Scale </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0003" title="ADERE PEDIATRIC1 . Prospective, parallel‐group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticasone 50/250 mcg (Seretide) twice a day. ADERE PROJECT (Pediatric). //www.gsk‐clinicalstudyregister.com/study/ADERE%20PEDIATRIC%201?search=compound&amp;compound=fluticasone‐propionate‐salmeterol#rs (first received 28 September 2008). ">ADERE PEDIATRIC 1</a> </p> <p>(2008)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>298</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Brazil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Telephone follow‐up intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage of actual doses/number expected</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, disease control, quality of life (SF‐36)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0015" title="HartCAH , LoveAM , GibsonNA , MorganN , PatonJY . Effects of an educational intervention directed at parental beliefs and anxieties about inhaled steroid medication of adherence. American Journal of Respiratory and Critical Care Medicine2002;165:A420. ">Hart 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Asthma education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, beliefs and anxieties about adherence</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0026" title="HederosCA , JansonS , HedlinG . Group discussions with parents have long‐term positive effects on the management of asthma with good cost‐benefit. Acta Paediatrica2005;94(5):602‐8. NCT00516633 . Intervention study to improve adherence in asthma [Does improved information in the form of group discussions with parents of newly diagnosed asthmatic children lead to a better quality of life for the families, an improved adherence and better development of the lung function of the children?]. clinicaltrials.gov/show/NCT00516633 (first received 13 August 2007). ">NCT00516633</a> </p> <p>(2007)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26 weeks/78 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sweden</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group discussion plus basic education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Basic education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diaries and canister weight</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, views on adherence, days hospitalised, ED visits, exacerbations</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0016" title="KampsJL . Improving adherence to inhaled corticosteroids in children with asthma [Dissertation]. University of Kansas, 2002. KampsJL , RapoffMA , RobertsMC , VarelaRE , BarnardM , OlsonN . Improving adherence to inhaled corticosteroids in children with asthma: a pilot of a randomized clinical trial. Children's Health Care2008;37(4):261‐77. ">Kamps 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks/52 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Specific adherence improvement strategies (education, monitoring, etc.)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care plus education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, LFTs, PedsQL, healthcare costs</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0029" title="LavoieK , MoullecG , BlaisL , BeauchesneM‐F , LemiereC , LabrecqueM , et al. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, nonadherent asthmatics: results from a randomized controlled pilot study [Abstract]. Chest2011;140(4):915A. LavoieKL , LemiereC , LabrecqueM , BlaisL , BeauchesneM , MoullecG , et al. The efficacy of motivational interviewing on asthma medication adherence in non‐adherent, poorly controlled asthmatics: preliminary results of the asthma control trial (ACT). Psychosomatic Medicine2011;7(3):A‐9. LavoieKL , MoullecG , LemiereC , BlaisL , LabrecqueM , BeauchesneM‐F , et al. Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial. Patient Preference and Adherence2014;8:1555‐69. NCT01132430 . Motivational interviewing for medication adherence in asthma [Impact of a motivational interviewing intervention on medication adherence in patients with asthma]. https://clinicaltrials.gov/show/NCT01132430 (first received 27 May 2010). ">NCT01132430</a> </p> <p>(2010)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks/52 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Canada</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Motivational interviewing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prescribed treatment days/number of days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, asthma control, quality of life, asthma‐related self‐efficacy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0019" title="MehuysE , VanBortelL , DeBolleL , VanTongelenI , AnnemansL , RemonJP , et al. Effectiveness of pharmacist intervention for asthma control improvement. European Respiratory Journal2008;31(4):790‐9. MehuysE , vanBortelL , deBolleL , vanTongelenI , RemonJ‐P , AnnemansL , et al. Does pharmacist intervention lead to appropriate use of asthma medication and improved asthma control? [Leidt apothekersadvies over het optimaal gebruik van astmamedicatie tot een verbetering van de astmacontrole? Een gerandomiseerde gecontroleerde studie]. Farmaceutisch Tijdschrift voor Belgie2008;85(1):1‐9. ">Mehuys 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Belgium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prescription refill rates, self‐reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ACT, diary card, rescue medication use, ED visits, hospitalisations, AQLQ, Knowledge of Asthma and Asthma Medicine Questionnaire, inhalation technique </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0030" title="MosnaimG , LiH , MartinM , BelicePJ , AveryE , RyanN , et al. The use of coping peer support and mp3 technology to improve adherence to inhaled corticosteroids among low‐income minority adolescents. Journal of Allergy and Clinical Immunology2013;131(2):AB133 [478]. MosnaimG , LiH , MartinM , RichardsonD , BelicePJ , AveryE , et al. The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology: In Practice2013;1(5):485‐93. NCT01169883 . Coping peer intervention for adherence. https://clinicaltrials.gov/show/NCT01169883 (first received 23 July 2010). PowellL . The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial. Journal of Allergy and Clinical Immunology2013;0(5):485‐93. ">NCT01169883</a> </p> <p>(2010)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adolescents</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence messaging and group sessions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Attention control"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, asthma knowledge, ICS knowledge, ICS self‐efficacy, social support, exacerbations</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0033" title="NCT02413528 . Pilot study of a mobile asthma adherence intervention [Pilot study of a mobile intervention to increase adherence to asthma medication among adolescents]. https://clinicaltrials.gov/show/NCT02413528 (first received 7 April 2015). ">NCT02413528</a> </p> <p>(2015)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adolescents</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence monitoring and incentivisation via app and sensor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, ACT</p> <p><b>NB:</b> study terminated </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0035" title="OnyirimbaF , ApterA , ReisineS , LittM , McCuskerC , ConnorsM , et al. Direct clinician‐to‐patient feedback discussion of inhaled steroid use: its effect on adherence. Annals of Allergy, Asthma and Immunology2003;90(4):411‐5. ">Onyirimba 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence monitoring and education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Monitoring without feedback</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, rescue medication use, AQLQ, LFTs</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a> </p> <p>(2005)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prescription refill rates, self‐reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, symptoms, night‐time awakenings, ED visits, hospitalisation, OCS courses</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0038" title="UlrikCS , ClaudiusBK , TammM , HarvingH , SierstedHC , BackerV , et al. Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial.[Erratum appears in Clin Respir J. 2009 Jul;3(3):185]. Clinical Respiratory Journal2009;3(3):161‐8. ">Ulrik 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Denmark and Switzerland</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence education and study medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study medication alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dose counting in returned investigational product</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, asthma control, LFTs, symptoms, rescue medication use, night‐time awakenings, adverse events, AQLQ, asthma severity, adverse events, vital signs </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0024" title="NCT00414817 . Telephone‐based program to promote inhaled corticosteroid adherence among individuals with asthma [Phone calls to promote adherence with inhaled corticosteroids]. clinicaltrials.gov/show/NCT00414817 (first received 20 December 2006). VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of automated phone calls to support inhaled corticosteroids (ICS) adherence. American Thoracic Society International Conference; May 15‐20, 2009; San Diego. 2009:A1089 [Poster #518]. VollmerWM , FeldsteinA , SmithDH , DubanoskiJP , WaterburyA , SchneiderJL , et al. Use of health information technology to improve medication adherence. American Journal of Managed Care2011;17(12):SP79‐87. VollmerWM , XuM , FeldsteinA , SmithD , WaterburyA , RandC . Comparison of pharmacy‐based measures of medication adherence. BMC Health Services Research2012;12:155. ">NCT00414817</a> </p> <p>(2006)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14,064 (6903 previous ICS users)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Telephone interactive voice recognition intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacy‐based adherence measures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, use of healthcare services, economic evaluation</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>ACQ: Asthma Control Questionnaire; ACT: Asthma Control Test; AQLQ: Asthma Quality of Life Questionnaire; ED: emergency department; GP: general practitioner; ICS: inhaled corticosteroid; IRF: inhaler reminder feedback; LFTs: lung function tests; OCS: oral corticosteroid; PAD: personalised adherence discussion; PedsQL: Paediatric Quality of Life Inventory; SF‐36: Short‐Form Health Survey </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Comparison 1 study characteristics: adherence education</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012226-tbl-0006"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Comparison 2 study characteristics: electronic trackers or reminders</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total n</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration of intervention/follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adherence measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0005" title="BlackPN , GarrattE , ArandjusC , SalmonBT , SutherlandG . An inhaler with ring tones improves compliance with inhaled steroids in childhood asthma [Abstract]. American Thoracic Society International Conference; May 16‐21, 2008; Toronto. 2008:Poster #A46. ">Black 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>New Zealand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inhaler alarm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, AQLQ, LFTs, beta‐agonist use</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0002" title="ACTRN12607000489493 . The impact of providing feedback on adherence in childhood asthma. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=82288 (first received 14 September 2007). BurgessSW , SlyPD , DevadasonSG . Providing feedback on adherence increases use of preventive medication by asthmatic children. Journal of Asthma2010;47(2):198‐201. ">ACTRN12607000489493</a> </p> <p>(2007)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence feedback during consultations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, symptoms, LFTs</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0008" title="ChanAH , StewartAW , HarrisonJ , CamargoCAJr , BlackPN , MitchellEA . The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial. Lancet Respiratory Medicine2015;3(3):210‐9. ">Chan 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>New Zealand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Audiovisual inhaler reminder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, school/work absences, ACT, Asthma Morbidity Score, exacerbations, unscheduled visits, beta‐agonist use, LFTs </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0009" title="CharlesT , QuinnD , WeatherallM , AldingtonS , BeasleyR , HoltS . An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. Journal of Allergy and Clinical Immunology2007;119(4):811‐6. ">Charles 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adolescents and adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>New Zealand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Audiovisual inhaler reminder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, ACQ, LFTs</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0011" title="FosterJ , SmithL , UsherwoodT , SawyerS , ReddelH . Electronic reminders improve adherence with preventer inhalers in Australian primary care patients. Respirology2014;0:24 [TO 034]. FosterJM , UsherwoodT , SmithL , SawyerSM , XuanW , RandCS , et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. Journal of Allergy and Clinical Immunology2014;134(6):1260‐8. ">Foster 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 GPs, 143 patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adolescents and adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inhaler reminder and feedback (IRF)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ACT, AQLQ, Hospital Anxiety and Depression Scale, Medication Adherence Report Scale, LFTs, exacerbations </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0032" title="Kolmodin MacDonellK , NaarS , Gibson‐ScipioW , LamP , SecordE . The Detroit young adult asthma project: pilot of a technology‐based medication adherence intervention for African‐American emerging adults. Journal of Adolescent Health2016;59(4):465‐71. [DOI: 10.1016/j.jadohealth.2016.05.016] NCT01714141 . Multi‐component technology intervention for minority emerging adults with asthma. https://clinicaltrials.gov/ct2/show/NCT01714141 (accessed 21 July 2016). ">NCT01714141</a> </p> <p>(2012)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Young adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Computer sessions and tailored text reminders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Asthma education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Self‐reported missed doses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, ACT, LFTs, participant satisfaction</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0034" title="MortonR , EverardM , ElphickH . Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma. European Respiratory Journal2015;46:OA4772. MortonRW , ElphickHE , Rigby AS DawWJ , KingDA , SmithLJ , et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax2016;0:1‐8. NCT02451709 . STudy of Asthma Adherence Reminders (STAAR) [Can electronic adherence monitors with feedback and daily reminders improve adherence and health outcomes in children with asthma?]. clinicaltrials.gov/show/NCT02451709 (first received 5 May 2015). ">NCT02451709</a> </p> <p>(2015)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence monitoring with feedback</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence monitoring but no feedback</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Clinical outcomes", adherence, LFTs, exacerbations</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0023" title="NCT00233181 . Adherence intervention for minority children with asthma. clinicaltrials.gov/show/NCT00233181 (first received 3 October 2005). OtsukiM , EakinMN , RandCS , ButzAM , HsuVD , ZuckermanIH , et al. Adherence feedback to improve asthma outcomes among inner‐city children: a randomized trial. Pediatrics2009;124(6):1513‐21. ">NCT00233181</a> </p> <p>(2005)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence monitoring and education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prescription refill rates, self‐reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, symptoms, night‐time awakenings, ED visits, hospitalisation, OCS courses</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0037" title="StrandbygaardU , ThomsenSF , BackerV . A daily SMS reminder increases adherence to asthma treatment: a three‐month follow‐up study. Respiratory Medicine2010;104(2):166‐71. ">Strandbygaard 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SMS (text message) adherence reminders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Dose‐count" on the Seretide was diskus</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, change in FeNO, LFTs, airway responsiveness</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0039" title="GoossensLMA , VasbinderEC , van DenBemtPMLA , Rutten‐Van MolkenMPMH . Cost‐effectiveness of real‐time medication monitoring in children with asthma. Value in Health2014;17(7):A329. VasbinderE , GoossensL , JanssensH , deWinterB , vanDijkL , VultoA , et al. E‐monitoring of asthma therapy to improve compliance in children (E‐MATIC). European Respiratory Journal2016;46:758‐67. [DOI: 10.1183/13993003.01698‐2015] VasbinderEC , GoossensLMA , JanssensH , deWinterBCM , vanDijkL , VultoAG , et al. E‐Monitoring of asthma therapy to improve compliance in children (E‐MATIC). Pharmacoepidemiology and Drug Safety2015;24(S1):489. [DOI: 10.1002/pds] VasbinderEC , JanssensHM , Rutten‐van MolkenMP , vanDijkL , deWinterBC , deGrootRC , et al. e‐Monitoring of asthma therapy to improve compliance in children using a real‐time medication monitoring system (RTMM): the e‐MATIC study protocol. BMC Medical Informatics and Decision Making2013;13(1):38. ">Vasbinder 2015 E‐MATIC</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The Netherlands</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SMS (text message) adherence reminders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, ACT, exacerbations, use of healthcare services, AQLQ, school/work absence, acceptance of e‐monitoring, economic evaluation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0025" title="AhmedaniBK , PetersonEL , WellsKE , RandCS , WilliamsLK . Asthma medication adherence: the role of God and other health locus of control factors. Annals of Allergy, Asthma &amp; Immunology2013;110(2):75‐9. NCT00459368 . Using information technology to improve asthma adherence (AFFIRM) [Adherence feedback for improving respiratory medication use]. clinicaltrials.gov/show/NCT00459368 (first received 9 April 2007). WilliamsLK , PetersonEL , WellsK , CampbellJ , WangM , ChowdhryVK , et al. A cluster‐randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology2010;126(2):225‐31. ">NCT00459368</a> </p> <p>(2007)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2698 (34 clusters)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children and adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence education with adherence feedback</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence education alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic prescribing data/refill rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, ED visits, hospitalisation, OCS use</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>ACQ: Asthma Control Questionnaire; ACT: Asthma Control Test; AQLQ: Asthma Quality of Life Questionnaire; ED: emergency department; FeNO: fractional exhaled nitric oxide; ICS: inhaled corticosteroid; LFTs: lung function tests; OCS: oral corticosteroid </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Comparison 2 study characteristics: electronic trackers or reminders</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012226-tbl-0007"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Comparison 3 study characteristics: simplified regimens</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total n</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration of intervention/follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adherence measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0006" title="BosleyCM , ParryDT , CochraneGM . Patient compliance with inhaled medication: does combining beta‐agonists with corticosteroids improve compliance?. European Respiratory Journal1994;7(3):504‐9. ">Bosley 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Combined inhaler</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Separate inhalers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, LFTs</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0018" title="MannM , EliassonO , PatelK , ZuWallackRL . A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992;101(2):496‐9. ">Mann 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks/12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Twice‐daily dosing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Four‐times‐daily dosing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, LFTs, symptoms</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0001" title="ACTRN12606000508572 . Does combination therapy increase adherence with inhaled corticosteroids and improve clinical outcomes in asthma?. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000508572 (first received 5 February 2007). PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Erratum: Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma (Journal of Allergy and Clinical Immunology (2010) 126 (505‐10)). Journal of Allergy and Clinical Immunology2012;129(6):1691. PerrinK , WilliamsM , WijesingheM , JamesK , WeatherallM , BeasleyR . Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long‐acting beta‐agonist inhaler therapy in asthma. Journal of Allergy and Clinical Immunology2010;126(3):505‐10. ">ACTRN12606000508572</a> </p> <p>(2007)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>New Zealand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Combined inhaler</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Separate inhalers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electronic inhaler monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, LFTs, ACQ, OCS, unscheduled visits</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0036" title="PriceD , RobertsonA , BullenK , RandC , HorneR , StaudingerH . Improved adherence with once‐daily versus twice‐daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open‐label study. BMC Pulmonary Medicine2010;10:1. ">Price 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1233</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adolescents and adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Once‐daily ICS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Twice‐daily ICS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Device counter number"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adherence, physician assessment of response, quality of life, use of healthcare services, days of school/work missed, adverse events, worsening asthma </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>ACQ: Asthma Control Questionnaire; ICS: inhaled corticosteroid; LFTs: lung function tests; OCS: oral corticosteroid </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Comparison 3 study characteristics: simplified regimens</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012226-tbl-0008"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Comparison 4 study characteristics: school‐based ICS therapy</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total n</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration of intervention/follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adherence measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0013" title="GeraldLB , McClureLA , HarringtonKF , ManganJM , GibsonL , AtchisonJ , et al. Design of the supervised asthma therapy study: implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials2008;29(2):304‐10. GeraldLB , McClureLA , ManganJM , HarringtonKF , GibsonL , ErwinS , et al. Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school‐based supervised asthma therapy. Pediatrics2009;123(2):466‐74. GeraldLB , PatelK , ZhangS , McClureL . Secondhand smoke exposure and asthma morbidity among elementary school children enrolled in a clinical trial. Chest2007;132(4):461. [DOI: 10.1378/chest.132.4_MeetingAbstracts.461] McClureLA , HarringtonKF , GrahamH , GeraldLB . Internet‐based monitoring of asthma symptoms, peak flow meter readings, and absence data in a school‐based clinical trial. Clinical Trials2008;5(1):31‐7. ">Gerald 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised ICS therapy at school</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Episodes of poor asthma control, school absences, rescue medication use at school</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0014" title="HaltermanJS , SzilagyiPG , YoosHL , ConnKM , KaczorowskiJM , HolzhauerRJ , et al. Benefits of a school‐based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Archives of Pediatric and Adolescent Medicine2004;158(5):460‐7. ">Halterman 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised ICS therapy at school</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Symptom‐free days, daytime and night‐time symptoms, rescue medication use, school absences </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012226-bbs2-0031" title="HaltermanJS , FagnanoM , MontesG , FisherS , TremblayP , TajonR , et al. The school‐based preventive asthma care trial: results of a pilot study. Journal of Pediatrics2012;161(6):1109‐15. HaltermanJS , SauerJ , FagnanoM , MontesG , FisherS , TremblayP , et al. Working toward a sustainable system of asthma care: development of the School‐Based Preventive Asthma Care Technology (SB‐PACT) trial. Journal of Asthma2012;49(4):395‐400. NCT01175434 . School‐based preventive asthma care technology: a trial using a novel technology to improve adherence (SB‐PACT). https://clinicaltrials.gov/ct2/show/NCT01175434 (first received 16 April 2010). ">NCT01175434</a> </p> <p>(2010)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 8 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised ICS therapy at school</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Feasibility, symptom‐free days, numbers of days and nights with symptoms, activity limitation, rescue medication use, school absenteeism, parent sleep interruption, change in family plans due to the child’s asthma, PAQLQ, utilisation of healthcare services, FeNO </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>FeNO: fractional exhaled nitric oxide; ICS: inhaled corticosteroid; PAQLQ: Pediatric Asthma Quality of Life Questionnaire </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Comparison 4 study characteristics: school‐based ICS therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/full#CD012226-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012226-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Adherence education versus controls</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 % Adherence (objective measures) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>20.13 [7.52, 32.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Complex</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>21.55 [4.71, 38.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Simple education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.40 [5.98, 24.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 % Adherence (all measures) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1693</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.59 [3.72, 19.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Complex</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>744</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.21 [1.26, 23.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Simple education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>949</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.60 [5.17, 16.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 &gt; 85% adherence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.68 [1.61, 4.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Exacerbations requiring OCS (people with 1 or more) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>349</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.82 [0.99, 3.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Asthma control <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 ACQ</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>455</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.49, 0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 ACT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.82, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Unsheduled visits to a healthcare provider (people with 1 or more) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>688</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.19, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.56, 2.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.06, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 GP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.07, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Quality of life (AQLQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>734</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.20, 0.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Adherence education versus controls</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012226-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Electronic trackers or reminders (± feedback) versus controls</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 % Adherence (objective measures) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>555</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>19.86 [14.47, 25.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Reminders/trackers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.29 [9.53, 23.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 With feedback</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>24.98 [17.53, 32.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 % Adherence (all measures) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>762</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>18.41 [11.82, 25.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Reminders/trackers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>361</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.92 [10.82, 23.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 With feedback</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>20.06 [7.27, 32.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Exacerbations requiring OCS (people with at least 1) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3063</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.37, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Asthma control <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 ACQ</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐0.29, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 ACT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>596</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [‐0.20, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Unscheduled visits to a healthcare provider <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 ED</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2918</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.88, 1.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2865</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.53, 1.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Unscheduled visits to a healthcare provider <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 GP/ED visits</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Hospitalisations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Absenteeism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Absenteeism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Quality of life (AQLQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>369</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.20, 0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Electronic trackers or reminders (± feedback) versus controls</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012226-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Simplified versus usual regimens</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 % Adherence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.02 [1.88, 6.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Exacerbations requiring OCS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Asthma control (ACQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Unscheduled visits <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Absence from work/school <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Quality of life (ITG‐ASF % change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 All adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Simplified versus usual regimens</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012226-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">School‐based ICS therapy versus controls</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Unscheduled visits (1 or more hospitalisations for any cause) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.16, 2.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Quality of life (PAQLQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.01, 0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">School‐based ICS therapy versus controls</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012226-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Subgroup analyses for % adherence</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Comparison 1. Children vs adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1693</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.59 [3.72, 19.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.01 [‐4.77, 20.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Adults/adolescents and adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>452</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>14.43 [5.49, 23.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Comparison 2. Complex vs simple interventions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>555</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>19.86 [14.47, 25.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Complex</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>24.98 [17.53, 32.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Simple</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.29 [9.53, 23.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Comparison 2. Children vs adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>555</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>19.86 [14.47, 25.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>17.29 [8.32, 26.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Adults/adolescents and adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>22.84 [16.66, 29.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Subgroup analyses for % adherence</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012226.pub2/references#CD012226-tbl-0013">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012226.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012226-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012226-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012226-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD012226-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD012226-note-0003">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD012226-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012226-note-0018">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012226\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012226\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012226\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012226\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012226\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=FKeXZrqu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012226.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012226.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012226.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012226.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012226.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727224174"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012226.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727224178"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012226.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea6d5e9969365',t:'MTc0MDcyNzIyNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 